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Summary 
 
 
Optimization of lysine production in an industrial relevant lysine producing Corynebacterium 
glutamicum strain was done using a combination of mathematically modelling, metabolic 
engineering and metabolic flux estimation.  
 
A mathematical model of the metabolic network of C. glutamicum based on genomic information, 
and based on the wealth of biochemical information which is available for this organism due to its 
long history as a commercial relevant organism was constructed and validated against earlier 
published data. The model comprising 446 reactions and 411 metabolites was extensively validated 
against earlier published data. The model was used to analyze the metabolic network during lysine 
production, and based on this a number of biochemical hypotheses were suggested to improve 
lysine production in C. glutamicum. The first prediction made by the model was that a high ATP 
production under high lysine production resulted in a limitation in lysine production. This was the 
case at high lysine yield (>55%) and low growth. Secondly, the model predicted a limitation in 
lysine production when the succinylase branch of the lysine synthetic pathway was preferred over 
the dehydrogenase branch. The result was a decrease in maximal theoretical lysine yield from 0.75 
mmol lysine ⋅ (mmol glucose)-1 to 0.57 mmol lysine ⋅ (mmol glucose)-1 due to a relatively higher 
activity of the TCA cycle because of the involvement of the TCA intermediate Succinyl-CoA. The 
higher TCA cycle activity was suboptimal for lysine production because of a loss of carbon due to 
CO2 –production. Thirdly, the model predicted a correlation between a high pentose phosphate 
pathway flux and high lysine production. The fourth prediction made from the analysis of the in 
silico model was that there is a correlation between increasing anaplerotic net flux and increasing 
lysine production.  
 
Various metabolic engineering strategies were tested in a high producing C. glutamicum strain 
Based on the findings in the metabolic network reconstruction and based on results reported in 
literature three parts of the metabolism were selected for metabolic engineering. As predicted by the 
in silico model the pentose phosphate pathway is a target as it may lead to an increase in the 
NADPH formation. The two NADPH generating enzymes glucose-6-phosphate dehydrogenase 
(zwf) and 6-phosphogluconate dehydrogenase (gnd) were up-regulated, and both modifications were 
seen to have a positive effect on lysine yield of 5% and 6%, respectively, indicating that NADPH 
was in fact limiting under high lysine producing conditions. The enzyme pyruvate carboxylase was 
also selected for up-regulations to increase the anaplerotic net flux, which is believed to be 
beneficial for lysine production based on findings in literature and predictions by the in silico 
model. This modification resulted in a decrease in lysine production and did not fit the initial 
expectations. Five enzymes in the lysine synthetic pathway were selected for up-regulation based on 
results found in literature. The enzymes were aspartate kinase (lysC), dihydrodipicolate syntase 
(dapA), succinylaminoketopimelate transaminase (dapC), diaminopimelate epimerase (dapF) and 
lysine permerase (lysE). Only the strain with an up-regulated aspartate kinase activity showed a 
significant effect on the overall lysine yield, and this effect was negative. In this study it was seen 
that although metabolic engineering strategies had earlier shown to be beneficial for lysine 
production in C. glutamicum strains, many of these strategies could not be transferred directly to a 
high producing industrial strain. 
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Finally, estimations of in vivo fluxes under growth and lysine production in complex medium and 
during batch and fed-batch fermentation were conducted. For the industrial strain, C. glutamicum 
KK-11, a higher flux through the pentose phosphate pathway was seen compared to earlier 
published data. In addition to flux estimations during balanced growth present in the batch phase of 
the fermentation the method was employed on samples from the fed-batch phase of the 
fermentation. These results were used to identify metabolic changes when the physiological state of 
the cells was changed. The tendencies identified employing this method was an increase in the 
pentose phosphate pathway flux, a decrease in the TCA flux, and an increase in the anaplerotic net 
flux. Another C. glutamicum strain, ATCC 21253, earlier used in flux estimation studies were also 
included in the flux estimation study. This strain was found to have lower pentose phosphate 
pathway flux compared to the industrial strain. And during the change from batch to fed-batch 
fermentation the tendencies were different than what was seen for the industrial strain. The pentose 
phosphate pathway flux was increased as seen for the industrial strain, but the TCA flux was 
increased and the anaplerotic net flux decreased.  
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Dansk Sammenfatning 
 
 
Optimering af lysin produktion i en industriel relevant Corynebacterium glutamicum stamme blev 
udført ved at anvende en kombination af matematisk modellering, ”metabolic engineering” og 
estimering af intracellulære metaboliske fluxe. 
 
En matematisk model af det metaboliske netværk i C. glutamicum blev lavet baseret på tilgængelige 
information fra genomet for denne organisme, samt ved at anvende den imponerende mængde af 
tilgængelig biologisk og biokemisk information. Modellen blev valideret mod tidligere publicerede 
data. Modellen består af 446 reaktioner samt 411 metabolitter. Modellen blev anvendt til at 
analysere det metaboliske netværk for C. glutamicum under forskellige vækst- og lysin 
producerende betingelser, og baseret på dette blev en række biologiske hypoteser til at øge 
lysindannelsen i denne organisme foreslået. Den første hypotese gik ud på at der under stor 
lysinproduktion og lav vækst blev dannet et overskud af ATP, og at dette overskud fører til en 
reduktion i lysinproduktionen. Modellen forudså at dette var et problem når lysinudbyttet er over 
55%. Den anden forudsigelse lavet ved brug af modellen var at der er en begrænsning i 
lysinsyntese-vejen når succinylase-vejen blev foretrukket frem for dehydrogenase-vejen. Resultatet 
var ifølge modellen at det teoretiske maksimale udbytte faldt fra 75% til 57% på grund af en højere 
aktivitet af TCA cyklus for at producere succinyl-CoA, som indgår som led i lysindannelsen når 
syccinyl-vejen bliver brugt. En højere TCA cyklus aktivitet er suboptimal for lysinsyntese fordi der 
mistes kulstof til CO2 –produktion. Modellen forudså desuden en sammenhæng mellem en højere 
flux gennem pentose fosfat-vejen og en højere lysinproduktion. Dette var ifølge modellen også 
tilfældet for et højre anaplerotisk netfluks.  
 
Forskellige ”metabolic engineering” strategier til forøgelse af lysin udbyttet i en højt producerende 
C. glutamicum stamme blev testet. Baseret til dels på simulerings resultater fra den metaboliske 
matematiske model og resultater fra den videnskabelige litteratur tre dele af metabolismen blev 
udvalgt til metabolic engineering. Den matematiske model forudså at en forøget flux gennem 
pentose fosfat-vejen ville øge lysineudbyttet, angiveligt fordi NADPH vil blive begrænsende ved 
høje lysinudbytter. De to NADPH genererende enzymer glucose-6-phosphate dehydrogenase (zwf) 
of 6-phosphogluconate dehydrogenase (gnd) blev udvalgt til opregulering. Begge modifikationer 
gav et positivt resultat med henholdsvis 5% og 6% bedre udbytter, hvilket indikerede at NADPH 
var begrænsende for lysinproduktionen i denne stamme. Enzymet pyruvate decarboxylase (pyc) 
blev ligeledes udvalgt til opregulering fordi en øget anaplerotic netflux har vist sig at være 
korreleret med øget lysinproduktion, både baseret på resultater fra litteraturen og den matematiske 
models forudsigelser. Resultaterne var dog ikke som forventet, idet effekten var negativ. Fem 
reaktioner i lysinsyntese-vejen blev overudtrykt. Disse blev valgt baseret på tidligere resultater 
rapporteret i litteraturen. De fem reaktioner var aspartate kinase (lysC), dihydrodipicolate syntase 
(dapA), succinylaminoketopimelate transaminase (dapC), diaminopimelate epimerase (dapF) og 
lysine permerase (lysE). Kun stammen med en overudtrykt aspartate kinase viste en effekt, og 
denne effekt var negativ på lysinudbyttet. I dette studie blev det set at selvom nogle ”metabolic 
engineering” strategier har vist sig at have positiv effekt i nogle stammer kan dette ikke altid 
overføres direkte til en industriel stamme.  
 
Estimering af in vivo fluxe under vækst og lysinproduktion i komplekst medium og under både 
batch og fed-batch fermentering blev udført. For den industrielle stamme, C. glutamicum KK-11, 
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blev der set en betydeligt højere flux gennem pentose phosphat-vejen end der normalt ses for C. 
glutamicum stammer. Foruden flux estimering under balanceret vækst der ses under den 
eksponentielle vækstfase, blev der ligeledes lavet flux estimering for prøver udtaget under fed-batch 
fasen. Disse resultater blev brugt til at identificere flux ændringer som følge af den fysiologiske 
ændring der skete i cellerne som et resultat af at kulturen gik fra batch til fed-batch fermentering. 
Resultaterne viste at fluxen gennem pentose fosfat-vejen blev forøget, mens fluxen gennem TCA 
cyklus gik ned og den anaplerotiske netflux gik op. En anden C. glutamicum stamme, ATCC 21253, 
blev ligeledes analyseret med denne metode. Denne stamme, der producerer lysin, men i mindre 
grad end den industrielle stamme, viste andre tendenser end den industrielle stamme. Fluxen 
gennem pentose fosfat-vejen gik op i fed-batch fasen, som det var tilfældet for den indusrielle 
stamme, mens TCA cyklus fluxen gik op og den anaplerotiske net flux gik ned hvilket var modsat 
hvad der var set for den industrielle stamme.  
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Chapter 1 
1. Introduction 
 
 
 
Bacteria belonging to the genus Corynebacterium are due to their ability to produce and secrete a 
number of industrially important amino acids and nucleotides used in industrial production 
processes, in particular for large scale production of the amino acids glutamate and lysine.  
 
Lysine is produced in an aerobic fermentation process using the bacterium Corynebacterium 
glutamicum or Escherichia coli. Lysine is an essential amino acid for animals, and since the content 
of lysine often is suboptimal in corn, barley and wheat, the feedstuffs traditionally used as the major 
ingredients for animal feed, this amino acid often becomes limiting for feed efficiency. 
Supplementing lysine in concentrations between 0.5% and 1% to the feed leads to an optimized 
protein utilization of the feed which improves the growth of especially pigs and poultry with up to 
20%. In addition to the economical benefit from the increased productivity, less nitrogen is released 
to the environment, which is an issue that has received a lot of attention in recent years.  
 
As lysine-production costs have been lowered due to a continuous optimization of the process, the 
lysine price has followed this development and the demand has increased leading to an annual 
production of 1,100,000 tones lysine,HCl annually (Feedinfo.com). Since the demand for white 
meat from pigs and poultry is increasing in a combination with environmental issues, a further 
increase in lysine demand of about 8% per year is expected (Feedinfo.com). In spite of increased 
lysine demands worldwide, further development of the lysine production process, including strain 
development is essential to be competitive in the lysine production-business.              
 
A biotechnological production process like lysine production with C. glutamicum, employ self 
reproducing living organisms, which serves as living cell factories for the conversion of chemicals 
involving a complex network of enzymes, substrates and products inside and outside the cell. The 
development and optimization of production strains by random mutagenesis followed by extensive 
screening programs to find and isolate superior mutants have been shown to be a successful 
strategy. However, with the rapid development of methods for metabolic engineering this has 
opened new possibilities for strain improvements by targeted genetic modifications. Today, 
experimental protocols for almost any genetic manipulation in C. glutamicum are available. The 
challenge is not how to apply the genetic manipulations - but where to apply them. 
 
The major challenge in this respect is that living organisms are complex systems with thousands of 
reactions and multiple variables interacting with each other. Using traditional reductionistic 
approaches focusing on the generation of information about individual cellular components is often 
not enough when such complex networks needs to be analyzed. A more holistic approach needs to 
be applied focusing on the system rather than the individual reactions. 
 
With the developments in genomics there has been an increased focus on the behavior of complete 
biological systems, which has led to the development of systems biology. Biological data from 
different levels of the metabolism, i.e. genome, fluxome, transcriptome, metabolome, proteome and 
interactome are integrated in order to analyze an organism. To cope with the large amount of data 
Chapter 1 
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generated the development of mathematical models describing the biological systems has played a 
major role in systems biology. With the large sequencing-effort that has been conducted recently, 
whole genomes are now made available, including the C. glutamicum genome. This information can 
be used to make mathematical models which can serve as platforms for whole cell models able to 
predict cellular phenotypes. 
Within the field of metabolic engineering the prediction power of mathematical models can be used 
to find and select targets for metabolic engineering strategies.             
 
Corynebacterium – A working horse in amino acid production  
 
The production of amino acids is in terms of quantity the third most important within white 
biotechnology, only surpassed by ethanol- and antibiotics production (Leuchtenberger et al., 2005). 
The two most important amino acids in this respect are L-glutamate and L-lysine with a marked 
value exceeding $1.5 billion annually (Demain and Adrio, 2008), both of which is produced by 
various species of the genera Corynebacterium and Brevibacterium. In addition to lysine and 
glutamate Corynebacterium has also been used as a platform for the production of other amino 
acids such as L-threonine (Shiio, 1990; Kase and Nakayama, 1974; Shiio et al., 1991), L-
methionine (Nakayama et al., 1973; Kase and Nakayama, 1975), L-serine (Eggeling, 2007), L-
histidine (Araki et al., 1974), L-valine (Ruklisha et al., 2007), L-tryptophan (Ikeda, 2006), L-
phenylalanine and L-tyrosine (Ikeda and Katsumata, 1992), L-leucine (Pátek, 2007) and L-
isoleucine (Guillout et al., 2002).  
 
Industrial L-lysine production 
 
The first steps towards industrial production of lysine were done in Japan in the 1950s when Kyowa 
Hakko Co., Ltd., Tokyo started a research program aiming at finding a microorganim able to 
produce glutamate. One of the results from this was the isolation of a microorganism Micrococcus 
glutamicus, later renamed to C. glutamicum, which was able to produce glutamate (Kinoshita et al., 
1957; Udaka, 1960). During the following mutagenesis and screening program lysine producing 
mutants were discovered (Kinoshita et al., 1958), and the foundation for lysine production was 
made. Within a few years the first large scale lysine production facility was in use. 
Since then lysine fermentation processes have been developed for the very large scale as the 
demand for a cost effective production has increased as product-prices have decreased. Today 
lysine production involves fermentation in very large fermentation tanks, often exceeding hundreds 
of cubic meters, which makes it challenging to obtain homogeneity in the fermenter and to maintain 
sufficient mass-transfer rates. Normally traditional stirred-tank reactors are used since they allow 
for a high specific power intake, which makes it possible to obtain high oxygen transfer rates (Kelle 
et al., 2005). The fermentation process consists of multiple steps with several propagation steps to 
obtain sufficient biomass for the main fermentation process. The number of propagation steps can 
vary, but usually 1:10 steps between each propagation step is applied (Hermann, 2003). To optimize 
lysine yield and productivity the process is normally run as a fed-batch or repeated fed-batch 
process. Attempts have been made to develop a continuous  process (Hirao et al., 1989). However, 
due to numerous practical aspects such as sterility and strain stability in industrial scale, continuous 
production is generally not applied (Kelle et al., 2005).  
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Figure 1.1: Lysine biosynthetic pathway in Corynebacterium glutamicum, including gene-names (grey letters) and 
patent and patent applications (red numbers) claming an improved lysine production through modification of the lysine 
biosynthetic pathway in C. glutamicum. The information on patents and the companies behind the patents (1: Archer 
Daniels Midland, 2: Ajinomoto, 3: BASF, 4: Degussa (now Evonik); 5: Kyowa Hakko Kogyo) was taken from Kelle et 
al. (2005). 
Chapter 1 
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The lysine synthetic pathway in C. glutamicum 
 
An overview of the lysine synthetic pathway in C. glutamicum can be seen in figure 1.1. Lysine is 
produced in seven or ten steps from its precursor oxaloacetate, depending on which route is used. 
The first step in the lysine synthetic pathway is the conversion of oxaloacetate to aspartate by 
adding an amino-group from glutamate, catalyzed by the aspB-gene-product. Aspartate is 
phosphorylated to L-4-aspartyl phosphate by the reaction catalyzed by the lysC-gene-product, 
which is further converted to L-aspartate 4-semialdehyde via asd. L-4-aspartyl phosphate is further 
converted to dehydrodipicolinate by dapA. In the next step L-piperidine 2,6-dicarboxylate is made 
by dapB. At the level of L-piperidine 2,6-dicarboxylate there are two possibilities for the conversion 
to meso-2,6-diaminopimelate, the last step before lysine. Either the direct reaction adding the 
second amino-group in one single step is used (ddh), known as the dehydrogenase variant, or four 
successive reactions, named the succinyl variant, is used. The succinylase variant involves the 
dapD-, dapC-, dapE- and dapF-gene-products, and using this variant the TCA intermediate 
succinyl-Coa is involved. The final step is the decarboxylation of meso-2,6-diaminopimelate to 
lysine (lysA), which finally is exported out of the cell by lysine permerase (lysE). 
 
Due to the commercial importance of lysine production in C. glutamicum, the lysine synthetic 
pathway has received a lot of attention, which has led to an impressive list of patents and patent 
applications (Figure 1.1).    
 
Maximal lysine yield for C. glutamicum 
 
The calculation of the maximal theoretical lysine yield on substrate for C. glutamicum is interesting 
because it gives an estimate for the existing potential for a given strain. Earlier stoichiometric 
calculations found that the maximum lysine yield on glucose was 0.75 mol ⋅ mol-1 for this organism 
when no biomass was produced (Stephanopoulos and Vallino, 1991). Recently a maximum yield of  
0.82 mol ⋅ mol-1 was proposed (Wittmann and Becker, 2007). In this calculation the action of a 
cycle between three enzymes: pyruvate carboxylase (EC 6.4.1.1), malate dehydrogenase (EC 
1.1.1.37) and malic enzyme (EC 1.1.1.40) formed a transhydrogenase-like reaction contributing 
significant to the NADPH supply. However, based on biochemical information the operation of 
such a cycle can be discussed (Petersen et al., 2000). For both yield calculations no activity of the 
TCA cycle was included and the dehydrogenase variant (ddh) of the lysine synthesis pathway was 
exclusively used. This would in practice not be the case during the fermentation process of lysine, 
and in addition to that biomass needs to be produced, why a discussion of theoretical possible yields 
is rather useless without considering the context of the whole metabolism of the organism, 
including reactions involved in biomass formation. This type of calculations needs a more complex 
network of reactions, information and estimations. This will give more reliable information about 
the maximum achievable yield, and in addition to this it can provide information about reactions 
and flux-distributions during optimal lysine production. The maximum yields for the production 
strains used today are not public due to competitive issues. However, yields up to 55% have been 
reported in literature (Shiio et al., 1987), and it can be expected that the intensive effort that have 
been made recent years have increased this even further. 
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Figure 1.2: Metabolic flux distribution in Corynebacterium glutamicum with maximal theoretical lysine yield on 
glucose. All fluxes are given as relative molar fluxes to the glucose uptake in mol ⋅ (mol)-1 × 100. Upper values: 
Stephanopoulos and Vallino (1991); lower values: Wittmann and Becker (2007). Abbreviations:  GLCex: 
extracellular glucose; G6P: glucose-6-phosphate; F6P: fructose-6-phosphate; P5P: pentose-5-phosphate; E4P: 
erythose-4-phosphate; S7P: sedoheptulose-7-phosphate; G3P: glyceraldehyde phosphate; PEP: 
phosphoenolpyruvate; PYR: pyruvate; Ac-CoA: acetyl CoA; ICIT: isocitrate; AKG: α-ketogluterate; SUCC: 
succinate; OA: oxaloacetate; PIPER26DC: L-piperidine 2,6-dicarboxylate; MDAPIM: meso-2,6-
diaminopimelate.     
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Production strain development 
 
Lysine producing strains of C. glutamicum have continuously been improved since the development 
of the first large scale process for the production of this compound. Classical mutagenesis followed 
by screening has been proven very successful in this respect, and recently more rational approaches 
using recombinant DNA technologies, in some cases in combination with systems biology, have 
been applied with success. This later part later will be reviewed more in detail in chapter 2.      
 
Outline and background for PhD thesis 
 
This thesis is based on work performed during an industrial PhD project. The project has been 
carried out in a collaboration between the lysine producer Agro&Ferm A/S and Center for 
Microbial Biotechnology (CMB), BioSys, DTU. The aim of the project was to improve lysine 
production in a C. glutamicum production strain. 
 
This thesis is divided into chapters where the first chapters introduce the subject and methods used 
and the following describes the work performed during this PhD study.  
 
Chapter 1 gives an introduction to the thesis, and gives and introduction to C. glutamicum and 
commercial lysine production. Chapter 2 introduces the methods used in this work. Flux balance 
analysis, genome scale modeling, flux analysis and metabolic engineering in C. glutamicum are 
presented. Chapter 3 is a review on the biochemistry of C. glutamicum, and this chapter is making 
the basis for the reconstruction of the metabolic network of C. glutamicum presented in chapter 4. 
 
The chapters 4-6 are manuscripts presenting the scientific work of this thesis. Chapter 4 (manuscript 
A) presents the reconstruction and validation of the C. glutamicum metabolic network. Chapter 5 
(Manuscript B) presents a comparison of several different metabolic engineering strategies 
implemented in a C. glutamicum production strain for improving lysine production and evaluation 
of the different strategies applied. In chapter 6 (Manuscript C) flux analysis in complex media on 
two C. glutamicum production strains is presented. 
 
Finally chapter 7 summarizes the work and comments on future perspectives for improving lysine 
production in C. glutamicum.              
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Chapter 2 
2. Flux balance analysis and metabolic engineering  
 
 
Biological systems are complex, and knowledge about pathways, regulation and metabolic 
capability of the system is essential in order to design efficient cell factories. It is often necessary to 
analyze the system as a whole. This may be approached by using mathematical modeling as a tool. 
By modeling the metabolic network using information available about the whole biological system 
as a context, it is possible to design an improved metabolic network, i.e. by suggesting changes in 
the genotype (Covert et al., 2001b; Palsson, 2000). Recent developments in genome sequencing and 
annotation, and an increasing amount of biological information in public databases have made 
reconstruction of metabolic networks relatively straightforward (Price et al., 2003; Åkesson et al., 
2004).   
 
Stoichiometri and structure of biochemical reaction networks 
 
The interconnectivity of metabolites in a network of biological reactions is given by reaction 
equations, defining the stoichiometric conversion of substrates into products for each reaction 
 
 
Figure 2.1: Mass balance around the metabolite i in a metabolic system. Xi: the concentration of metabolite i; 
vgenerate: flux towards the generation of the metabolite i; vdegenerate: flux of metabolite i degenerated; vuse: flux of the 
metabolite i used for metabolic requirements (growth and maintenance); vin: flux of the metabolite i into the 
system; vout: flux of the metabolite i out of the system. 
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(Schilling et al., 1999). Reactions are enzymatic reactions converting a substrate into a product, or 
transport reactions moving metabolites between different parts of the system, intracellular, 
extracellular or between different compartments. The result of active reactions in the biological 
system is fluxes serving to dissipate or generate metabolites. Following the law of conservation of 
mass, a balance describing the reaction rate of a particular metabolite through a particular reaction 
can be written:  
(eq. 2.1) metmetmet Xrdt
dX μ−=  
  
where the difference between the rate of production and consumption of a particular metabolite is 
equivalent to the changes in concentration of that particular metabolite over time. In eq. (2.1) Xmet is 
the concentration vector for the intracellular metabolite, and rmet is a vector containing the net rates 
of formation of the intracellular metabolite for each single reaction of the network. The last term on 
the right hand side accounts for dilution due to biomass growth. In figure 2.1 equation (2.1) is 
illustrated showing the mass balance around the metabolite i in a metabolic system. The consuming 
fluxes of metabolite i is divided into the flux towards metabolic requirements (Vuse), the flux 
towards export from the cell (Vout), and the flux towards the degeneration reactions (Vdegeneration). 
Two fluxes are serving to increase the concentration of Xi:  import from outside the cell (Vin) and 
reactions serving to generate the metabolite (Vgenerate). At steady state the concentrations of all 
metabolites are constant, and the reaction rate of the specific fluxes generating a metabolite must be 
equivalent to the reaction rate of the fluxes that consumes the metabolite. Since time constants 
associated with growth are much larger than those associated with kinetic reactions, it is reasonable 
to place the metabolic system in a pseudo-steady state (Stephanopoulos et al., 1998), which allow 
us to neglect metabolite accumulation leading to:  
 
(eq. 2.2) metmet Xr μ−=0      
 
Because metabolite concentrations generally are low compared to netflux rates of metabolites the 
last term, corresponding to the dilution due to growth, can generally be neglected (Stephanopoulos 
et al., 1998). In this case it is possible to reduce the system to a homogeneous linear equation, 
which in matrix notation is written as:  
 
(eq. 2.3) vSrmet ⋅==0  
 
The stoichiometric matrix S is an m x n matrix where m is the number of metabolites and n is the 
number of reactions or fluxes taking place within the metabolic network. The vector v refers to the 
reaction rate of each individual reaction or flux in the metabolic network. Metabolic models usually 
also include constraints, which will lead to the definition of a solution space in which the solution to 
the network equation must lie (Price et al., 2003). Constraints in a model are dealt with by 
introducing constraint equations to the metabolic network, which can assign a direction of a given 
reaction (reversibility or irreversibility) according to known thermodynamic constraints. These 
equations are typically of the form αi ≤ vi ≤ βi, where αi and βi are the feasible lower and upper 
limit of the reaction rate vi, respectively. In practice the upper and lower limits are set to arbitrarily 
high values when a reaction is reversible without any regulation, whereas αi  is set to zero when a 
reaction is irreversible. Constrain reactions can also be used to set a maximum flux through a given 
reaction based on biochemical information.  
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Flux balance analysis 
 
The above described equation system is usually underdetermined due to the fact that the number of 
unknown fluxes exceeds the number of metabolites in the network, leading to a number of possible 
solutions, and hence, no unique solution (Bonarius et al., 1997) (Figure 2.2A). By the introduction 
of constraints to the network, leading to the definition of a solution space in which the solution to 
the network equation must lie (Price et al., 2003) this problem can be handled. To cope with this, 
linear programming optimization can be used to maximize (or minimize) for a certain metabolite 
objective (e.g. growth or product formation), and seeking its maximal (or minimal) value within the 
stoichiometrically defined domain. This procedure is often referred to as flux balance analysis 
(FBA) (Palsson, 2006). FBA is based on fundamental physiochemical constraints on metabolic 
networks, and it only requires information about stoichiometri of metabolic pathways and the 
metabolic demands. Furthermore, it is possible to include additional information about the 
metabolic network when it is available. FBA can be used to investigate the capabilities of a 
reconstructed biological network only based on systematic mass balances of the network, and some 
biological constraints based on knowledge about the biological system. In this way some limits are 
defined for the metabolic behavior of the biological system, and within these limits “optimal” 
steady-state solutions can be found using linear optimization techniques (Covert et al., 2001b). This 
limitation is often referred to as a “solution space” in literature. Setting individual fluxes it is 
possible to constrain the magnitude and direction of a particular reaction, hence limiting the number 
of feasible reactions. These equality and inequality constraints define the closed solution space 
(Covert et al., 2001b). FBA uses linear programming optimization techniques to determine the 
optimal flux distribution within a network by minimizing or maximizing a particular objective 
function. The suggested optimization problem can then be solved using linear programming 
(Bertsimas and Tsitsiklis, 1997). A presentation of a defined solution space and a particular solution 
(optimal) is presented in figure 2.2. FBA have successfully been used for prediction of outcomes of 
gene-knockout experiments (Edwards and Palsson, 2000), prediction of phenotypic behavior during 
different oxygen availabilities (Varma et al., 1993b), obtaining quantitative genotype-phenotype 
 
 
Figure 2.2: Constrain based analysis of metabolic networks. (A): An unbounded space where every possible flux 
distribution for every reaction is possible. This often makes the linear problem infeasible. (B): Presentation of 
the defined solution space which has been defined by applying constraints such as system stoichiometri, 
thermodynamics (reversibility of reactions) and maximum capacity of the system. Within this defined solution 
space the optimal steady-state solution to the flux vector is found.   
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relationship (Edwards et al., 2001) and predicting gene targets for enhancing production of 
biological compounds (Burgard et al., 2003). FBA can also be used to predict maximal growth rates 
or maximal production of a given metabolite in terms of yield on substrate.        
 
Applications of flux balance analysis 
 
FBA have been widely applied as a tool in analyzing the metabolic capabilities of metabolic 
networks – in particular for organisms relevant for industrial production of biochemicals. Some of 
the work reported so far in this respect has been the evaluation of metabolic networks for the 
production of anaerobic fermentation products (Papoutsakis, 1984; Papoutsakis and Meyer, 1985); 
the metabolic capabilities of Escherichia coli (Varma et al., 1993a; Förberg et al., 1988); the 
metabolic network of C. glutamicum for the potential and limitations in amino acid production 
(Hollander, 1994; Vallino and Stephanopoulos, 1993; Vallino and Stephanopoulos, 1994a; Vallino 
and Stephanopoulos, 1994b); and the metabolic capacity of Bacillus subtilis for the production of 
purine nucleotides, riboflavin, and folic acid (Sauer et al., 1998).   
 
Recently the availability of annotated genome sequences has enabled the reconstruction of genome-
scale metabolic networks (Covert et al., 2001a). Genomes of a large number of organisms have up 
till today been sequenced and annotated, and more will come within the neatest future. To date 
(April, 2008) 619 bacterial and 82 eukaryote genomes have been completed and 1753 bacterial and 
914 eukaryotic genome projects are ongoing (www.genomesonline.org). In addition most of this 
sequence data is made available in public databases making it relatively straightforward to extract 
genome information from many organisms. This information can be used to make stoichiometric 
models of biological networks. Genome-scale metabolic models have already been constructed for a 
number of micro-organisms such as Saccharomyces cerevisiae (Förster et al., 2003), Escherichia 
coli (Reed et al., 2003), Lactococcus lactis (Oliviera et al., 2005), Staphylococcus aurerus 
(Heinemann et al., 2005), Streptomyces coelicolor (Borodina et al., 2005), Helicobacter pylori 
(Schilling et al., 2002), Haemophilus influenzae (Schilling and Palsson, 2000), Methanosarcina 
barkeri (Feist et al., 2006) and Lactobacillus plantarum (Teusink et al., 2006).  
 
To improve the prediction power of the FBA models the stoichiometric genome-scale model can be 
combined with additional biological knowledge. This can be accomplished by incorporation of data 
from high-throughput techniques such as transcriptomics (Covert et al., 2004; Åkesson et al., 2004) 
or fluxomics (Herrgård et al., 2006), and combining this with the constrain-based method (Price et 
al., 2003). It is also possible to incorporate regulatory constraints, representing temporary flux 
constraints mediated by specific environmental conditions, rather than physiochemical constraints. 
This approach has been applied by Covert and co-workers (Covert et al., 2001b). Covert et al. 
(2001b) introduced transcriptional regulatory events as time-dependent constrains, which led to an 
additional constraining of the metabolic network, and consequently made it possible to predict 
dynamic flux profiles for microbial growth. Using the same methods the steady-state solution space 
of a FBA model could be reduced (Covert and Palsson, 2003). Recent results on integration of gene 
expression data into a S. cerevisiae genome-scale model showed a significant improvement in 
prediction power during batch fermentations (Åkesson et al., 2004), leading to the conclusion that 
this approach looks promising for improving FBA models. However, it needs to be emphasized that 
this approach also has some disadvantages as discussed by Åkesson et al. (2004), i.e. the fact that 
gene expression and metabolic fluxes does not always correlate (Yang et al., 2002). 
Flux balance analysis and metabolic engineering  
________________________________________________________________________________ 
 
25 
The incorporation of experimentally determined flux values into FBA models has also been applied 
for improving the prediction power of the models. Herrgård et al. (2006) used this approach, and 
was able to improve the performance of an E. coli FBA model.                             
 
The considerable interest in the redirection of metabolic fluxes to improve or develop production 
strains for industrial production of biochemicals, has led to the development of metabolic 
engineering (Bailey, 1991). Today, experimental protocols for almost any genetic manipulation in a 
wide variety of industrial relevant organisms are available. The challenge is therefore not how to 
apply genetic manipulations - but where to apply them. Besides from a convenient overview of the 
organism and its capabilities, stoichiometric models in a combination with FBA can be used in this 
respect. The prediction of phenotypic behavior during different environmental and genetic 
conditions has been presented (Edwards and Palsson, 2000; Edwards et al., 2001; Oliviera et al., 
2005), and this can directly be used to test biological hypotheses (Patil et al., 2004), and 
consequently predict metabolic engineering strategies as in the case of improving bioethanol-
production in S. cerevisiae (Bro et al., 2006).            
    
Reconstruction of the metabolic network  
 
The first step of the reconstruction of a metabolic network is in principle, to make a list of reactions 
present in the organism. This is done by gathering information about the organism from the 
sequenced genome, relevant literature from biochemical textbooks and scientific papers, and finally 
by searching reaction databases (Figure 2.3). The backbone in reconstruction of a metabolic 
network is the annotated genome. Normally, the reconstruction of a given metabolic network begins 
with a thorough examination of the genome(Covert et al., 2001a). The first step in this examination 
is the annotation where all open reading frames (ORFs) are identified from the sequence of the 
genome, and these ORFs are searched against databases using special designed algorithms for 
comparing DNA-sequences as i.e. BLAST (McGinnis and Madden, 2004) or FASTA (Shpaer et al., 
1996). Using these databases one is able to extract and utilize information about already identified 
ORFs from other organisms. Based on this search and comparison, the function and presence of a 
large number of ORFs can be identified. Depending on which organism is object to the construction 
there is a number of options for helpful internet-resources, which can be used. Some organisms 
have organism-specific databases (i.e. E. coli and yeast) whereas others are included in more 
general databases, like KEGG (Kanehisa et al., 2006) or BioCyc (Karp et al., 2005). Finally, there 
are some general databases like MetaCyc (Caspi et al., 2006) making an overview over all 
biological pathways, which can be used to find “missing links” in the biological network. From 
these databases valuable information can be found about an organism, and user friendly interfaces 
have made it relatively straightforward to get a quick overview. To complement the database 
resources, available literature is used to confirm the individual reactions or the network. 
When all reactions and transport mechanisms have been identified the second step of the 
reconstruction is to make a dynamic mass balance for the metabolites in the metabolic network. The 
mass balance is defined in terms of flux through each reaction and the stoichiometri of that reaction. 
The result is a set of differential equations, which can be simplified to Eq. 2.3 as shown earlier in 
this chapter.   
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The third step is to define the solution space (Figure 2.2) wherein the optimal solution must lie. This 
is done by reviewing literature. Here relevant biochemical books, organism specific books and 
recent papers can be used. Some constraints that are typically used is physiochemical data (i.e. 
reversibility of each individual reaction), or information about the maximum capacity of given 
reactions. Another important part of a metabolic network, which is used for constraining the model, 
is the composition of the macromolecules of the organism. This part of the reconstruction work can 
be quite difficult because it often is necessary to collect information from many different resources, 
and these resources are not always comparable due to different environmental conditions (media, 
substrate, oxygen availability, pH, fermentation strategy etc.). And in some cases it is not possible 
to find quantitative data for some components.    
 
When the metabolic network has been created some validation needs to be done. Either by 
comparing simulations with published experimental data, or by designing and carrying out own 
 
 
Figure 2.3: Construction of the metabolic network. Based on information from the annotated genome, relevant 
literature from biochemical textbooks and scientific papers and metabolic pathway and reaction databases it is 
possible to construct a metabolic network representing the overall set of metabolic reactions occurring in the cell. 
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experiments. From published data and own experimental work some constraints can be set in order 
to fit the metabolic model to the real behavior of the organism, i.e. when pathways or enzymes are 
preferred compared to others or if futile cycles is present in the organism.       
 
Metabolic flux analysis  
 
The identification and quantification of metabolic reactions in an organism is a central element in 
metabolic engineering (Bailey, 1991; Stephanopoulos, 1999). The determination and study of 
metabolic fluxes in vivo has been termed metabolic flux analysis (Stephanopoulos, 1999), and the 
great scientific interest within this field has led to the development of a number of methods, which 
can be applied for metabolic flux analysis. One of the major challenges in flux analysis is the fact 
that the total number of fluxes exceeds the number of fluxes that can be measured. In some cases 
for small metabolic models it is, however, possible to measure sufficient fluxes to estimate all the 
other fluxes, and among measurable fluxes are typically the glucose uptake rate or product 
formation (Christensen and Nielsen, 1999b). This approach is often referred to as metabolite 
balancing. From a given bioreaction network stoichiometri, intracellular fluxes are reconstructed so 
as to satisfy the measured rates of extracellular metabolite accumulation or depletion 
(Stephanopoulos, 1999). No reaction kinetics needs to be taken into account, and the metabolic 
fluxes can be estimated using linear algebraic equations. Some examples where this approach has 
been applied for the estimation of fluxes is in C. glutamicum during growth and lysine production 
(Vallino and Stephanopoulos, 1993; Vallino and Stephanopoulos, 1994a; Vallino and 
Stephanopoulos, 1994b), in Penicillum chrysogenum for antibiotic production (Jørgenen et al., 
1995), and in the industrial important yeast S. cerevisiae (Nissen et al., 1997). However, if the 
biological network contains more than one pathway leading to the same metabolite, this method can 
not be applied to discriminate between the different pathways. Using isotopic labeled substrates (i.e. 
13C-labelled glucose) this challenge can be handled (Christensen and Nielsen, 1999a). This 
methodology named isotopic balancing utilizes the asymmetry which often is present at splits 
between different pathways leading to the same end-product. When substrates labeled with i.e. 13C 
at specific carbon locations is used, the ratio between the labeling states of metabolites can be used 
to determine the flux of the competing pathways (Stephanopoulos et al., 1998). The number of 
different labeling states depends on the number of C-atoms present in the given metabolite. A 
metabolite with n carbon-atoms has 2n possible labeling states. As an example a C-3 molecule 
would have eight different labeling states (Table 2.1). The different combinations of labeling states 
are called isotope isomers or isotopomers. 
 
Metabolite balancing is limited to the estimation of absolute fluxes, i.e. the absolute carbon entering 
a metabolite pool also has to leave the pool, whereas isotope balancing enables estimation of 
relative fluxes. Combining the two methods it is possible to estimate all fluxes within the system 
(Christensen and Nielsen, 1999b), as it have been illustrated in studies of C. glutamicum (Marx et 
al., 1996) and P. chrysogenum (Christensen and Nielsen, 2000).   
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13C-labelling experiments 
 
Since the primary metabolism in many cases is able to generate all precursors needed for 
biochemical reactions within the microbial cell, the use of 13C-labelling substrate for flux analysis 
in such systems has been widely applied. In particular 13C-glucose has been used intensively 
because it through catabolic reactions is incorporated into all cellular compounds. The labeling 
patterns of the compounds synthesized by the organism are governed by the labeling pattern of the 
precursor, which is governed by the labeling pattern of the substrate etc. These labeling patterns can 
be used to elucidate the flux distribution in the cell as described in Christensen and Nielsen (1999a). 
Due to practical reasons not all compounds are suitable for labeling analysis. Amino acids from the 
hydrolyzed protein fraction of the cell are often preferred in this respect (Christensen and Nielsen, 
1999a), mainly because these compounds are present in high quantities in cell extracts and biomass 
hydrolysates, and because the flux through the pool of amino acids is low compared to the total 
amino acid pool, which makes sampling procedures and the following measurements less difficult. 
Those characteristics are in contrast to those of the precursors present in the central metabolites 
where concentrations are small compared to the flux, making sampling and analysis much more 
challenging. Knowing the precursor-amino acid relationship, it is possible to deduce the labeling 
pattern of the precursors from the central metabolism from the labeling pattern of the amino acids 
(Christensen and Nielsen, 1999a), and hence predict the metabolic flux distributions. 
 
Table 2.1: The different isotopomers of a C3 molecule. Shaded circles are 13C and white circles are 12C. 
Isotopic composition 
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Reciprocal labeling 
 
As mentioned above labeling experiments based on specific labeled substrates are very powerful for 
elucidating and analyzing flux distributions of biological networks. However, an important feature 
that can not be addressed by the methods mentioned above is the uptake and conversion of other 
carbon sources than the labeled substrate. In some experiments it may be necessary to add 
unlabelled co-substrates to the medium, i.e. if the behavior of an organism in complex media needs 
to be studied, or if the strain has certain auxotrophies. And if one wants to study the uptake, 
degradation and conversion of these compounds, alternative methods need to be applied. Reciprocal 
labeling can be used for this purpose as discussed by Christensen (2001). The idea in reciprocal 
labeling is that instead of using labeled substrate with only one 13C (i.e. [1-13C]glucose), substrate 
labeled in all positions is used (i.e. [U-13C6]glucose). A high 13C-background is generated, and this 
way the contribution from the non-labeled substrate can be elucidated from the 12C-labeling, hence 
making it possible to determine the role of the non-labeled co-substrate (Christensen, 2001).              
         
Current status for metabolic engineering activities in C. glutamicum 
 
Since the development and prevalence of metabolic engineering for improving product yields and 
productivity, C. glutamicum has undergone a large number of metabolic engineering strategies, of 
which the major milestones will be reviewed here. The metabolic engineering efforts have been 
focusing on various parts of the metabolism, of which the more important can be overviewed in 
figure 2.3.   
 
Metabolic engineering of reactions within the lysine pathway 
 
The lysine synthetic pathway of C. glutamicum has been the main focus of many metabolic 
engineering strategies presented so far. Many of these studies have focused on optimizing the flux 
through this pathway by altering enzymes or enzyme activities of this pathway. A reaction and gene 
which have received a lot of attention in this respect is the aspartate kinase (lysC) due to its 
importance in the regulation of flux towards lysine-, methionine- and threonine- biosynthesis. In the 
wild type strain this reaction is feed back inhibited by lysine and threonine, making this reaction a 
key step in regulation of the biosynthesis of lysine (Kelle et al., 2005). In most C. glutamicum 
strains overproducing lysine at a production scale the lysC-gene is known to have mutations causing 
feed back resistance. The best described mutations in this respect is T311I (Ohnishi et al., 2002), 
and S301Y and S301F (Lu and Liao, 1997). The effect of the feedback resistant lysC-gene was 
shown in a study where the wild type lysC-gene was replaced by a mutated gene in a wild type 
background leading to lysine accumulation, which was not seen for the wild type strain (Cremer et 
al., 1991; Eggeling et al., 1998). Furthermore, an increase in lysine production was observed when 
the mutated lysC-gene was over-expressed in the lysine producing strain C. glutamicum DG 52-5, 
(Cremer et al., 1991; Eggeling et al., 1998). These results showed the importance of this reaction in 
lysine production. However, no effect was seen when the same strategy was applied in a high level  
lysine producing strain C. glutamicum MH20-22B (Eggeling et al., 1998). A possible explanation 
for this disagreement between the results is that C. glutamicum DG 52-5 is a low-level producer 
whereas C. glutamicum MH20-22B is a high level producer (Eggeling et al., 1998), and it can be 
expected that some of the limitations present in MH20-22B are not present in DG 52-5. 
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Figure 2.4: Overview of important targets for metabolic engineering for optimizing C. glutamicum for lysine 
production. Dashed lines represent multiple reactions. For abbreviations see text.   
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 Another gene in the lysine synthetic pathway which has been identified to be involved in lysine 
productivity is dihydrodipicolinate syntase (dapA). Over-expression of this gene led to production 
of lysine in a wild type strain (Cremer et al., 1991). In addition an increase in lysine production was 
seen when the same strategy was applied on DG 52-5 (Cremer et al., 1991; Eggeling et al., 1998) 
and MH20-22B (Eggeling et al., 1998). In another lysine producer, C. glutamicum ATCC 21253, 
up-regulation of lysC showed positive lysine production whereas dapA showed no effect (Hua et al., 
2000). The simultaneous up-regulation of dapA and lysC resulted in further increase in lysine 
production, compared to the situation where the genes were up-regulated individually (Eggeling et 
al., 1998). 
 
This strategy was not applied in the study of Hua et al. (2000).  In addition to lysC and dapA both 
Eggeling et al. (1998) and Cremer et al. (1991) up-regulated the genes asd (aspartosemialdehyde 
dehydrogenase), dapB (dihydrodipicolinate), ddh (diamonopimelate dehydrogenase), lysA 
(diaminopimelate decarboxylase) without effect, and for ddh a negative effect on lysine 
accumulation was seen in the study of Eggeling et al. (1998).   
 
The succinyl branch of the lysine pathway has also been investigated in order to find bottlenecks. 
Over-expression of dapF or dapC in a lysine producer (C. glutamicum DSM5715) increased lysine 
accumulation (Hartmann et al., 2003), whereas it have been shown that disruption of dapE had no 
effect on lysine production in C. glutamicum ATCC 21253 (Shaw-Reid et al., 1999).  
The efflux of lysine from the cytosol of the bacterium is done by the transport protein lysine 
permerase (LysE)(Bellmann et al., 2001; Vrljic et al., 1996). This exporter is tightly controlled in 
the wild type strain, making this an obvious candidate for optimization of lysine production. Vrljic 
et al. (1996) improved the efflux of lysine in the wild type strain (ATCC 13032) five fold by over-
expressing lysE, identifying this as a key reaction in optimization of lysine producers.       
  
Metabolic engineering of NADPH metabolism 
 
In C. glutamicum the co-factor NADPH has been object to a lot of attention due to its role in lysine 
synthesis where four moles of NADPH is consumed for the synthesis of one molecule of lysine 
(Marx et al., 1997). A detailed insight into the NADPH metabolism has been made through 13C 
metabolic flux analysis, which has been conducted under various physiological conditions (Becker 
et al., 2005; Becker et al., 2007; Dominguez et al., 1998; Kiefer et al., 2004; Marx et al., 1996; 
Marx et al., 1997; Marx et al., 1999; Petersen et al., 2000; Petersen et al., 2001; Sonntag et al., 
1995; Wendisch et al., 2000; Wittmann and Heinzle, 2001; Wittmann and Heinzle, 2002; Wittmann 
et al., 2004). These results have demonstrated that the NADPH supply and consumption are fairly 
flexible (Marx et al., 1997; Marx et al., 1999), and it varies depending on the carbon source used 
(Dominguez et al., 1998; Kiefer et al., 2004; Wendisch et al., 2000; Wittmann et al., 2004), the 
physiological state of the cells (Marx et al., 1997), and the genetic background of the cells including 
introduction of genetic modifications (Becker et al., 2005; Becker et al., 2007; Marx et al., 1999; 
Petersen et al., 2001; Wittmann and Heinzle, 2002). In many cases an apparent NADPH excess 
have been reported (Dominguez et al., 1998; Marx et al., 1996; Sonntag et al., 1995; Wittmann and 
Heinzle, 2001; Wittmann and Heinzle, 2002; Wittmann et al., 2004). The presence of additional not 
yet identified NADPH consuming reactions not included in the models used for estimating the 
metabolic fluxes have been proposed as an explanation for this apparent NADPH excess in the 
metabolic flux analysis experiments (Wittmann et al., 2004). In addition to this it needs to be taken 
into account that when the data mentioned above is extrapolated to industrial lysine producers 
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where lysine yields are significantly higher than what is reported here, it can be expected that 
NADPH is in fact limiting during maximal lysine production.         
 
In C. glutamicum NADPH can be generated by four different reactions: glucose-6-phosphate 
dehydrogenase (zwf); 6-phosphogluconate dehydrogenase (gnd); isocitrate dehydrogenase (icd); and 
malic enzyme (mez). Carbon flux analysis revealed the critical importance of the PPP during lysine 
synthesis (Figure 2.5), why the two NADPH-generating enzymes present within the PPP, zwf and 
gnd, have received a lot of attention. Enzyme studies demonstrated that both enzymes are strongly 
inhibited by NADPH (Moritz et al., 2000), which may explain why no successful studies on over-
expression of the wild type variants of these genes have been reported so far. However, feed-back 
insensitive variants of both the zwf-gene-product (Becker et al., 2007) and the gnd-gene-product 
(Ohnishi et al., 2005) have been identified, and individual over-expression of these gene-products in 
lysine producing C. glutamicum strains have resulted in increased lysine production (Becker et al., 
2007; Ohnishi et al., 2005). Another strategy to increase the flux through the PPP is by removing 
the competing reaction to glucose-6-phosphate, glucose-6-phospoglucose isomerase (pgi), was 
proposed (Dunican et al., 2001) and further studies showed an increased PPP flux and consequently 
an increased lysine yield (Marx et al., 2003). Based on flux analysis studies the deregulation of 
another gene-target , fructose 1,6-bisphosphatase (fdp), was proposed for increasing the PPP flux 
(Kiefer et al., 2004; Wittmann et al., 2004). Over-expression of this gene in a lysine producing C. 
glutamicum strain (wild type background introduced with a lysCT311I mutation) led to an increased 
lysine yield on glucose, fructose and sucrose (Becker et al., 2005). In another study over-expression 
of fdp in a C. glutamicum strain (wild type background introduced with defined mutations (pycP458S, 
homV59A, lysCT311I, zwfA243T)) led to improved lysine yields when glucose and fructose mixtures, or 
sucrose was used as carbon source, while no effect was seen on the modification when glucose or 
fructose was used (Georgi et al., 2005). By metabolic flux analysis Becker et al. (2005) was able to 
identify a 19% increase in the PPP flux in the strain with an over-expressed fdp-reaction indicating 
that the increased lysine yield was in fact due to an increase in NADPH supply.   
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Another NADPH generating reaction, malic enzyme (mez), has been suggested as a target for 
improving lysine production (Dominguez et al., 1998). It was proposed that this reaction together 
with NAD-dependent-malate dehydrogenase (mdh) and pyruvate carboxylase (pyc) was able to 
make a cycling between pyruvate, oxaloacetate and malate, forming NADPH by the use of NADH 
and ATP. Recently, the effect on lysine yield of over-expression mez in a lysine producing C. 
glutamicum was tested (Georgi et al., 2005). No effect on lysine yield were observed when mez was 
over-expressed in a lysine producing C. glutamicum strain (wild type background introduced with 
defined mutations (pycP458S, homV59A, lysCT311I, zwfA243T)) when glucose, fructose, glucose and 
fructose or sucrose was used as substrate, although enzyme activities observed were about three 
fold higher as compared to negative controls (Georgi et al., 2005). The physiological role of mez in 
C. glutamicum is thought to be during growth on gluconeogenic carbon sources such as acetate or 
citrate (Netzer et al., 2004) or lactate (Gourdon et al., 2000). Gourdon et al. (2000) generalized the 
role of mez to be involved in NADPH generation during growth on substrates with low PPP flux. 
With the results from Georgi et al. (2005) in mind and observations from glucose grown cells where 
no detectable flux was seen for mez in a wild type strain (Petersen et al., 2000), it can be concluded 
that this reaction is controlled tightly, and more sophisticated strategies needs to be applied.  
 
The last NADPH generating reaction identified so far in C. glutamicum, isocitrate dehydrogenase 
(icd), was earlier characterized (Eikmanns et al., 1995). This reaction is part of the TCA cycle, and 
based on stoichiometric considerations NADPH generation using this reaction is not as efficient (1 
NADPH per CO2) as when the two reactions in the PPP is used (2 NADPH per CO2). Therefore, icd 
has not been included in metabolic engineering strategies for lysine production so far.   
 
 
Figure 2.5: Lysine yield (mol lysine ⋅ (mol glucose)-1) versus metabolic flux through the pentose phosphate 
pathway (PPP) normalised to total substrate uptake. Studies included are: Wittmann and Heinzle (2001) (closed 
squares); Wittmann and Heinzle (2002) (open squares); Sonntag et al. (1995) (closed triangles); Marx et al. 
(1997) (crosses); Marx et al. (1999) (open diamonds); Becker et al. (2005) (closed diamonds); and Becker et al. 
(2007) (open triangles).      
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An alternative strategy to optimize NADPH metabolism for lysine production was evaluated in a 
study by Marx et al. (1999). The background for this strategy is the fact that two of the four 
NADPH-molecules consumed for the biosynthesis of one molecule of lysine are associated with the 
incorporation of amine to α-ketoglutarate forming glutamate. This reaction is catalyzed by the 
NADPH-dependent glutamate dehydrogenase (gnd) in C. glutamicum. Marx et al. (1999) 
substituted this gene with a gene coding for the NADH-dependent glutamate dehydrogenase, which 
essentially decreased the demand for NADPH for biomass- and lysine-production. However, the 
response of this genetic modification was not increased lysine production. In stead a decrease in 
lysine yield was seen, whereas biomass- and CO2 yields increased significantly. The study of Marx 
et al. (1999) demonstrated that the cells adjust fluxes to the reduced NADPH demand, and in this 
case the potentially available increase in NADPH did not result in increased lysine production.     
 
From the work done so far on NADPH metabolism in C. glutamicum it can be concluded that lysine 
production most likely is limited by NADPH supply when lysine production is high, and the PPP is 
the major pathway for NADPH supply in this organism.         
 
Metabolic engineering of the anaplerotic reactions 
 
In C. glutamicum there are a number of potential reactions involved in the supply of oxaloacetate, 
which is the direct precursor for lysine. 13C-flux analysis has revealed the importance of these 
reactions, since a correlation between lysine yield and the anaplerotic netflux is seen (Figure 2.6). In 
order to increase the anaplerotic flux various strategies have been suggested and tested. The 
carboxylation of phosphoenolpyruvate catalyzed by phosphoenolpyruvate carboxylase (ppc), was 
proposed as a promising target for metabolic engineering based on carbon flux simulations 
(Stephanopoulos and Vallino, 1991; Vallino and Stephanopoulos, 1993). When this gene was over-
expressed or inactivated in the lysine producing C. glutamicum strains MH20-22H, no effect was 
seen on lysine production (Gubler et al., 1994; Peters-Wendisch et al., 1993; Eggeling et al., 1998). 
In another strain, C. glutamicum DG 52-5, a positive effect was observed on over-expressing ppc 
(Cremer et al., 1991; Eggeling et al., 1998).   
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Another oxaloacetate generating reaction which have received attention is the carboxylation of 
pyruvate catalyzed by pyruvate carboxylase (pyc) (Peters-Wendisch et al., 1998). This reaction is 
considered the major anaplerotic reaction in C. glutamicum (Petersen et al., 2000). Over-expression 
of this gene has, as it was the case for ppc, given different results with respect to lysine production. 
In the lysine producing strain C. glutamicum DG 52-5 over-expression resulted in an increase in 
lysine production, whereas inactivation of the pyc-gene resulted in a negative response (Peters-
Wendisch et al., 2001). In another study applying the same strategy in two different strains (C. 
glutamicum ATCC 21253 and ATCC 21799) no significant effect was seen on the final lysine 
production (Koffas et al., 2002). Data from Koffas et al. (2002) indicated the presence of a 
limitation in the lysine pathway somewhere downstream oxaloacetate, and it was suggested that 
simultaneous over-expression of lysC and pyc could increase lysine production. This hypothesis 
was confirmed in a later study where a C. glutamicum ATCC 21253 with over-expressed pyc and 
lysC increased lysine production (Koffas et al., 2003). Recently, the point mutation C1372T in the 
pyc-gene sequence were identified to be beneficial for lysine production (Ohnishi et al., 2002). 
From the results presented above, and the learning from 13C-flux analysis (Figure 2.6) it can be 
concluded that an increased netflux towards oxaloacetate is beneficial for lysine production. An 
alternative to increasing the flux of the carboxylation reactions is decreasing the decarboxylating 
reactions. Two reactions decarboxylating oxaloacetate are present in C. glutamicum, 
phosphoenolpyruvate carboxykinase (pckG) (Riedel et al., 2001) and oxaloacetate decarboxylase 
(odx) (Jetten and Sinskey, 1995). The activity of pckG was found to be counteractive to lysine 
production, since a decrease was seen for a strain with increased activity of the enzyme, and since 
an increase was seen in a strain where pckG was inactivated (Petersen et al., 2001; Riedel et al., 
 
Figure 2.6: Lysine yield (mol lysine ⋅ (mol glucose)-1) versus anaplerotic netflux normalised to total substrate 
uptake. Studies included are: Wittmann and Heinzle (2001) (closed squares); Wittmann and Heinzle (2002) 
(open squares); Sonntag et al. (1995) (closed triangles); Marx et al. (1997) (crosses); Marx et al. (1999) (open 
diamonds); Becker et al. (2005) (closed diamonds); and Beckers et al. (2007) (open triangles).      
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2001). The role for the second decarboxylation reaction, odx, has not yet been thoroughly 
investigated with respect to lysine production. However, based on 13C-flux analysis, the flux from 
oxaloacetate to pyruvate, and therefore also odx activity, is insignificant under normal conditions 
(Petersen et al., 2000; Petersen et al., 2001), why the expected effect of an inactivation would be 
limited or absent. 
 
The last reaction involved in anaplerotic fluxes in C. glutamicum is mez, which have been discussed 
earlier.  
 
Utilization of alternative substrates  
 
The major part of the variable costs in lysine production is the carbon source (Seibold et al., 2006). 
Most work on developing production strains has therefore been focusing on improving product 
yields. However, another strategy which has been persued is designing C. glutamicum strains able 
to utilize cheap raw materials. 
 
C. glutamicum is unable to metabolize lactose and galactose, and is therefore unable to utilize dairy 
based waste-products, such as whey. By inserting the lactose operon (lacYZ) from E. coli containing 
lactose permerase and β-galactosidase a non lysine producing C. glutamicum was able to grow on 
lactose as the only carbon source (Brabetz et al., 1991). However, in the study of Brabetz et al. 
(1991) the galactose part of the disaccharide was not utilised, and an accumulation of this 
compound was observed in the fermentation broth. In a later study galactose accumulation was 
abolished by making a double mutant containing both the lactose operon from Lactobacillus 
delbrueckii susp. bulgarisus and the galactose operon (galMKTE) from a Lactococcus lactis subsp. 
cremoris MG13063 coding for the enzymes responsible for galactose catabolism in this organism 
(aldose-1-epimerase, galactokinase, UDP-glucose-1-P-uridylyltransferase, UDP-galactose-4-
epimerase) (Barret et al., 2004). Barret et al. (2004) used this strategy on a lysine producing C. 
glutamicum strain which was able to produce lysine on a whey based medium. Despite the 
increased catabolic flexibility of the mutants, slower growth rates and strain instability was 
observed. 
 
Another substrate which has received some attention as a potential substrate for lysine production is 
starch. Starch hydrolysates from corn, wheat or cassava are today one of the major substrates for 
lysine production (Seibold et al., 2006). However, for practical and economical reasons it would be 
beneficial if C. glutamicum could directly metabolize soluble starch (Seibold et al., 2006). By 
introducing the amyE gene from Streptomyces griseus into a lysine producing C. glutamicum 
Seibold et al. (2006) was able to construct a mutant excreting α-amylase, and able to grow and 
produce lysine on a starch based medium.  
 
With the recent developments in utilizing lignocellulosic biomass from agricultural waste in 
bioprocesses, a palette of interesting alternative substrates has emerged. These substrates are often 
complex and contain a wide variety of different carbon sources (Aristidou and Penttilä, 2000), many 
of which are not utilizable for C. glutamicum. The composition of lignicellulosic biomass varies 
depending on the biomass source, but in general the carbohydrate fraction typically consists of 40% 
glucose (Aristidou and Penttilä, 2000). However, the pentose fraction is rather significant, the two 
major fractions being xylose (5-20%) and arabinose (1-5%) (Aristidou and Penttilä, 2000). C. 
glutamicum is unable to utilize both pentoses. Introducing two E. coli genes xylA and xylB, a C. 
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glutamicum strain was able to utilize xylose (Kawaguchi et al., 2006). Later, the same strategy was 
used on arabinose, where the E. coli genes araA, araB and araD with success was introduced into a 
C. glutamicum strain making it able to utilize this carbohydrate (Kawaguchi et al., 2008). In both 
cases the strains used were not lysine producing strains why the application for this still needs to be 
proven. 
 
Although the examples mentioned above are very good starting points, further metabolic 
engineering efforts and process optimization needs to be done to enable efficient and sustainable 
production of lysine on alternative substrates.                
        
Systems biology in improving metabolic engineering in C. glutamicum 
 
Systems biology can be used for the elucidations of cell function and physiology through integrated 
use of genomic and physiological data. The use of systems biology for improving metabolic 
engineering strategies is not a new concept and some of the early examples using flux balance 
analysis (FBA) for predicting metabolic engineering strategies have already been mentioned earlier 
in this chapter (Vallino and Stephanopoulos, 1993; Stephanopoulos and Vallino, 1991). With the 
sequencing and annotation of the whole genome of the wild type strain C. glutamicum ATCC 13032 
(Ikeda and Nakagawa, 2003; Kalinowski et al., 2003), the development in systems biology has been 
intensified. Transciptome analysis using DNA microarrays has been developed (Wendisch, 2003) 
and provided valuable insights into gene expression under various conditions in C. glutamicum. 
Also protocols for proteome analysis have been developed (Hermann et al., 2001), and results from 
this have given some insight into C. glutamicum microbiology. However, the method which has 
contributed the most to understanding C. glutamicum metabolism is metabolic flux analysis by 13C 
based methods (Becker et al., 2005; Becker et al., 2007; Dominguez et al., 1998; Kiefer et al., 
2004; Marx et al., 1996; Marx et al., 1997; Marx et al., 1999; Petersen et al., 2000; Petersen et al., 
2001; Sonntag et al., 1995; Wendisch et al., 2000; Wittmann and Heinzle, 2001; Wittmann and 
Heinzle, 2002; Wittmann et al., 2004). Development of methods for parallel integration of high-
throughput genomic and physiological data sets has facilitated the application of a holistic approach 
allowing links between different parts of cell physiology, such as transcriptome and fluxome to be 
elucidated (Krömer et al., 2004). It is expected that such systematic approaches can be used to 
predict metabolic engineering strategies for designing optimized C. glutamicum strains for lysine 
production, as it has been seen for bioethanol production in S. cerevisieae (Bro et al., 2006).   
  
With the developments in C. glutamicum genomics a new methodology has been developed named 
“genome breeding”(Ohnishi et al., 2003; Ohnishi et al., 2002). In this approach a “minimal 
mutation strain” is created by carrying our comparative genomic analysis between a high level 
producing mutant and the wild type strain to identify those mutations beneficial for production of 
the desired bioproduct. Those mutations are then transferred to a wild type background. This way a 
production strain is made without unnecessary and counter-productive mutations normally obtained 
by random mutagenesis. Using this methodology a high producing strain was generated (Ohnishi et 
al., 2002), and one important feature in this new strain was that it was able to grow and produce 
lysine at higher temperatures (40°C) when compared to the production strain (30°C) obtained by 
classical mutagenesis (Ohnishi et al., 2003).       
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Chapter 3 
3. Microbiology and biochemistry of Corynebacterium 
glutamicum 
 
 
In this chapter a short introduction to the microbiology of Corynebacterium glutamicum is given, 
followed by a review of biochemistry of C. glutamicum. The review is used as the basis for the later 
reconstruction of the C. glutamicum metabolic network which is presented in chapter 4. 
Abbreviations used in this chapter are also used for the model reconstruction.    
 
Microbiology of Corynebacterium glutamicum 
 
C. glutamicum is a gram-positive, non-sporulating, non-motile, ellipsoidal bacteria (Abe et al., 
1967). It is aerobic and catalase-positive (Liebl, 2005) and most strains form pale yellow colonies, 
but some cream-white variants are also known to occur (Abe et al., 1967). The type strain 
Corynebacterium glutamicum ATCC 13032 (alternative designations: DSM 20300, IMET 10482, 
and NCIB 10025) was originally isolated from sewage. Other strains have been isolated from soils, 
soils contaminated with bird faeces, sewage and manure (Liebl, 2005). C. glutamicum is able to 
utilize various carbon sources i.e. sugars such as glucose and fructose (Dominguez et al., 1997) and 
sucrose (Dominguez and Lindley, 1996), and organic acids such as acetate (Gerstmeier et al., 
2003), lactate and pyruvate (Cocaign-Bousquet et al., 1993) and gluconate (Lee et al., 1998). In 
addition to this it is able to co-metabolize substrates of which some examples have been reported in 
literature i.e. lactate and acetate, glucose and pyruvate, glucose and lactate (Cocaign-Bousquet et 
al., 1993), and acetate and glucose (Wendisch et al., 2000). Cocaign-Bousquet et al., (1993) found 
simultaneous consumption kinetics during co-metabolism of sugars and organic acids. This lack of 
diauxic growth patterns is quite rarely reported in literature.  
 
C. glutamicum is able to take up and utilize the inorganic nitrogen sources ammonia and ammonium 
(Burkovski, 2003a). In addition to that some organic sources can be used as nitrogen donors i.e. 
urea (Siewe et al., 1998), glutamine (Siewe et al., 1995), glutamate (Kronemeyer et al., 1995) and 
serine (Netzer et al., 2004). It is generally known that other amino acids such as alanine, aspargine, 
and threonine also can be used. The C. glutamicum parent strain is prototrophic for all amino acids 
and vitamins, except for biotin (Liebl, 2005). Some amino acid production strains derived by strain 
improvement programs have obtained some amino acid auxotropies such as threonine, methionine, 
leucine and isoleucine, and in some cases also vitamin auxotrophies such as thiamine and 4-amino 
benzoic acid have been reported (Abe et al., 1967).  
 
C. glutamicum grow well in complex media such as brain heart infusion broth (Difco), LB5G broth 
(0.5% yeast extract, 1% tryptone, 0.5% glucose and 0.5% NaCl; pH 7.2-7.4)) (Vallino and 
Stephanopoulos, 1993); Corynebacterium medium: (1% casein peptone, 0.5% yeast extract, 0.5% 
glucose and 0.5% NaCl; pH 7.2-7.4) (Deutze Sammling von Microorganismen und Zellkulturen 
GmbH (DSMZ)) or similar tryptone, peptone, yeast extract based medium. Also less expensive 
components can be used for complex media preparations such as corn steep liquor (CSL) or 
soybean meal hydrolysate. Those types of complex raw materials are normally used on industry 
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scale fermentations. Defined media have also been developed for this organism (Marx et al., 1996; 
Moritz et al., 2000; Petersen et al., 2000; Vallino and Stephanopoulos, 1993). This type of media is 
used in experiments where complex compounds can compromise the results, i.e. in flux analysis.          
 
The C. glutamicum ATCC 13032 parent strain have been reported to grow well at 40°C (Ohnishi et 
al., 2003), whereas optimal temperatures for amino acid producing strains typically have been 
reported between 25 and 37°C (Abe et al., 1967).  Traditionally cultivation temperature for lysine 
fermentations is 30-34°C (Hermann, 2003). Optimum pH is in the range of 7.2-7.4 (DSMZ). C. 
glutamicum has a high demand for oxygen and an efficient oxygen supply is important for efficient 
growth and lysine production.   
 
The Corynebacterium glutamicum genome 
 
The genome of C. glutamicum ATCC 13032 have been sequenced by at least three independent 
research groups of which two are now available via open databases (Ikeda and Nakagawa, 2003; 
Kalinowski et al., 2003). Recently another strain, C. glutamicum R (Inui et al., 2004), was 
sequenced, published and made available in public databases (Yukawa et al., 2007).  In addition to 
this, genome sequence projects have been conducted for closely related organisms such as  
Corynebacterium efficiens YS-314 (Nishio et al., 2003), Corynebacterium jeikeium K411 (Tauch et 
al., 2005) and Corynebacterium diphtheriae NCTC 13129 (Ceredeño-Tárraga et al., 2003). Based 
on this intensive genome analysis it could be concluded that the size of the C. glutamicum genome 
is 3.3 kb and the following annotations have revealed about 3000 ORFs. The G+C content is 54% 
of the C. glutamicum genome. 
 
Biochemistry of C. glutamicum 
 
Substrate uptake and utilization 
 
C. glutamicum is able to utilize a variety of sugars, sugar alcohols and organic acids as carbon 
sources, either as a single substrate or during co-metabolism. The sugars fructose, glucose and 
sucrose are all mainly taken up by specific PTS systems (Moon et al., 2005), which phosphorylates 
these sugars to either glucose-6-phosphate or fructose-6-phosphate by the conversion of 
phosphoenolpyruvate to pyruvate. In the case of sucrose only the glucose part is phosphorylated 
using this system (Dominguez et al., 1997). Phosphorylation of fructose is only possible using the 
PTS-system, why internal fructose is transported out of the cell by a unknown transport-mechanism, 
followed by transport and phosphorylation using the PTS-system (Dominguez et al., 1997; 
Dominguez and Lindley, 1996). The presence of an mannose specific PTS-system have also been 
suggested and confirmed by complementation in E. coli (Lee et al., 1993). However, the 
physiological role of this system in C. glutamicum is complex since it has been found to also be 
involved in fructose transport (Kiefer et al., 2004), and glucose transport during osmotic stress 
(Gourdon et al., 2003). Growth of C. glutamicum in the presence of mannose as the only carbon 
source is lower than for growth on glucose (Parche et al., 2001). Parche et al. (2001) also tested 
maltose as a carbon source and found growth similar to glucose grown cells. The presence of an 
alternative glucose uptake system has been identified, and in addition to this a glucose kinase (glk) 
is present in the organism (Park et al., 2000), making an alternative to the PTS-system for glucose 
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utilization. A number of organic acids have been investigated as substrate for C. glutamicum. 
Lactate can be used as a single carbon source or in co-metabolism with other substrates (Cocaign-
Bousquet and Lindley, 1995). Both D- and the L-lactate can be utilized, and lactate enters the 
metabolism via lactate dehydrogenase converting lactate to pyruvate (Bott and Niebisch, 2003). 
Acetate can be used as a single carbon source or in co-metabolism with other carbon sources 
(Wendisch et al., 2000), and enters the TCA cycle as Acetyl-CoA after the combined activities of 
acetate kinase (ackA) and phosphotransacetylase (pta) (Reinscheid et al., 1999). Propionate can be 
used as a single carbon source or in a combination with other carbon sources (Claes et al., 2002), 
and enters the metabolism forming pyruvate and succcinate by reaction with oxaloacetate. Pyruvate 
metabolism is involved in the respiratory energy metabolism (Bott and Niebisch, 2003). It can be 
used as a single carbon source or in co-metabolism (Cocaign-Bousquet et al., 1993). The organic 
acid gluconate enters the organism by the use of a gluconate permerase. Subsequently it is 
phosphorylated by gluconate kinase (gntK) forming 6-phosphogluconate, which is an intermediate 
in the pentose phosphate pathway (Lee et al., 1998; Frunzke et al., 2008). Recently citrate have 
been evaluated as a substrate for C. glutamicum, and it was seen that this substrate could be utilized 
either as the only carbon source or simultaneous with glucose (Polen et al., 2007).  
 
Nitrogen metabolism 
 
Nitrogen uptake and the regulation of nitrogen metabolism have been investigated and reviewed 
intensively in C. glutamicum (Burkovski, 2003a; Burkovski, 2003b). The organism is able to utilize 
inorganic nitrogen as ammonium or ammonia, or as organic nitrogen in the presence of urea or 
amino acids. Ammonia or ammonium can be taken op either by diffusion when concentrations are 
high or by active uptake systems when concentrations are lower (Meier-Wagner et al., 2001; Siewe 
et al., 1996). This is also the case for urea (Siewe et al., 1998). Some amino acids can also serve as 
nitrogen donors for C. glutamicum. L-glutamine (Siewe et al., 1995), L-glutamate (Kronemeyer et 
al., 1995) and L-serine (Netzer et al., 2004) have been studied in this respect, and in addition to 
these L-alanine, L-aspargine and L-threonine are generally accepted to serve as potential nitrogen 
sources for C. glutamicum, although no systematic studies have been conducted so far. The major 
route of ammonium assimilation at high concentrations in C. glutamicum is through glutamate 
dehydrogenase (gdh: EC 1.4.1.4) (Eq. 3.1). At lower ammonium concentrations (≤0.1 mM) the high 
affinity system GS/GOGAT is used instead involving two sequential reactions catalysed by 
glutamine syntase (glnA: EC 6.3.1.2), Eq. 3.2, and glutamate syntase (gltBD: EC 1.4.1.13), Eq. 3.3, 
(Jakoby et al., 1997). The difference between the net result of the GS/GOGAT and gnd is the 
consumption of one mole of ATP, making this system less energy efficient. During relevant 
fermentation conditions ammonium concentrations are always high (≥ 0.5 mM), which makes gdh 
most significant for ammonium assimilation during amino acid production.        
 
Eq. 3.1 (gdh):  α-ketogluterate + NADPH + NH4+→ glutamate + NADP+ 
 
Eq. 3.2 (glnA):  glutamate + ATP + NH4+→ glutamine + ADP + Pi  
 
Eq. 3.3 (gltBD): glutamine + α-ketogluterate + NADPH → 2 glutamate + NADP+ 
 
When inside the cell urea is hydrolysed by the enzyme urease (ureA: EC 3.5.1.5) (Siewe et al., 
1998) yielding two molecules of ammonia and one molecule of carbon dioxide. Ammonia is further 
assimilated into glutamate or glutamine as described above.      
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Phosphorous metabolism 
 
In bacterial cells phosphorous occurs in inorganic form, mostly orthophosphate (Pi), pyrophosphate 
(PPi) or polyphosphates (polyPi), and in organic form mostly as a component in a number of 
biomass components, the most important being RNA and DNA. In addition phosphorous plays a 
central role in energy metabolism since biochemical energy obtained by the oxidation of substrates 
is used to form ATP from ADP and Pi. The most important source of phosphorous for C. 
glutamicum is phosphate (PO43+). The presence of three different systems (pitA, nptA, and pst) for 
the uptake of inorganic phosphorous have been proposed in C. glutamicum based on the annotated 
genome (Ishige et al., 2003).The pitA-system is a low affinity transporter with a high capacity using 
the proton motive force, and is preferably used when phosphorous concentrations are high. The 
nptA-system is a Na+-dependent symporter transport system. The last system is an ABC-type ATP-
driven high affinity transport system, probably used during conditions where phosphorous 
concentrations are low since this system is strongly upregulated during phosphorous starvation 
conditions (Ishige et al., 2003).         
 
Sulfur metabolism 
 
Sulfur is used as a constituent of a large number of biomass components, methionine and cysteine 
being the most dominant. The main source of sulfur for micro-organisms in nature and in 
fermentations is the inorganic compound sulfate (SO42-), which will be the main focus here. Sulfate 
enters the cell via an ATP-dependent transport-system, and is reduced to the bio-available sulfide 
(H2S) via a sequence of steps (Lee, 2005). These steps involves an activation to adenosine-5’-
phosphosulphate (APS) followed by a reduction to sulfite (SO32-), and a further reduction step to 
sulfide. An alternative pathway which has been proposed due to its presence in other bacteria is the 
phosphorylation of APS to 3’-phosphoadenosine 5’phosphosulphate (PAPS), which is reduced to 
sulfite. However, the presence or this pathway has not yet been confirmed, and the apparent lack of 
the gene encoding the enzyme catalyzing the first reaction in the annotated genome indicates that 
only the first pathway is in fact present in C. glutamicum (Lee, 2005). An alternative to the 
assimilation of inorganic sulfur is the degradation of sulfur containing amino acids. Cysteine can be 
degraded to pyruvate, H2S, and NH3 by cysteine desulfhydrase (aecD) (Rossol and Pühler, 2003). 
Methionine degradation is not well investigated. Based on genome data it is likely that it is a three 
step pathway forming α-ketobutyrate, methanethiol, and NH3. Another variant involves an 
additional step yielding α-keto-γ-thiobutyrate and glutamate from methionine and α-ketobutyrate. 
However, no biological evidence has yet been presented for these pathways.                
 
Central Carbon Metabolism 
 
The Glycolysis 
 
After sugars has been taken up and phosphorylated they enter the glycolytic pathway or the pentose 
phosphate pathway (see later in this chapter) (Figure 3.1). The point for the metabolic flux towards 
either glycolysis or pentose phosphate pathway is at the metabolite glucose-6-phosphate, which 
earlier have been identified as a branch point for central metabolism in C. glutamicum (Vallino and 
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Stephanopoulos, 1994). The first step in glycolysis is catalysed by the enzyme glucose-6-phosphate 
isomerase (pgi) catalysing the reversible reaction between glucose-6-phosphate and fructose-6-
phosphate (Marx et al., 2003). Fructose-6-phosphate is further converted to fructose-1,6-
bisphosphate via 6-phosphofructokinase (pfkA) (Sugimoto and Shiio, 1989b). During 
gluconegenesis the enzyme fructose-1,6-bisphosphatase (fbp) is essential catalysing the reverse 
reaction of pfkA (Rittmann et al., 2003). The further conversion of fructose-1,6-bisphosphate is 
catalysed by glyceraldehydes-3-phosphate dehydrogenase (fda) forming dihydroxyacetone 
phosphate and glycaldehyde 3-phosphate (von der Osten et al., 1989). The generated 
dihydroxyacetone phosphate is converted to glycaldehyde 3-phosphate by triosephosphate 
isomerase (tpiA), and glycaldehyde 3-phosphate is further converted to 1,3-biphosphoglycerate by 
glycaldehyde 3-phosphate dehydrogenase (gapA) using NAD+ as a co-enzyme (Eikmanns, 1992; 
Omumasaba et al., 2004). The presence of an NADPH dependent glycaldehyde 3-phosphate 
dehydrogenase (gapB) have also been confirmed and investigated (Omumasaba et al., 2004). 
Omumasaba et al. (2004) investigated the role of both enzymes and found that gapA was essential 
for growth on glucose, whereas the deletion of gapB did not have any effect. During growth on 
organic acids (lactate, acetate and pyruvate) growth was seen for both ΔgapA- and ΔgapB-mutants, 
although a more abundant negative effect was observed for the ΔgapB-mutant. These results 
indicate that gapA is reversible, and strictly used during growth on glucose, whereas gapB only is 
active during gluconeogenic growth, where this pathway is more effective than gapA. The next 
reaction is the reversible reaction converting 1,3-biphosphoglycerate to 3-phosphoglycerate coupled 
to phosphorylation of ADP to ATP, catalysed by 3-phosphoglycerate kinase (pgk) (Eikmanns, 
1992). Based on the annotated genome 3-phosphoglycerate is converted to 2-phosphoglycerate by 
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Figure 3.1: Glycolysis and pentose phosphate pathway in C. glutamicum. Genes and enzymes involved: ptsG: EC 
2.7.1.69 (PTS-permerase); pgi: EC 5.3.1.9 (glucose-6-phosphate isomerase); pfkA: EC 2.7.1.11 (6-
phosphofructokinase); fbp: EC 3.1.3.11 (fructose-bisphosphatase); fda: EC 4.1.2.13 (fructose-bisphosphate aldolase); 
tpiA: EC 5.3.1.1 (trisose-phosphate isomerise); gapA: EC 1.2.1.12 (glycaldehyde-3-phosphate dehydrogenase); gapB: 
EC 1.2.1.12 (glycaldehyde-3-phosphate dehydrogenase); pgk: EC 2.7.2.3 (phosphoglycerate kinase); pgm: EC 5.4.2.1 
(phosphoglycerate mutase); eno: EC 4.2.1.11 (enolase);  zwf: EC 1.1.149 (glucose-6-phosphate dehydrogenase); gnd: 
EC 1.1.1.44 ( phosphogluconate dehydrogenase); rpe: EC 5.1.3.1 (ribose-phosphate 3 isomerase); rpi: EC 5.3.1.6 
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phosphoglycerate mutase (pgm), which is a reversible reaction, and 2-phosphoglycerate is further 
converted to phosphoenolpyruvate by another reversible reaction catalysed by enolase (eno). None 
of these enzymes have yet been purified and characterised in C. glutamicum. In the last reaction of 
the glycolysis phosphoenolpyruvate is converted to pyruvate by pyruvate kinase (pyk), a reaction 
which is coupled to phosphorylation of ADP to ATP (Jetten et al., 1994). Phosphoenolpyruvate and 
pyruvate is involved in a number of anaploretic reactions and in the PTS-sugar uptake system. This 
will be discussed more in detail elsewhere.             
 
The Pentose Phosphate Pathway 
 
The initial reactions of the pentose phosphate pathway is the formation of 6-phosphogluconate from 
glucose-6-phosphate by glucose-6-phosphate dehydrogenase (zwf,opcA) (Sugimoto and Shiio, 
1987a), followed by a conversion to ribulose-6-phosphate by 6-phosphogluconate dehydrogenase 
(gnd) (Sugimoto and Shiio, 1987b), with the formation of two moles of NADPH from NADH+ and 
the formation of one mole of CO2 (Figure 3.1) Glucose-6-phosphate dehydrogenase consists of two 
subunits (zwf and opcA), forming a heteromultimeric complex, and both zwf,opcA- and gnd-gene-
products are inhibited by NADPH (Moritz et al., 2000). The rest of the reactions and enzymes 
involved in the pentose phosphate pathway have not been investigated in detail in C. glutamicum. 
However, based on the genome annotation and available experimental data for C. glutamicum 
(Sugimoto and Shiio, 1989a; Ikeda et al., 1998) and the related Corynebacterium ammoniagenses 
(Kamada et al., 2001; Kamada et al., 2003), an unravelling of this pathway can be conducted 
(Figure 3.1). Ribulose-5-phosphate can be converted to either ribose-5-phosphate or xulose-5-
phosphate by ribose-5-phosphate isomerase (rpi) or ribulose-5-phosphate isomerase (rpe), 
respectively. Both are reversible reactions. The tkt-gene-product transketolase is able to catalyse 
two reactions: xulose-5-phosphate + ribulose-5-phosphate ↔ glycaldehyde 3-phosphate + 
sedohepulose 7-phosphate and xulose-5-phosphate + erythose 4-phosphate ↔ glycaldehyde 3-
phosphate + fructose-6-phosphate. The transaldolase (tal) catalyses the reaction glycaldehyde 3-
phosphate + sedohepulose 7-phosphate ↔ erythose 4-phosphate + fructose-6-phosphate. These 
reactions catalysed by transketolase and transaldolase create a reversible link between the glycolysis 
and the pentose phosphate pathway. However, little is known about the distribution between these 
reactions in C. glutamicum.           
 
TCA cycle 
 
The replenishment of carbon into the TCA cycle is mediated by acetyl-CoA (Figure 3.2). During 
growth on carbohydrates acetyl-CoA is generated by oxidative decarboxylation of pyruvate yielding 
Acetyl-CoA, CO2 and NAD+. In C. glutamicum this reaction is catalysed by the pyruvate 
dehydrogenase complex (Schwinde et al., 2001; Cocaign-Bousquet and Lindley, 1995). This 
enzyme complex is composed of three subunits (de Kok et al., 1998). The activity of two of these 
subunits (lpd) (Schwinde et al., 2001) and (aceE) (Schreiner et al., 2005) have been confirmed by 
experimental work. Presence of the third subunit in C. glutamicum has been proposed from genome 
annotation where an ORF sharing similarity to the gene (aceF) encoding this enzyme in E. coli has 
been found. The first compound in the TCA cycle citrate is generated as a condensation of acetyl-
CoA and oxaloacetate. The enzyme citrate synthase (gltA) catalyses this reaction (Eikmanns et al., 
1994). The next reaction step is reversible isomerization of citrate to isocitrate catalysed by the 
enzyme aconitase (acn) (Krug et al., 2005). Isocitrate dehydrogenase (icd) further catalyzes the 
conversion of isocitrateto 2-oxoglutarate and CO2 by the reduction of NADP+ (Audette et al., 1999; 
Eikmanns et al., 1995). 2-oxoglutarate can then be aminated to form glutamate (this reaction step is 
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described elsewhere), or be converted to succinyl-CoA, another TCA intermediate, and NADH via 
the 2-oxoglutarate dehydrogenase complex. The 2-oxoglutamate dehydrogenase complex share 
some similarity to the pyruvate dehydrogenase complex described above. One of the subunits (lpd) 
is even shared between the two enzyme complexes. The two existing subunits (odhA and sucB) 
have both been identified in C. glutamicum by experiments (Kataoka et al., 2006; Usuda et al., 
1996). Succinyl-CoA synthase catalyses the next reaction in the TCA cycle converting succinyl-
CoA to succinate and CoA yielding one ATP (Zhao and Lin, 2002). The further conversion of 
succinate to fumarate is done by the membrane bound succinate dehydrogenase enzyme complex, 
which consists of three subunits sdhA, sdhB and sdhC. This complex is part of the respiratory chain 
in C. glutamicum (Bott and Niebisch, 2003), which will be described more in detail elsewhere. 
Fumerate is converted to malate via the reversible reaction catalysed by the enzyme fumerase 
(fumC) (Genda et al., 2006). The last reaction in the TCA cycle is the conversion between malate 
and oxaloacetate. This reaction can be conducted via two different reactions: the NAD dependent 
malate dehydrogenase (mdh) or the membrane associated malate:quinone oxidoreduktase (mqo) 
(Molenaar et al., 2000), both of which are part of the respiratory chain of C. glutamicum (Bott and 
Niebisch, 2003). However, due the energetically unfavourable properties of the mdh reactions, the 
mqo reaction will be preferred during standard growth conditions, and mdh will only occur during 
low oxaloacetate and/or high malate concentrations (Molenaar et al., 1998). During growth on 
carbon sources entering the central metabolism as acetyl-CoA (i.e. acetate, ethanol or fatty acids) 
the glyoxylate cycle must be active in order to obtain sufficient amounts of oxaloacetate to fulfil 
anaplerotic function of the organism (Gerstmeier et al., 2003). Using the glyoxylate cycle three 
reactions of the TCA cycle are bypassed (Figure 3.2). Isocitrate is converted directly to succinate 
and glyoxylate via isocitrate lyase (aceA), and glyoxylate is further converted to malate using a 
Acetyl-CoA yielding CoA via malate syntase (aceB) (Reinscheid et al., 1994). Activity of the 
glyoxylate cycle is tightly controlled at a transcriptional level, and is down regulated during growth 
on carbohydrates (Reinscheid et al., 1994; Wendisch et al., 2004). 
 
*** 
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Figure 3.2: TCA cycle and anaploretic reactions in C. glutamicum. Genes and enzymes involved: pckG: EC 4.1.1.32 
(phosphoenolpyruvate carboxykinase (GTP)); ppc: EC 4.1.1.31 ( phosphoenolpyruvate carboxylase); pps: EC 2.7.9.2 
(phosphoenolpyruvate syntase); pyk: 2.7.1.40 (pyruvate kinase); pyc: EC 6.4.1.1 (pyruvate carboxylase); odX: EC 
4.1.1.3 (oxaloacetate decarboxylase); aceE: EC 1.2.4.1 (pyruvate dehydrogenase); aceF: EC 2.3.1.12; gltA: 2.3.3.1 
(citrate syntase); acn: EC 4.2.1.3 (aconitate hydratase); icd: EC 1.1.1.42 (isocitrate dehydrogenase); odhA: EC 1.2.4.2 
(oxoglutarate dehydrogenase); sucB: EC 2.3.1.61; sucD: EC 6.2.1.5 (succinate-CoA ligase); sdhCAB: EC 1.3.5.1 
(succinate dehydrogenase); fumC: EC4.2.1.2 (fumerate hydratase); mdh: EC 1.1.1.37 (malate dehydrogenase); mqo: EC 
1.1.99.16 (malate dehydrogenase); aceA: 4.1.3.1 (isocitrate lyase); aceB: EC 2.3.3.9 (formerly EC 4.1.3.2) (malate 
syntase); mez: EC 1.1.140 (malic enzyme).    
Chapter 3 
________________________________________________________________________________ 
56 
Anaplerotic reactions around the phosphoenolpyruvate-pyruvate-oxaloacetate node 
 
The phosphoenolpyruvate-pyruvate-oxaloacetate node has been given a lot of attention due to its 
central position in the metabolism directing carbon towards the TCA-cycle. C. glutamicum possess 
a number of enzymes and reactions around this node (Figure 3.2). Two C3-carboxylating enzymes: 
pyruvate carboxylase (pyc) (Peters-Wendisch et al., 1998) and phosphoenolpyruvate carboxylase 
(ppc) (Eikmanns et al., 1989); three C4-decarboxylating enzymes malic enzyme (mez) (Gourdon et 
al., 2000), oxaloacetate decarboxylase (Odx) (Jetten and Sinskey, 1995); phosphoenolpyruvate 
carboxykinase (pckG) (Jetten and Sinskey, 1993); and the ATP-yielding pyruvate kinase (pyk) 
(Jetten et al., 1994) are present. However, the level of activity of these enzymes, and consequently 
the flux-distributions, are highly dependent on the substrate(s) utilized by the organism (Petersen et 
al., 2000; Peters-Wendisch et al., 1998; Gourdon et al., 2000; Dominguez et al., 1998). Based on 
the annotated genome another two enzymes are present at this node: Phosphoenolpyruvate syntase 
(pps; EC 2.7.9.2) and malate dehydrogenase (mdh2; EC 1.1.1.82). However, the presence of these 
enzymes in C. glutamicum has until today not been shown experimentally. During growth on 
carbohydrates pyc and ppc are essential as anaplerotic enzymes (Peters-Wendisch et al., 1998), and 
those are also the dominating pathways during growth and lysine synthesis on carbohydrates, with 
pyc being the most significant (90%) (Petersen et al., 2000; Park et al., 1997). Although the role of 
mez, Odx and pckG have been excluded during anaploreis (Peters-Wendisch et al., 1998), some 
activity of these enzymes are still seen during utilization of carbohydrates (Petersen et al., 2001; 
Petersen et al., 2000; Gourdon et al., 2000; Jetten and Sinskey, 1995), why the significance of these 
enzymes can not be neglected. However, based on data from Petersen et al. (2000) the only C4-
decarboxylating reaction contributing with a significant flux is pckG. The consequence of this flux 
is a GTP consuming futile cycle in which pyruvate is converted to oxaloacetate (via pyc), 
oxaloacetate is converted to phosphoenolpyruvate (via pckG) and phosphoenolpyruvate is converted 
back to pyruvate (via pyk). Petersen et al. (2000) suggested that this cycling between the C4- and 
C3-pool serves as a fine tuning within the central metabolism to balance anaplerosis with 
catabolism, and to be able to make rapid responses to alterations in the environment.   
 
 
*** 
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Respiratory Energy Metabolism 
 
C. glutamicum has a respiratory energy metabolism, with oxygen as the terminal electron donor. 
Reducing equivalents obtained by oxidation of various substrates are transferred to a menaquinone 
via eight different dehydrogenases which have been identified from the annotated genome (Bott and 
Niebisch, 2003)(Figure 3.3). These are NADH dehydrogenase (ndh), succinate dehydrogenase 
(sdhCAB), malate:quinone oxidoreductase (mqo), pyruvate:quinone oxidoreductase (poxB), L-
lactate dehydrogenase (lldD), D-lactate dehydrogenase (dld2), glycerol-3-phosphate dehydrogenase 
(glpD), and proline dehydrogenase (putA). From menaquinone the electrons are transferred to 
oxygen via either the cytochrome bc1–aa3 supercomplex (qcrCAB, ctaCDEF) (Niebisch and Bott, 
2003) or via cytochrome bd menaquinol oxidase (cydAB) (Kusumoto et al., 2000). In addition to 
oxygen, nitrate can serve as an electron acceptor in C. glutamicum by reduction to nitrite via nitrate 
reductase (narGHIJ) (Bott and Niebisch, 2003). The physiological role of nitrate reductase is yet 
unknown and no reports about anaerobic growth with nitrate as terminal electron acceptor has been 
published so far. The final step in oxidative phosphorylation is the generation of ATP via the F1F0-
ATP synthase (atpIBEFHAGDC) driven by an electrochemical proton gradient across the 
cytoplasmic membrane. According to generally accepted values the number of protons transferred 
across the membrane per electron (H+/e-) is three for the cytochrome bc1–aa3 supercomplex 
 
 
Figure 3.3: Proposed model of the respiratory chain of C. glutamicum. The number of electrons and protons 
presumable transferred is indicated. The route involving cytochrome bc1–aa3 supercomplex is used under normal 
conditions.  Modified after Bott and Niebisch (2003). 
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(Nicholls and Ferguson, 1992), and one for cytochrome bd menaquinol oxidase (Stryer, 1995a). 
Production of one molecule of ATP by the F1F0-ATP synthase requires transport of three to four 
protons, consequently leading to a maximum P/O-value of 1.5-2 when the cytochrome bc1–aa3 
supercomplex is used for electron transfer and 0.5-2/3 when cytochrome bd menaquinol oxidase is 
used (Bott and Niebisch, 2003).Under normal conditions the more efficient cytochrome bc1–aa3 
supercomplex is used, and mutants lacking this complex have been shown to have severe growth 
defects (Niebisch and Bott, 2001; Niebisch and Bott, 2003).    
 
Biomass components 
 
Amino acid biosynthesis 
 
The wild-type strain of C. glutamicum ATCC 13032 is prototrophic with respect to all amino acids. 
In many cases the synthesis of the individual amino acids has been investigated quite thoroughly in 
C. glutamicum, and not surprisingly the lysine and glutamate synthesis pathways are among the 
most well characterised pathways in this organism. 
 
Glutamate family (glutamate, glutamine, arginine and proline) 
 
The major route of ammonia assimilation in C. glutamicum is the incorporation of 
ammonia/ammonium to glutamate or glutamine through either glutamate dehydrogenase (gdh) or 
through the GS/GOGAT system, both of which have been presented in the “nitrogen metabolism”-
part of this chapter. From glutamate proline is synthesized from glutamate via three gene-products 
λ-glytamylkinase (proB), λ-glytamyl phosphate reductase (proA) and Δ1-pyrroline-5-carboxylate 
reductase (proC) (Ankri et al., 1996; Serebrijski et al., 1995)(Figure 3.4). In addition L-glutamate 
5-semialdehyde is converted to (S)-1-Pyrroline-5-carboxylate via a non-enzymatic reaction. proB 
and proC are essential for growth, whereas ΔproA mutants are able to grow slowly, suggesting an 
alternative to the proA pathway (Ankri et al., 1996). Ankari et al. (1996) suggested that the asd-
gene present in the lysine synthetic pathway was involved in this bypass. In addition to being a 
biomass component, proline is also used as a compatible solute during osmotic stress, resulting in 
an accumulation of intracellular proline under such conditions (Guillouet and Engasser, 1995).  
 
The arginine synthetic pathway has not been investigated as thoroughly as it is the case for most 
other amino acid pathways in Corynebacterium, in spite of the fact that strains of Corynebacterium 
have been and still are used for production of L-arginine (Utagawa, 2004; Lu, 2006). Arginine is 
synthesised from glutamate and Acetyl-CoA in a series of reactions where eight genes are involved: 
argR; argB; argC; argD; argJ; argF; argG; argH (Utagawa, 2004). The proposed arginine pathway 
in C. glutamicum is summarised in figure 3.5. The gene-product from argB (N-acetylglucokinase) is 
inhibited by arginine making this enzyme the control point of this pathway (Utagawa, 2004). 
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 The branched chain amino acids (isoleucine, valine, leucine) 
 
The synthesis of the three branched amino acids isoleucine, leucine and valine is tightly correlated 
due to the fact that a number of enzymes are shared in the biosynthetic pathways of these 
compounds (Radmacher et al., 2002). Also the synthesis of the vitamin D-pantothenate is sharing 
some of these enzymes, since the intermediate 2-oxoisovalerate is used in the first step of the 
synthesis of this compound (Sahm and Eggeling, 1999) in competition with leucine and valine 
biosynthesis. Isoleucine and valine biosynthesis (and in principle also leucine and pantothenate) 
share three enzymes, and one enzyme is shared between all three branched chain amino acids 
(Figure 3.6). Isoleucine is synthesized from threonine. The first step is catalyzed by threonine 
ammonialyase (ilvA) yielding 2-oxobutanate. From here the next three reactions are shearing 
enzymes with the valine- and leucine biosynthetic pathways: ilvBN, ilvC, ilvD and ilvE yielding the 
gene-products acetohydroxyacid synthase, isomero reductase, dihydroxyacid dehydratase and 
transaminase B, respectively. During this sequence of reactions a pyruvate is consumed in addition 
to a NADPH and one amine-group which is transferred from glutamate by the formation of 2-
oxogluterate. Both valine and leucine biosynthesis are initiated by the condensation of two moles of 
pyruvate. Via three steps the intermediate 2-oxoisovalerate is synthesized producing one mole of 
CO2 and consuming NADPH. From this compound valine is synthesized by transferring an amine 
from glutamate catalyzed by the ilvE gene-product. Leucine is synthesized from 2-oxoisovalerate 
via another four reactions catalyzed by the enzymes 2-isopropylmalate synthase, 3-isopropylmalate 
dehydratase, isopropylmalate dehydrogenase and finally transaminase B, which are gene-products 
from leuA, leuCD, leuBP and ilvE, respectively. Due to the complexity of this system a tight control 
must be present in order to maintain sufficient concentrations of each single metabolite without 
 
 
Figure 3.4: The consensus biosynthetic pathway of proline in C. glutamicum. Genes and enzymes involved: proB: EC 
2.7.2.11 (λ-glytamylkinase); proA: EC 1.2.1.41 (λ-glytamyl phosphate reductase); proC: EC 1.5.1.2 (Δ1-pyrroline-5-
carboxylate reductase).   
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overproducing others. Isoleucine synthesis is controlled at the first reaction step (ilvA) by feedback 
inhibition by isoleucine, whereas valine has the opposite effect. Using this mechanism the organism 
is able to balance the isoleucine and valine biosynthesis by restricting the synthesis of 2-
oxobutanoate when isoleucine is in excess and by promoting 2-oxobutanoate synthesis when valine 
is in excess (Möckel et al., 1992). The activity of the gene-product of ilvBN is increased by 2-
oxobutanoate, which is due to a higher transcription of this gene (Keilhauer et al., 1993). Valine on 
the other hand decreases the activity of the ilvBN gene-product (Eggeling et al., 1987). As 2-
oxoisovalerate is precursor for leucine, valine and panthenoate there is a tight regulation of enzymes 
at this point. Leucine is a strong feed-back inhibitor of the leuA (Patek et al., 1994) and leuB (Patek 
et al., 1998) gene-products, which catalyses the first and the third reaction in the leucine synthesis 
pathway.     
 
 
*** 
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Figure 3.5: Arginine synthetic pathway in C. glutamicum based on the annotated genome and Utawa (2004). Genes 
and enzymes involved: argR: EC 2.3.1.1 (N-acetylglutamate synthase); argB: EC 2.7.2.8 (Acetylglutamate kinase); 
argC: EC 1.2.1.38 (N-acetyl-gamma-glutamyl-phosphate reductase); argD: EC 2.6.1.11 (Acetylornithine 
transaminase); argJ: EC 2.3.1.35 (Glutamate N-acetyltransferase); carA: EC 6.3.5.5 (carbamoyl-phosphate syntase) 
argF: EC 2.1.3.3 (Ornithine carbamoyltransferase); argG: EC 6.3.4.5 (Argininosuccinate synthase); argH: EC 
4.3.2.1 (Argininosuccinate lyase) 
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Figure 3.6: Biosynthetic pathways of the branched amino acids, L-leucine, L-valine and L-isoleucine in C. 
glutamicum. Genes and enzymes involved: ilvA: EC 4.3.1.19 (formerly EC 4.2.1.16) (threonine-ammonia lyase); ilvBN: 
EC 2.2.1.16 (acetohydroxy-acid syntase); ilvC: EC 1.1.1.86 (ketol-acid reductoisomerase); ilvD: EC 4.2.1.9 
(dihydroxy-acid dehydratase); ilvE: EC 2.6.1.42 (transaminase B); leuA: EC 2.3.3.13 (isopropylmalate syntase); leuCD: 
EC 4.2.1.33 (isopropylmalate dehydratase); leuBP: EC 1.1.1.85 (isopropylmalate dehydrogenase).    
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Figure 3.7: Biosynthetic pathways of aspartate family amino acids, L-aspartate, L-aspargine, L-threonine and L-lysine 
in C. glutamicum. Genes and enzymes involved: aspB: EC: 2.6.1.1 (aspartate transaminase); ltsA: EC 6.3.5.4 (aspargine 
syntase); lysC: EC 2.7.2.4 (aspartate kinase); asd: 1.2.1.11 (aspartate semialdehyde dehydrogenase); dapA: EC 4.2.1.52 
(dihydrodipicolinate synthase); dapB: EC 1.3.1.26 (dihydrodipicolinate reductase); dapD: EC2.3.1.117 (2,3,4,5-
tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase); dapC: EC 2.6.1.17 (succinyl-amino-ketopimelate 
transaminase);  dapE: EC 3.5.1.18 (succinyl-diaminopimelate desuccinylase); dapF: EC 5.1.1.7 (diaminopimelate 
epimerase); lysA: EC 4.1.1.20 (diaminopimelate decarboxylase); ddh: EC 1.4.1.16 (diaminopimelate dehydrogenase); 
hom: EC 1.1.1.3 (homoserine dehydrogenase); thrB: EC 2.7.1.39 (homoserine kinase); thrC: EC 4.2.3.1 (threonine 
synthase).   
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The aspartate family (aspartate, aspargine, threonine, lysine, methionine) 
All amino acids part of the aspartate family are synthesized from aspartate. Due to the commercial 
importance of a number of these amino acids, and the high potential of C. glutamicum to produce 
some of these amino acids, these synthetic pathways have been thoroughly investigated. Aspartate 
is synthesized from oxaloacetate via aspartate transaminase (aspB: EC 2.6.1.1). Aspargine 
biosynthesis has not been given a lot of attention compared to the rest of the aspartate family amino 
acids. Based on the annotated genome two aspargine synthase enzymes are present in C. 
glutamicum: ltsA (EC 6.3.5.4) and NCgl2116 (EC 6.3.1.1). However, none of these enzymes have 
been characterized so far.   
 
The initial reactions of the lysine-, threonine- and methionine pathways are shared. From aspartate, 
aspartylphosphate is synthesized via aspartate kinase (lysC). Aspartylphosphate is then further 
converted to aspartatesemialdehyde by aspartatesemialdehyde dehydrogenase (asd). 
Aspartatesemialdehyde is further converted either towards threonine and methionine (hom) or 
towards lysine synthesis (dapA). In C. glutamicum there are two possible lysine pathways (Figure 
3.7). Via dapA and dapB dehydrodipicolinate and L-piperidine 2,6-dicarboxylate is synthesized. 
From here meso-2,6-diaminopimelate is synthesized either directly via ddh, called the 
dehydrogenase variant, or via four reactions catalyzed by gene-products from dapD, dapC, dapE or 
dapF, known as the succinylase variant (Schrumpf et al., 1991). The final step in the lysine 
synthesis is carried out by the lysA gene-product diaminopimelate decarboxylase. Due to the large 
commercial interest in lysine the pathway for this amino acid has been intensively investigated. A 
detailed review on the lysine synthetic pathway and various strategies for improving this pathway is 
given in chapter 2.   
 
At the split between threonine/methionine and lysine synthesis some metabolic control is present in 
order to balance amino acid synthesis for biomass production without overproduction. The hom 
gene-product homoserine dehydrogenase is inhibited by threonine and isoleucine (Miyajima et al., 
1968). From homoserine, threonine is synthesized via two reactions: thrB and thrC (Willis et al., 
2005). The thrB gene-product homoserine kinase is strongly inhibited by threonine, whereas the 
other aspartate family amino acids shows slightly inhibitory effects when concentrations exceeds 10 
mM (Miyajima et al., 1968). The last enzyme in the threonine synthesis pathway threonine syntase 
(thrC) is scarcely inhibited by amino acids of the aspartate family and strongly inhibited by cysteine 
and the tripeptide glutathione (Miyajima et al., 1968).  
 
The last aspartate family amino acid is methionine, and two possible pathways are present leading 
to this amino acid in C. glutamicum (Lee and Hwang, 2003)(Figure 3.8). The first reaction in the 
biosynthesis of this compound is catalyzed by homoserine acetyltransferase (metX) (Park et al., 
1998), converting homoserine into O-acetylhomoserine using Acetyl-CoA as an acyl donor. O-
acetylhomoserine is further converted to homocysteine either by one step via the metY-gene-product 
homoserine O-acetyltransferase using inorganic sulfur as sulfur source, or by two steps involving 
metB and metC with cystathionine as an intermediate and using cysteine as sulfur source. Both 
pathways are equally functional in the organism (Hwang et al., 2002). Homocysteine is converted 
to methionine by a reaction donating a methyl group from 5,10-methenylenetetrahydrofolate 
(MTHF) to the compound. This reaction can be catalyzed by two different gene-products: metE or 
metH, metE being B12-dependent whereas this is not the case for metH (Rückert et al., 2003). 
MTHF for this reaction is formed from serine and tetrahydrofolate (THF) in two steps yielding 
glycine as a by-product involving gene-products from glyA  and metF. From methionine S-
adnosylmethionine (SAM) can be synthesized in a single step (metK) consuming one ATP. SAM is 
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an essential molecule and is involved in methylation reactions and polyamine biosynthesis (Lee, 
2005). Methionine biosynthesis is strictly regulated by inhibition and repression by methionine 
itself, and by other compounds i.e. threonine, homocysteine and SAM (Lee and Hwang, 2003).                            
 
The pyruvate family (alanine) 
Based on the annotated genome of C. glutamicum there is no alanine dehydrogenases present in this 
organism. The only alanine synthesizing pathways identified (based on annotated genome) to date 
are valine-pyruvate transaminase (NCgl0388: EC 2.6.1.66) and alanine racemase (alrK: EC 5.1.1.1) 
catalyzing the formation of alanine and 2-keto-isovalerate from valine and pyruvate and D-alanine 
from L-alanine, respectively.     
 
The serine family (serine, glycerine, cysteine) 
Serine is in C. glutamicum synthesized in three steps from 3-phosphoglycerate via the gene-
products serA (phosphoglycerate dehydrogenase), serC (phosphoserine transaminase) and serB 
(phosphoserine phosphatase) (Peters-Wendisch et al., 2005) (Figure 3.9). Only 16 % of synthesized 
 
 
Figure 3.8: Biosynthetic pathways of methionine in C. glutamicum. Genes and enzymes involved: metX: EC 2.3.1.31 
(homoserine acetyltransferase); metB: EC 2.5.1.48 (cystathionine gamma-synthase); metC: EC 4.4.1.8 (cystathionine 
beta-lyase); metY: EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase); metH: EC 2.1.1.13 (methionine 
synthase); glyA: EC 2.1.2.1 (glycine hydroxymethyltransferase); metF: EC 1.7.99.5 (5,10-methylenetetrahydrofolate 
reductase). Abbreviations: THF: Tetrahydrofolate; METHF: 5,10-Methenylenetetrahydrofolate; MTHF: 5-
Methyltetrahydrofolate.   
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L-serine is incorporated into protein to support biomass formation (Marx et al., 1996). The rest is 
used in glycine- or cysteine synthesis (see next sections) or can be converted to pyruvate via sdaA 
(L-serine aminase) (Netzer et al., 2004). Based on the results of Netzer et al. (2004) the flow 
towards amino acid synthesis is thought to contribute the most to the drain of serine under normal 
conditions since the sdaA gene-product has a low affinity to serine. Serine synthesis is controlled by 
feed-back inhibition by serine at the first step of the pathway (Peters-Wendisch et al., 2002).  
Two routes for the synthesis of glycine are present in C. glutamicum both of which are catalyzed by 
the same gene-product glyA (glycine hydroxymethyltransferase): via serine and tetrahydrofolate  
(THF) yielding glycine and 5,10-methenylenetetrahydrofolate (MTHF) or by degrading threonine to 
glycine and acetaldehyde (Simic et al., 2002) (Figure 3.9).  
 
 
Figure 3.9: Biosynthetic pathways of the serine family amino acids serine, glycine and cysteine in C. glutamicum. 
Genes and enzymes involved: serA: EC 1.1.1.95 (phosphoglycerate dehydrogenase); serC: EC 2.6.1.52 (phosposerine 
transaminase); serB: EC 3.1.3.3 (phosphoserine phosphatase); cysE: EC 2.3.1.30 (serine acetyltransferase); cysKM: EC 
2.5.1.47 (cysteine syntase); glyA: EC 2.1.2.1 (Glycine hydroxymethyltransferase). Abbreviations: THF: 
Tetrahydrofolate; METHF: 5,10-Methenylenetetrahydrofolate.  
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Figure 3.10: The histidine biosynthetic pathway in Corynebacterium glutamicum. Gene-products: hisG (EC 
2.4.2.17: ATP phosphoribosyltransferase); HisI (EC 3.6.1.31: phosphoribosyl-ATP diphosphatase); HisA (5.3.1.16: 
1-(5-phosphoribosyl)-5- ((5-phosphoribosylamino)methylideneamino)imidazole-4-carboxamide isomerase); 
HisFH (EC 2.4.2.17: ATP phosphoribosyltransferase); HisB (EC 4.2.1.19: imadazoleglycerol-phosphate 
dehydratase and EC 3.1.3.15: histidinol-phosphatase); HisC (EC 2.6.1.9: histidinol-phosphate transferase); HisD 
(EC 1.1.1.23: histidinol dehydrogenase). PRFP: 5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-
imidazole-4-carboxamide; PRLP: N-(5'-Phospho-D-1'-ribulosylformimino)-5-amino-1-(5"-phospho-D-ribosyl)-4-
imidazolecarboxamide. 
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Figure 3.11: The synthetic pathways of the aromatic amino acids, tryptophan, tyrosine and phenylanaline, in C. 
glutamicum. Genes and enzymes involved: aroG: EC 2.5.1.54 (3-deoxy-7-phosphoheptulonate synthase); aroB: 
EC 4.2.3.4 (3-dehydroquinate synthase); aroQ: 4.2.1.10 (3-dehydroquinate dehydratase); aroE: EC 1.1.1.25 
(shikimate dehydrogenase); aroK: EC 2.7.1.71 (shikimate kinase); aroA: EC 2.5.1.19 (3-phosphoshikimate 1-
carboxyvinyltransferase); aroC: EC 4.2.3.5 (chorismate synthase); trpEG EC 4.1.3.27 (anthranilate synthase); 
trpD: EC 2.4.2.18 (anthranilate phosphoribosyltransferase); trpC: EC 4.1.1.48 (indole-3-glycerol-phosphate 
synthase); trpAB: EC 4.2.1.20 (tryptophan synthase); csm: EC 5.4.99.5 (chorismate mutase); tyrAT: EC 1.3.1.12 
(prephenate dehydrogenase); r2.6.1.57: EC 2.6.1.57 (aromatic-amino-acid transaminase); pheA: EC 4.2.1.51 
(prephenate dehydratase).  
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Cysteine is synthesized in two steps (Figure 3.9). In the first step O-acetylserine is synthesized from 
serine using acetyl-CoA as an acetyl donor by the cysE gene-product serine acetyltransferase (Wada 
et al., 2002). O-acetyltransferase is converted to cysteine by the incorporation of sulphide (H2S) via 
CysK (Wada et al., 2004). It is also speculated that thiosulphate can be used as sulfur source using 
the cysM gene-product (O-acetylserine sulfhydrylase B) and an additional protein not yet identified 
to form cysteine (Lee, 2005). Cysteine can be degraded to pyruvate, NH3 and H2S by cysteine 
desulfhydrase (aecD) (Wada et al., 2002).   
 
Histidine  
Histidine biosynthesis in C. glutamicum has not yet been fully elucidated. However, based on 
annotated genomic data and some experimental data it seems clear that the histidine pathway in this 
organism does not differentiate from most other prokaryotic organisms. In this respect the histidine 
pathway in C. glutamicum consists of 10 enzymatic reactions catalyzed by 8 different gene-products 
requiring phosphor-ribosyl-pyrophosphate (PRPP) and ATP (Jung et al., 1998; Alifano et al., 1996; 
Mormann et al., 2006). The eight genes and gene-products involved in histidine synthesis are hisA, 
hisB, hisC, hisD, hisF, hisG, hisH and hisI, where the hisI, hisB and hisD gene-products are 
isoenzymes each catalysing two reactions within the pathway (Alifano et al., 1996). The hisF and 
hisH gene-products form an enzyme-complex (Jung et al., 1998). From figure 3.10 an overview of 
the reaction pathway and gene-products of histidine synthesis can be seen.                 
 
The aromatic family (Tryptophan, tyrosine and phenylalanine)  
The biosynthesis of all the aromatic amino acids begins with the formation of the precursor 
chorismate. Chorismate is synthesized in seven enzymatic steps beginning with the condensation of 
phosphoenolpyruvate and erythose 4-phosphate. This reaction step is catalyzed by feedback 
sensitive 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (aroG) yielding 3-deoxy-D-
arabino-heptulosonate 7-phosphate. This enzyme is slightly inhibited by tyrosine and phenylalanine 
when these amino acids are singly present, while the enzyme is strongly synergistically inhibited 
when both amino acids are present (Shiio et al., 1974). From 3-deoxy-D-arabino-heptulosonate 7-
phosphate chorismate is synthesised from six enzymatic reactions none of which have been reported 
to be subject to any kind of regulation. The reactions are catalyzed by AroB, AroQ, AroE, AroK, 
AroA and AroC (Figure 3.11). Chorismate can be converted to either anthranilate (precursor for 
tryptophan) or prephenate (precursor for tyrosine and phenylalanine) by the enzymes anthranilate 
synthase (trpEG) and chorismate mutase (csm), respectively. Both pathways are subject to control 
by inhibiting the end-products. In the tryptophan synthetic pathway anthranilate is further 
synthesized to phosphoribosyl anthranilate via TrpD, which is feedback inhibited by tryptophan 
(O'Gara and Dunican, 1995). The next two steps are known to form a multifunctional protein 
consisting of TrpF and TrpC forming indole 3-glycerolphosphate via 1-(2-carboxyphenylamino)-1-
deoxy-D-ribulose 5-phosphate. In the last step tryptophan is formed by the TrpAB enzyme complex. 
In addition to the enzymatic inhibition mentioned above negative transcriptional control of all 
enzymes in the tryptophan branch has been reported at high tryptophan concentrations (Sugimoto 
and Shiio, 1977). Tyrosine is synthesized from prephenate via pretyrosine by two enzymatic 
reactions: TyrA and pretyrosine dehydrogenase (Fazel and Jensen, 1979b). Phenylalanine is 
synthesized from prephenate via phenylpyruvate. Prephenate dehydratase (pheA) catalyze the first 
step of this pathway (Follettie and Sinskey, 1986), whereas the last step is catalyzed by tyrosine 
aminotransferase (tyrAT) (Fazel and Jensen, 1979a). 
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Nucleotide Metabolism and Biosynthesis 
 
Nucleotides in the forms of ribonucleotides and deoxyribonucleotides are the building blocks of 
DNA and RNA. In addition to be part of these important macromolecules for biomass, nucleotides 
also serve as constituents for a number of co-factors (e.g. CoA, FAD, NAD and NADP). Some 
nucleotides are also used for specific purposes in cellular metabolism as it is the case for ATP in 
energy metabolism. Nucleotides consist of a nitrogenous base, a sugar and one or more phosphate 
groups. Depending on weather it is a ribonucleotide 
or a deoxyribonucleotide the sugar group is a ribose or a deoxyribose, respectively. The nitrogenous 
bases are derivatives of purine or pyrimidine. The purines in DNA are adenine and guanine, and the 
pyrimidines are thymine and cytosine. In RNA thymine is replaced by the pyrimidine uracil. The 
nucleotide metabolism in C. glutamicum has not been thoroughly investigated. The related 
Corynebacterium ammoniagenes has been used for the production of some nucleotides, such as 
inosine, IMP, GTP, and ATP, why some work on this bacteria have been done. However, 
information is still sparse. Based on the annotated genome the biosynthetic pathways for purines 
and pyrimidines were reconstructed (Figure 3.12 and Figure 3.13) 
 
 
Figure 3.12: The pyrimidine metabolic pathways based on annotated genomic data. Gray text indicates tentative gene 
names.  
  
 
 
 
 
Figure 3.13: The purine metabolic pathways based on annotated genomic data. Gray text indicates tentative gene names.  
 
  
 
 
Figure 3.14: The biosynthetic pathways of phospholipids in C. glutamicum. Phospholipids in grey ovals are 
components of the phospholipids fraction in C. glutamicum biomass. The ratio of the fatty acids and glycerol-3-
phosphate is 1:1. The ratio between fatty acids determines the composition of the phosphatidate fraction, and hence the 
fatty acid composition of the phospholipids fraction. C140ACP: Myristoyl-[acyl-carrier protein]; C160ACP: 
Hexadecanoyl-[acyl-carrier protein]; C161ACP: Palmitoyl-[acyl-carrier protein]; C180ACP: Stearoyl-[acyl-carrier 
protein]; C181: Oleoyl-[acyl-carrier protein]. All fatty acids are in activated form, so no additional energy is needed for 
biosynthesis.    
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Cell wall components  
 
The chemical structure of the C. glutamicum cell-wall have received some interest due to its role in 
amino acid export (Eggeling and Sahm, 2001). In addition C. glutamicum belongs in the same 
suborder as the important human pathogens Corynebacterium diphtheriae and Mycobacterium 
tuberculosis, which have been studied intensively (Dower et al., 2004). The cell-wall consists of a 
complex network of the polysaccharide peptidoglycan covalently linked to another complex 
polysaccharide arabinogalactan, which is further esterified with mycolic acids (Puech et al., 2001). 
Associated with, but not covalently linked to this fraction a number of lipids are also connected to 
the cell-wall, the more abundant being phospholipids and trehalose mycolates (Daffé, 2005). The 
plasma membrane of C. glutamicum mainly consists of polar lipids, of which phospholipids are the 
dominant type. The major building blocks for lipids are fatty acids. Fatty acids are synthesized by 
fatty acid syntases (FAS), and it is generally believed that C. glutamicum (based on results from 
Brevibacterium ammoniagenes) posses two fatty acid syntase I (FAS-I) genes (FAS-IA and FAS-
I2) of which one (FAS-IA) is essential for growth (Stuible et al., 1996). The C. glutamicum genome 
does not contain genes encoding for the fatty acid syntase type II system (FAS II) (Daffé, 2005). 
FAS is a protein complex which is able to synthesize fatty acids in successive additions of two 
carbon units to an activated form of acetyl-CoA (Stephanopoulos et al., 1998). The carbon units in 
the fatty acid synthesis are donated from malonyl-CoA which is formed from Ac-CoA via acetyl 
CoA carboxylase using one ATP (Stryer, 1995b). 
 
Phospholipids biosynthesis 
 
In C. glutamicum the major phospholipids constituents are oleic acid (18:1) and palmic acid (16:0) 
which contribute to more than 90% of the lipid pool of the phospholipids (Collins et al., 1982b; 
Hoischen and Krämer, 1990). In addition to these fatty acids myristic acid (14:0), pentadecanoic 
acid (15:0), stearic acid (16:1) and tuberculostearic acid (18:0) are present in minor quantities 
(Collins et al., 1982b). Based on the annotated genome and experimental data  (Hoischen and 
Krämer, 1990; Nampoothiri et al., 2002),the phospholipids biosynthetic pathways in C. glutamicum 
was reconstructed (Figure 3.14). Phospholipids are synthesized from dihydroxyacetone phosphate 
via glycerol-3-phosphate which is synthesized by the consumption of NADH. An Acyl-glycerol-3-
phosphate is further synthesized by adding fatty acids to glycerol-3-phosphate, and this step is 
repeated to form phosphatidate. The fatty acids are provided as already activated building blocks – 
conjugated to acyl carrier protein (ACP). This activation is done during fatty acid biosynthesis. 
From phosphatidate all other phospholipids are synthesized (Figure 3.14).    
 
Mycolic acids biosynthesis 
 
The majority of the mycolic acid fraction in C. glutamicum consists of the 32:2 3OH and 34:1 3OH 
mycolic acids (Collins et al., 1982a). Other mycolic acids identified are 32:0, 34:0, 36:1 and 36:2 
(Jang et al., 1997). In general two types of mycolates are considered to be present in the C. 
glutamicum cell wall: trehalose monocorynemycolate (TMCM) and trehalose decorynemycolate 
(TDCM) (Daffé, 2005). The “free” mycolic acids are known to form esters with trehalose in order 
to form mycolates where the mycolic acids are bound within the cell wall. The mycolic acid 
synthetic pathway is not well characterized, although some of the genes involved have been 
identified (Brand et al., 2003). Based on structural considerations it has been postulated that 
mycolic acids are synthesized by condensation and decarboxylation reactions (Daffé, 2005).  
 
 74 
Arabinogalactan biosynthesis 
 
Arabinogalactan is a heterogeneous polysaccharide composed mainly of galactosyl residues and 
arabinofuranosyl residues. C. glutamicum cell wall arabinogalactan consists of alternating β(1→5) 
and β(1→6) linked galactfuranose residues which are polymerized by the high-energy sugar donor 
UDP-galactofuranosyl to produce a linear galactan domain (Alderwick et al., 2005; Sanders et al., 
2001). Three branched arabinan motifs are attached to the C5 position of the β(1→6) linked 
galactose residue at the 8th, 10th and 12th galactofuranosyl residues of the galactan domain 
(Alderwick et al., 2005). The arabinan motif consist of a linear β(1→5) arabian core with branching 
introduced at specific C3 positions along the arabinan polysaccharide (Daffe et al., 1990; Alderwick 
et al., 2005). Arabinogalactan terminates with β(1→2) linked arabinofuranosyl units in a unique 
hexa-arabinofuranosyl motif. This is the site where arabinogalactans and mycolic acids are linked 
together (McNeil et al., 1991). In most mycobacterial species arabinogalactan is covalently attached 
to peptidoglycan through a phosphodiester linkage via rhamnose and glucosamine (McNeil et al., 
1990). This step has not yet been unraveled for C. glutamicum; however, it is likely that a similar 
step occurs in this organism.    
     
Peptidoglycan 
 
Peptidoglycan in C. glutamicum is thought to be similar to the most common types present in 
bacteria, and of same type as found in Escherichia coli (Wijayarathua et al., 2001). Peptidoglycan is 
synthesized from the intermediates, UDP-N-acetylmuramate, UDP-N-acetyl-D-glucosamine, L-
alanine, D-glutamate,, L-glycine, D-alanyl-D-alanine, and meso-2,6-diaminopimelate (Ingraham et 
al., 1983; Schleifer and Kandler, 1972). In figure 3.15 the reactions and corresponding genes for the 
biosyntehsis of intermediates used for peptidoglycan in C. glutamicum is presented. In addition an 
overview of the lumped polymerization reaction is shown. The polymerization consists of several 
reactions that sequentially add the amino acids to the lactyl residue of UDP-N-acetylmuramate, 
followed by addition of UDP-N-acetyl-D-glucosamine, forming a peptidoglycan subunit (Ingraham 
et al., 1983). These subunits are further polymerized, and further linked with peptide bonds by the 
expense of ATP. During this step an L-alanine molecule is liberated from the chain. Chains of 20-
80 subunits are formed (Ingraham et al., 1983). 
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Abstract  
 
A genome-scale metabolic model of the Gram-positive bacteria Corynebacterium glutamicum 
ATCC 13032 was constructed comprising 446 reactions and 411 metabolites, based on the 
annotated genome and available biochemical information. The network was analyzed using 
constraint based methods. The model was extensively validated against published flux data, and 
flux distribution values were found to correlate well between simulations and experiments. The split 
pathway of the lysine synthesis pathway of C. glutamicum was investigated, and it was found that 
the direct dehydrogenase variant gave a higher lysine yield than the alternative succinyl pathway at 
high lysine production rates. The NADPH demand of the network was not found to be critical for 
lysine production until lysine yields exceeded 55% (mmol lysine ⋅ (mmol glucose)-1). The model 
was validated during growth on the organic acids acetate and lactate. Comparable flux values 
between in silico model and experimental values were seen, although some differences in the 
phenotypic behavior between the model and the experimental data were observed. 
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Introduction 
 
The Gram-positive bacterium Corynebacterium glutamicum is used for the industrial production of 
different amino acids, of which L-lysine and L-glutamate are produced in the largest quantities with 
annual production levels of 800,000 ton and 1,300,000 ton respectively. Due to its commercial 
importance, this organism has received at lot of attention, and significant resources have been 
invested in the development of efficient producer strains. Various approaches have been pursued in 
order to improve product yield and productivity. Mutagenesis and screening have been used with 
success, but with the development of molecular biological methods metabolic engineering has been 
applied extensively also (Cremer et al., 1991; Eggeling et al., 1998). Furthermore, fluxomics 
(Wittmann and Heinzle, 2002), metabolomics (Strelkov et al., 2004) or a combination of methods 
(Krömer et al., 2004) have been used to characterize engineered strains. These studies, often where 
different parts of the cell have been studied separately, have given a lot of insight into C. 
glutamicum. However, with the development of high-throughput technologies it is believed that a 
more holistic understanding of the whole system is essential to help extracting knowledge from 
these data (Palsson, 2000), consequently allowing a better identification of targets improving yields 
and productivity. The final goal in this respect is to develop an in silico model combining kinetic 
information about specific reactions. Due to the complexity of biology and the lack of kinetic 
information, such a model has not yet been constructed for C. glutamicum or any other organism. 
The first step towards a complete model of an organism is a genome-scale metabolic 
model where the annotated genome is used in combination with available experimental data to 
create a list of reactions that then forms the basis for a stoichiometric model. This type of models 
have already been constructed for a number of species such as Saccharomyces cerevisiae (Förster et 
al., 2003), Escherichia coli (Reed et al., 2003), Lactococcus lactis (Oliveira et al., 2005), 
Staphylococcus aurerus (Heinemann et al., 2005), Streptomyces coelicolor (Borodina et al., 2005), 
Helicobacter pylori K (Schilling et al., 2002), Haemophilus influenzae (Schilling and Palsson, 
2000), Methanosarcina barkeri (Feist et al., 2006) and Lactobacillus plantarum (Teusink et al., 
2006). Besides from a convenient overview of the organism and its capabilities, stoichiometric 
models can in some cases be used to predict phenotypic behavior during different environmental 
and genetic conditions (Edwards and Palsson, 2000; Edwards et al., 2001; Oliveira et al., 2005), and 
can directly be used to test biological hypotheses (Patil et al., 2004). Stoichiometric genome-scale 
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models can be combined with data from high-throughput techniques such as transcriptomics 
(Covert et al., 2004; Åkesson et al., 2004) or fluxomics (Herrgård et al., 2006) and combining this 
with constraint-based methods (Price et al., 2003) the prediction power of the models can be 
improved. 
In this paper we present the first step towards a systematic biological model of C. 
glutamicum. A genome-scale metabolic model of the organism is constructed from the annotated 
genome of the wild type strain ATCC 13032, available literature and own experimental 
observations. The model is validated against data found in literature under different conditions such 
as different biomass production burdens and growth on different carbon sources. 
 
Materials and Methods 
 
The interconnectivity of metabolites in a network of biological reactions is given by reaction 
equations defining the stoichiometric conversion of substrates into products for each reaction 
(Schilling et al., 1999). Reactions are enzymatic reactions converting a substrate into a product, or 
transport reactions moving metabolites between different parts of the system, intracellular, 
extracellular or between different compartments. Active reactions in the biological system are 
fluxes serving to dissipate or generate metabolites. Following the law of conservation of mass, a 
balance describing the reaction rate of a particular metabolite through a particular reaction can be 
written as (Stephanopoulos et al., 1998): 
 
(eq. 1) vSrmet ⋅==0  
 
The stoichiometric matrix S is an m x n matrix where m is the number of metabolites and n is the 
number of reactions or fluxes taking place within the metabolic network. The vector v refers to the 
reaction rate of each individual reaction or flux in the metabolic network. Metabolic models usually 
also include constraints, which will lead to the definition of a solution space in which the solution to 
the network equation must lie (Price et al., 2003). Constraints in a model are dealt with by 
introducing constraint equations to the metabolic network, which can assign a direction of a given 
reaction (reversibility or irreversibility) according to known thermodynamic constraints. These 
equations are typically of the form αi ≤ vi ≤ βi, where αi and βi are the feasible lower and upper 
limit of the reaction rate vi, respectively. In practice the upper and lower limits are set to arbitrarily 
high values when a reaction is reversible without any regulation, whereas αi is set to zero when a 
reaction is irreversible. Constraint reactions can also be used to set a maximum flux through a given 
reaction based on biochemical information. 
The above described equation system is usually underdetermined due to the fact that 
the number of unknown fluxes exceeds the number of metabolites in the network, leading to a 
number of possible solutions, and hence, no unique solution (Bonarius et al., 1997). To cope with 
this linear programming/optimization can be used to maximize (or minimize) for a certain 
metabolite objective (e.g. growth or product formation) and seeking its maximal (or minimal) value 
within the stoichiometrically defined domain. This procedure is often referred to as flux-balance 
analysis (Palsson, 2006). In the present paper flux-balance analysis is carried out using linear 
optimization, where the objective functions used are optimizing for either growth or lysine 
production. Flux-balance analysis was performed using the in-house software BioOptv4.9 
employing LINDO API for linear optimization. BioOptv4.9 is available by contacting the 
corresponding author. 
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Construction of genome-scale metabolic model 
 
Genome scale metabolic models can be constructed using data from different sources. In this work 
the model was constructed in three steps: (i) construction of a crude model consisting of mass 
balances for catabolic reactions leading to the formation of metabolites; (ii) defining the reactions 
involved in polymer and biomass synthesis, and energy requirements; (iii) complete the metabolic 
network by adding missing reactions, and to revise the reactions added in the first step with respect 
to physiochemical conditions (reversibility of reactions). 
 
First step was carried out based on the published annotated genome (Kalinowski et al., 2003). The 
KEGG database (http://www.genome.ad.jp/kegg/) and the BioCyc database 
(http://www.biocyc.com/) were used in this process, because these databases present annotation of 
each gene linked to its function. In addition, these databases give a graphical overview of the 
metabolism of the organism. Data for step two was found in literature from different sources, as 
shown in the supplementary material (Appendix I). Maintenance requirements for the model was 
determined changing the ATP demand (ATP used for maintenance and assembling of 
Table 4.1: Metabolites considered being required for biomass in C. glutamicum. 
Protein (0.52 protein g/g DCW) mmol/g protein RNA (0.05 g RNA/g DCW) mmol/g RNA 
Alanine 1.268 AMP 0.69 
Arginine 0.361 GMP 1.01 
Aspartate 0.368 CMP 0.70 
Aspargine 0.368 UMP 0.70 
Cysteine 0.084 ATP (polymerization energy) 1.24 
Glutamate 1.044 Lipids (0.13 g Lipids/g DCW)  
Glutamine 0.650 Mycolic acids (0,102 g Mycolic acids/ 
g DCW) 
mmol/g mycolic 
acids 
Glycine 0.671 Trehalose monocyrynomycolate 0.061 
Histidine 0.128 Trehalose dicyrynomycolate 0.043 
Isoleucine 0.359 Free Mycolic Acids 1.875 
Leucine 0.669 Phospholids (0.028 g phospholipids/g 
DCW) 
mmol/g 
phospholipids 
Lysine 0.355 Phosphatic acid 0.033 
Methionine 0.144 Phosphatidylglycerol 1.133 
Phenylalanine 0.244 Cardiolipin 0.007 
Proline 0.303 Phosphatidyllinositol 0.042 
Serine 0.467 Phosphatidyllinositol mannoside 0.065 
Threonine 0.519 Cell Wall Carbohydrates (0.19 g Cell 
Wall Carbohydrate/g DCW) 
 
Tryptophan 0.052 Peptidoglycan (0.095 g 
peptidoglycan/g DCW)  
mmol/g 
peptidoglycan 
Tyrosine 0.148 N-acetylmuramic acid 1.026 
Valine 0.520 N-acetylglucosamine 1.026 
ATP (polymerization energy) 38.44 L-alanine 1.026 
DNA (0.01 g DNA/g DCW) mmol/g DNA Diaminopimelinic acid 1.026 
dAMP 0.748 D-glutamate 1.026 
dCMP 0.871 D-alanine 2.052 
dTMP 0.748 ATP (polymerization energy) 5.129 
dGMP 0.871 Arabinogalactan (0.095 g 
Arabinogalactan/g DCW) 
mmol/g 
arabinogalactan 
ATP (polymerization energy) 4.44 Arabinose 4.650 
  Galactose 0.498 
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macromolecules) for maximal biomass yield on substrate (Ysx) fitted experimental values. The third 
step was done by reviewing biochemical literature for C. glutamicum or by using own unpublished 
observations. 
The complete model including a list of references used for the re-construction is available as 
supplementary files (Appendix I). 
 
Biomass synthesis equations 
 
For genome scale metabolic models the equations defining the biomass synthesis in a genome-scale 
model are important. The biomass-equation consists of reactions converting single molecules into 
macromolecules, which are building blocks of the biomass. For each macromolecule an equation 
was formulated based on literature, and energy consumption associated with the assembling 
reactions was also included (see supplementary material – Appendix I). The representative averaged 
biomass composition of a C. glutamicum strain can be seen in table 4.1. Since no data on energy 
requirements for polymerization of macromolecules in C. glutamicum could be found, these values 
were approximated using values for E. coli (Ingraham et al., 1983). The macromolecule 
components were lumped in a final biomass assembly reaction based on their weight fraction of the 
biomass. In our model we included protein, DNA, RNA and cell-wall components as 
macromolecules.  The macromolecular composition of biomass was taken from Cocaign-Bousquet 
et al., (1996) whereas composition of each macromolecule was taken from different references (see 
supplementary material – Appendix II). This same biomass composition was used for all our 
simulations. 
 
Macromolecular composition 
Data for the amino acid composition of the protein fraction in C. glutamicum was taken from 
Cocaign-Bousquet et al., (1996). The composition of the DNA was calculated based on G+C-
content of the genomic sequence of C. glutamicum ATCC 13032 (Kalinowski et al., 2003). It was 
assumed that RNA consisted of 5% mRNA, 75% rRNA and 20% tRNA (molar). The nucleotide 
composition of mRNA was taken as for genomic DNA. The nucleotide composition of rRNA was 
calculated from the sequences of 16S, 23S and 5S ribosomal RNA units. And finally tRNA 
composition was found from sequences of leucine and glycine transporting RNAs. Sequences were 
downloaded from GenBank (http://www.ncbi.nlm.nih.gov). 
 
The chemical structure of the C. glutamicum cell-wall has been intensively studied and consists of a 
complex network of the polysaccharide peptidoglycan covalently linked to another complex 
polysaccharide arabinogalactan, which is further esterified with mycolic acids (Puerch et al., 2001). 
Associated with, but not covalently linked to this fraction a number of lipids are also connected to 
the cell-wall, the more abundant being phospholipids and trehalose mycolates (Daffé, 2005). For 
simplification the cell-wall components mentioned above have been divided into individual lumped 
reactions which are part of the biomass equation based on their fraction. 
The plasma membrane of C. glutamicum mainly consists of polar lipids, of which phospholipids are 
the dominant type. In C. glutamicum the major phospholipids constituents are oleic acid (18:1) and 
palmic acid (16:0), which contribute to more than 90% of the lipid pool of the phospholipids 
(Collins et al., 1982b; Hoischen and Krämer, 1990). In addition to these fatty acids, myristic acid 
(14:0), pentadecanoic acid (15:0), stearic acid (16:1) and tuberculostearic acid (18:0) are present in 
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minor quantities (Collins et al., 1982b). Based on the published data of C. glutamicum a lumped 
reaction with molar ratios of each individual phospholipid was made. 
 
The stoichiometric equation formation of peptidoglycan was described by a lumped reaction. The 
molar composition was estimated based on data from different sources (Daffé, 2005; Keedie and 
Cure, 1978).  Also the arabinogalactan fraction was described by a lumped reaction due to its 
complexity. Data used was taken from (Puerch et al., 2001). 
The mycolic acid synthetic pathway is not well characterized, although some of the genes involved 
have been identified (Brand et al., 2003). Based on structural considerations it has been postulated 
that mycolic acids are synthesised by a condensation and decarboxylation reactions (Daffé, 2005). 
The “free” mycolic acids are known to form esters with trehalose in order to form mycolates were 
the mycolic acids are bound within the cell wall. The majority of the mycolic acid fraction consists 
of the 32:2 3OH and 34:1 3OH mycolic acids (Collins et al., 1982a). Other mycylic acids identified 
are 32:0, 34:0, 36:1 and 36:2 (Jang et al., 1997). In general two types of mycolates are considered to 
be present in the C. glutamicum cell wall: trehalose monocorynemycolate (TMCM) and trehalose 
decorynemycolate (TDCM) (Daffé, 2005), both of which was included in the model. Data from 
Daffé (2005) was used to make a lumped reaction for the mycolic acid fraction of the cell. 
 
Energy requirements for growth and maintenance 
 
In addition to the stoichiometry of each individual macromolecule and the overall biomass 
assembling reaction, the stoichiometry of the growth and non-growth associated energy connected 
to biomass is important in a metabolic model. In our model we used the value of 29.2 mmol ATP · 
(g biomass)-1 for growth associated ATP demand as estimated by Cocaign-Bousquet et al. (1996) 
based on experimentally determined macromolecule composition of C. glutamicum and known 
anabolic pathways. ATP demand for growth associated maintenance reactions was found by fitting 
the biomass yield to experimental value of 0.61 g biomass· (g glucose)-1 found by Cocaign-
Bousquet et al. (1996). ATP requirements for growth were kept constant for biomass synthesis for 
all simulations, as generally done in flux-balance analysis simulations. 
 
Simulation methods 
 
As mentioned above, linear optimizations were conducted using the BioOptv4.9 software. Split 
points in the network solutions were checked to see if the results were unique, or if other optima 
were possible. Results presented in this paper were unique, unless else is mentioned. The NADPH 
generating reaction catalyzed by malic enzyme (EC 1.1.1.40) and the reaction decarboxylating 
oxaloacetate catalysed by oxaloacetate decarboxylase (EC 4.1.1.13) were constrained to zero when 
glucose was used as carbon source based on biochemical evidence (Petersen et al., 2000). 
 
Results & Discussion 
 
Reconstruction of the Corynebacterium glutamicum metabolic network: 
We constructed a genome scale model of the C. glutamicum metabolic network (for statistics see 
table 4.2). The constructed metabolic network consisted of 446 reactions, all of which were unique 
(iso-enzymes were removed), which represent 15% of the protein encoding genes identified in C. 
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glutamicum (Kalinowski et al., 2003). 411 metabolites were involved in the metabolic network of 
which 55 were involved in transport reactions, and had an internal equivalent (Table 4.2). 
 
Energy requirements for biomass formation 
Macromolecule composition of biomass was taken from Cocaign-Bousquet et al. (1996). ATP 
demand for biomass assembly was set to 29 mmol · (g biomass)-1 (Cocaign-Bousquet et al., 1996), 
and ATP demand for maintenance was adjusted so the maximum biomass yield (g biomass · (g 
glucose)-1) was 0.61 (Cocaign-Bousquet et al., 1996). The ATP demand for maintenance was found 
to be 19 mmol · (g biomass)-1, which is higher than values earlier reported in literature (1.8-9.2 
mmol ATP (g biomass)-1) (de Graaf, 2000; Verela et al., 2004). The high ATP demand for 
maintenance may be due to an underestimated growth associated ATP demand. Another reason may 
be that the composition of the respiratory chain affects the P/O-ratio and hence the ATP yield (Bott 
and Niebisch, 2003). When maximizing for growth the in silico model uses the most efficient 
oxidative phosphorylation, which may not be the case in reality. 
 
Model validation 
 
Simulations for model validation were carried out according to what is described in the section 
“simulation details”. Simulations were done by maximizing for lysine production and constraining 
biomass production. 
 
Pentose phosphate pathway (PPP) fluxes 
 
The genome-scale metabolic model was validated against published data on metabolic flux 
distributions during various growth- and lysine production regimes, and with different strains. The 
publications used for this comparison were Krömer et al. (2004); Wittmann and Heinzle (2001); 
Wittmann and Heinzle (2002) and Vallino & Stephanopoulos (1993). The data-sets Krömer et al. 
(2004), Wittmann and Heinzle (2001) and Wittmann and Heinzle (2002) were all based on batch 
cultivations where flux distributions were determined using 13C-labelled glucose, whereas Vallino 
& Stephanopoulos (1993) used bioreaction network analysis for estimation of flux distributions. 
Table 4.2: Statistics for the genome scale model 
  
Total Genes in C. glutamicum (ORFs) 3002 
  
  
Reactions in genome scale model 446  
Biochemical evidence 213  
Clear function (functional annotation derived from probable homologues) 209 
Tentative function (functional annotation derived from tentative homologues) 22 
Putative function (added reactions to complete network) 2 
  
Active reactions during growth on glucose 199  
  
Metabolites in genome scale model 411 
Internal metabolites 356 
External metabolites (metabolites involved in transport reactions) 55 
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The individual datasets for the three first references were selected to give the same lysine yields 
(18%) and three different stains were represented (ATCC 13287, ATCC 21253 and ATCC 21526, 
respectively). The fourth data-set from Vallino and Stephanopoulos (1993) was selected to have a 
data point at a higher lysine yield (30%). All the flux data are from balanced growth conditions, and 
details on how the fluxes were found are given in the original papers. In silico simulations were 
carried out yielding lysine conversion yields in the range of the values found in the published data, 
in this case being 18% (mmol lysine · (mmol glucose)-1) and 30%, respectively. In all the 
experiments used to validate the model the biomass yields were lower than the in silico model (in 
same order as above: 0.38; 0.33; 0.26 and 0.27 g biomass ⋅ (g glucose)-1)) which could partly be 
explained by the fact that by-products in all cases were produced, which were not the case for 
simulations. Moreover, stoichiometric parameters such as the P/O ratio and ATP yields and 
maintenance requirements may change due to different strain backgrounds and growth conditions. 
Although all three references of Krömer et al. (2004), Wittmann and Heinzle (2001) and Wittmann 
and Heinzle (2002) showed lysine yields of 18%, some variation in fluxes from reference to 
reference were seen (Figure 4.1; 3 first fluxes from the top). At the level of glucose-6-phosphate 
where this compound is converted either towards the pentose phosphate pathway (PPP) or the 
glycolysis a 12% absolute difference was seen (59% to 71% towards PPP) between the fluxes in the 
experiments. The in silico model predicted a 61% flux towards PPP at this split, which correlated 
well with two of the experiments (Figure 4.1) (Krömer et al., 2004; Wittmann and Heinzle, 2002), 
whereas the flux was higher (71%) for the data of Wittmann and Heinzle (2001) (Figure 4.1). For 
the three experiments the tricarboxyic acid (TCA)-flux ranged from 46% to 68% whereas the model 
simulated value was 51% (Figure 4.1). 
When simulations were carried out fitting the data of Vallino and Stephanoupoulos 
(1993) (Figure 4.1), a higher flux through the PPP was seen for the model (84%) than it was the 
case for literature values (69%). Instead Vallino and Stephanopoulos (1993) saw a higher flux 
through the TCA (46%) when compared to the in silico model (36%). Instead the anaplerotic flux 
from pyruvate/phosphoenolpyruvate into oxaloacetate was higher for the model (48%) than for the 
data of Vallino and Stephanopoulos (1993) (41%). Although differences were seen between the 
published data and the in silico model, fluxes were all in the same range, and coherence between 
experimental data and model data could be recognized. 
Data from Vallino and Stephanoupoulos (1993) was taken at early exponential phase, 
just as lysine synthesis had initiated after the depletion of threonine, and with a high growth rate. 
Looking at data from the same reference for late exponential phase, the difference between model 
predictions and observed values were bigger (data not shown), even though lysine yields were only 
marginally changed. The PPP-flux decreased to 41% and the TCA-flux increased to 70% (Vallino 
and Stephanopoulos, 1993). The change in fluxes was thought to be due to a decrease in growth 
rate, which were followed by ATP excess (Vallino and Stephanopoulos, 1993). The excess ATP 
needed to be consumed i.e. through futile cycles, which lead to a redirection of carbon from the PPP 
towards the TCA cycle due to biological regulatory issues. Such changes in metabolism due to 
biochemical regulation can not be predicted by the model, since it doesn’t take biological and 
biochemical regulations into account. 
 
Glycolysis fluxes 
 
Model flux values through the glycolysis were in general consistent with observed experimental 
values. A higher drain of carbon from glycolysis was seen in data from Krömer et al. (2004) when 
compared to model values and other experimental values. This can partly be explained by by-
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product formation, where significant amounts of extra-cellular glycerol and dehydroxyacetone 
phosphate were observed (Krömer et al., 2004). 
 
Relationship between PPP- and TCA-fluxes during lysine production 
 
It is known that the relationship between the TCA and the PPP is important for lysine production 
since a high reaction rate of the PPP is necessary to support NADPH generation when lysine 
synthesis is high. A tendency for this correlation can be seen from experimental data from literature 
when TCA- and PPP-fluxes at different lysine yields are compared (Figure 4.3; symbols), a 
correlation which have also been suggested by Kelle et al. (2005). Such a correlation is also 
predicted by the model (Figure 4.3; lines). In general the TCA-flux was higher for the experimental 
values when compared to the model, and the PPP-fluxes for the experimental data presented here 
were in most cases lower than values for the corresponding in silico simulations. The reason for the 
generally lower TCA-fluxes for the in silico model when compared to experimental data was the 
higher anaplerotic netflux, which from a stoichiometric point of view is optimal for lysine 
production. The in silico model will per definition chose this pathway which may not be the case in 
reality, where biological regulation will affect the operation of the biological network. 
 
 
A bend of both the TCA-flux and the PPP-flux curves were seen for the in silico flux 
data when lysine yield exceeded 55% (Figure 4.3). At this point a flattening of the curves was 
observed (the TCA-flux decreased at a lower rate and the PPP-flux increased at a lower rate). This 
metabolic change is discussed further in the next section. Some of the differences in flux 
distributions between the experiments mentioned above can probably be explained by different 
strain backgrounds, and different cultivation conditions. 
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Figure 4.1: Flux distribution values for genome-scale model simulations (shown in grey boxes) and literature values 
(shown in red ovals) found by metabolic flux analysis. Flux values are expressed as molar percentage of the specific 
uptake of glucose. When no flux was available from the data the symbol (-) was used. Ysx values for the model 
simulations was constrained to 0.48 and 0.40 (g biomass · (g glucose)-1), from top and down. Literature values were taken 
from (from top and down): Krömer et al. (2004); Wittmann and Heinzle (2001); Wittmann and Heinzle (2002) and 
Vallino and Stephanopoulos (1993). Abbreviations:  GLCex: extracellular glucose; G6P: glucose-6-phosphate; F6P: 
fructose-6-phosphate; P5P: pentose-5-phosphate; E4P: erythose-4-phosphate; S7P: sedoheptulose-7-phosphate; DHAP: 
dihydroxyacetone phosphate; G3P: glyceraldehyde phosphate; PEP: phosphoenolpyruvate; PYR: pyruvate; Ac-CoA: 
acetyl CoA; ICIT: isocitrate; AKG: α-ketogluterate; SUCC: succinate; OA: oxaloacetate; PIPER26DC: L-piperidine 2,6-
dicarboxylate; MDAPIM: meso-2,6-diaminopimelate.                                                 
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Maximizing for lysine production 
 
Simulations for lysine production were done by maximizing for lysine production as the objective 
function, and constraining biomass production at different levels (see text for details). Simulations 
were carried out according to what is described in the section “simulation details”. 
 
Negative effect of ATP excess on lysine production 
 
The maximum lysine yields were found constraining the biomass yields at different levels using the 
genome-scale model (Figure 4.4A and 4.5A). The model predicted a maximum lysine yield of 75% 
when no biomass was produced (Figure 4.4A and 4.5A), which is the maximum theoretical value 
for this organism (Stephanopoulos and Vallino, 1991). As biomass synthesis increased towards the 
maximum, lysine yields decreased (Figure 4.4A and 4.5A). The decrease observed was not linear as 
a bend of the curve was observed when the lysine yield was around 55%, and Ysx-values were 20%, 
corresponding to a decreasing Yxp-value: less lysine was produced per cell unit (Figure 4.4A). Also 
when plotting the TCA- and PPP-flux data versus the lysine yield, a bend is observed at a yield of 
55% (Figure 4.3). This shift in the central metabolism was investigated, and it was found that the 
change was due to a change in ATP availability, where the regime was changed from an ATP 
limiting condition to an ATP excess condition. During the synthesis of lysine in C. glutamicum, a 
net ATP-production is seen. ATP is consumed for biomass related reactions, however when the 
ATP produced during lysine production exceeds the ATP demand for biomass synthesis, ATP is in 
 
Figure 4.3: Flux through the TCA cycle and the Pentose phosphate pathway (PPP) at different lysine 
conversion yields. Black line: PPP flux for in silico organism; Grey line TCA flux for in silico organism. Open
symbols are PPP fluxes and filled symbols are TCA fluxes from experimental metabolic flux analysis from 
different references. Squares: Wittmann and Heinzle (2002); diamonds: Marx et al. (1999); Triangles: Vallino et 
al. (1993); Circles: Marx et al. (1997); Crosses: PPP data from Sonntag et al (1995). 
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excess. The way the model copes with this, is to burn ATP in a number of futile cycles, of which an 
example can be recognized in figure 4.5A, bottom flux, where a futile cycle between the C3-pool 
(pyruvate) and the C4-pool (oxaloacetate) can be recognized with the net reaction of ATP → AMP 
+ Pi + Pi. This change from ATP limitation to ATP excess changes the regime and hence can 
explain the changes observed in figure 4.5A and figure 4.3. 
 
 
 
 
 
 
 
 
Split in the lysine synthetic pathway and its effect on lysine yield 
 
In the lysine synthesis pathway of C. glutamicum two pathways are possible. Either the direct 
dehydrogenase variant (ddh), or the succinylase variant which involves four reactions (Schrumpf et 
al., 1991). When using the genome-scale model for maximizing for lysine production the 
dehydrogenase variant is always preferred. This is due to the fact that the succinylase variant 
consumes the intermediate succinyl-CoA, which is an intermediate of the TCA cycle, requiring this 
to be active during lysine synthesis, which is not the case when the dehydrogenase variant is used. 
The exclusive use of the dehydrogenase variant is however far from reality based on experimental 
data, which shows that both variants most often are used at different ratios. Experiments have 
shown that the ratio between the two variants varies between a ratio higher than 2:3 for the 
succinylase variant with values ranging from 67-68% (Sonntag et al., 1993) to 72-89% (Wittmann 
and Heinzle, 2002), and with the dehydrogenase variant being the dominant pathway with values of 
63% (Wittmann and Heinzle, 2001) using this pathway. The flux ratio between the two variants was 
even shown to change through a fermentation starting with a 72% flux through the dehydrogenase 
variant, decreasing to around zero at the end of the fermentation (Sonntag et al., 1993). This 
difference in the ratio of these two pathways was also seen for the experiments selected for the 
 
 
Figure 4.4: Simulation results for in silico model when maximizing for lysine production and constraining biomass 
production. Results presented as lysine yield (Ysp) as a function of the biomass yield (Ysx) both expressed as 
percentage. A) In silico model with dehydrogenase branch 100%. B) In silico model with dehydrogenase branch 
constrained to zero.      
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Figure 4.5: Flux distribution values (shown in grey boxes) for in silico simulations maximizing for lysine production 
constraining biomass production at different levels. Fluxes expressed as molar percentage of specific glucose uptake. 
Biomass yield (Ysx) constrained to (from top and down) 0.60, 0.50, 0.30, 0.10 and 0.0 (g biomass · (glucose)-1. A) 
Direct dehydrogenase variant of lysine synthesis pathway used. B) Succinylase variant of lysine synthesis pathway 
used. Abbreviations see figure 1.      
 
validation (Figure 4.1). Either the dehydrogenase variant was used alone (Figure 4.1; top), or a 
combination of the dehydrogenase variant and the succinyl variant with different ratios was seen 
(Figure 4.1; 2nd and 3rd value from the top). As mentioned earlier a significant difference was seen 
between the TCA-fluxes for the experiments shown in figure 4.1. In addition it can be seen that for 
the first three experiments (Krömer et al., (2004); Wittmann and Heinzle, (2001); Wittmann and 
Heinzle, (2002)), the flux through the TCA cycle and the route which was used through the lysine 
pathway (dehydrogenase variant or succinylase variant) correlated, so when a high flux through the 
succinylase variant was seen, a higher TCA-flux could be observed. This observation may explain 
some of the differences seen between the TCA-fluxes and the anaplerotic netfluxes (Figure 4.2). 
Based on these observations it was considered relevant to make simulations constraining the 
dehydrogenase variant to zero, in order to investigate the effect of this pathway on lysine yields. 
From these simulations it was seen that the maximum lysine yield dropped to 57%, when no 
biomass was produced (Figure 4.5B). The simulation results showed that as the carbon demand for 
biomass production was increased, the difference in lysine yields decreased, and at Ysx values 
higher than 40% (g biomass · (g glucose)-1) the maximum theoretical lysine yields were only 
marginally different, with the dehydrogenase variant being the most efficient pathway (Figure 4.4A 
and 4.4B). At high growth rate the TCA activity required for biomass synthesis was sufficient to 
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produce succinyl-CoA for lysine production via the succinyl branch. The succinylase variant of the 
lysine synthetic pathway is competing for succinylase-CoA with the TCA reaction succinyl-CoA 
synthease converting succinyl-CoA to succinate with the formation of an ATP. The marginally 
higher lysine yield for the dehydrogenase variant during high biomass formation could be explained 
by the missing ATP from the succinyl-CoA synthease reaction. Furthermore, it was seen that the 
decrease in the maximum lysine yield was due to the requirement for a higher activity of the TCA 
to support lysine synthesis with succinyl-CoA (Figure 4.5). As a consequence more CO2 was 
produced and carbon was lost. For simulations where the biomass formation was constrained to 
zero, the flux through the PPP was significantly lower (86%) for the ddh-negative strain (Figure 
4.5B), when compared to simulations where the dehydrogenase variant was used (150%) (Figure 
4.5A), and for the latter a cycling of the PPP was seen. The loss in carbon is due to the fact that the 
PPP is more efficient in NADPH generation (2 NADPH per CO2) than the TCA cycle (1 NADPH 
per CO2). If the efficiency of NADPH generation for the PPP was set to 1 mole of NADPH per 
CO2, the maximum lysine yield was found to be 57% as it was the case for the ddh-negative in 
silico strain (data not shown), indicating that the difference seen on the maximum yield between the 
two strains could be explained entirely by the increased activity of the TCA cycle. For the ddh-
negative in silico strain a bend of the curve was seen (Figure 4.4B; grey line), as it was observed for 
simulations using the dehydrogenase branch, although the bend was seen earlier. The explanation 
for this bend was however different. In the case of the ddh-negative strain it was due to a limitation 
of succinyl-CoA, and not related to ATP excess as it was the case where the dehydrogenase variant 
was exclusively used. Based on these results, the ddh-gene looks like a promising target for 
overexpression by metabolic engineering. ddh has already been investigated as a potential 
bottleneck in lysine production. The results have been inconsistent since both positive effects 
(Schrumpf et al., 1991) (2-5-fold decrease in lysine accumulation when ddh was knocked out) and 
negative effects (Eggeling et al., 1998) (10-30% decrease by up-regulation of ddh) on lysine 
production by altering the flux through this pathway have been seen. For the latter no growth rate 
was reported for the ddh-up-regulated strain. However, for the parental strain a specific growth rate 
of 0.27 hr-1 was reported. If it is assumed that the ddh-up-regulated strain had the same specific 
growth rate it is possible that TCA activity was sufficient to support the succinylase variant with 
succinyl-CoA, hence abolishing the potential positive effect of the genetic manipulation. Based on 
the reported simulations and the experimental work done so far on this target it would be interesting 
to investigate this pathway more intensively, since there is - from a theoretical point of view - a 
large potential for improving lysine production, at least when we are getting closer to the theoretical 
maximum for this organism. 
 
NADPH or NADH dependent Glutamate Dehydrogenase 
 
The simulation experiments comparing two different glutamate dehydrogenases were carried out 
according to what is described in the section “simulation details”, except that the NADPH-
dependent glutamate dehydrogenase (gdh) was replaced with a NADH-dependent glutamate 
dehydrogenase in some cases. The objective function used was maximization for lysine production 
and biomass was constrained to different levels as described in the text. 
 
Marginal improvement in lysine production, but significant redistribution of central carbon 
metabolis, as an effect of NADH-dependent glutamate dehydrogenase. 
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For the synthesis of one mole of lysine four molecules of NADPH is consumed. For this reason the 
NADPH supply in C. glutamicum has received a lot of attention. Marx et al. (1999) addressed this 
challenge by replacing the NADPH-dependent glutamate dehydrogenase (gdh) with an NADH-
dependent gdh. However, this change in the metabolism of the organism did not result in improved 
lysine production. Instead significant redistribution of the central metabolism was observed, 
consequently leading to increased biomass production and lower lysine yield (Marx et al., 1999). 
The study made by Marx et al. (1999) was used as a case study for the genome-scale model. 
Simulation experiments were carried out replacing the NADPH-dependent gdh-reaction with an 
NADH-dependent gdh-reaction, and the results were compared to “wild type” simulations with a 
NADPH-dependent gdh-reaction. Simulation data was further compared to experimental data. 
Simulation experiment data showed general higher lysine production with the NADH-
dependent gdh. However, the effect was only marginal when the biomass yield exceeded Ysx-values 
of about 0.15 g biomass · (g glucose)-1 consumed (Figure 4.6), which is typically the case in real 
fermentations. The maximum theoretical yield was increased to 80% (Figure 4.6). As it was seen in 
the work of Marx et al. (1999), the model predicted a higher lysine yield (45%: Figure 4.7A) for the 
in silico strain carrying the NADPH dependent gdh-reaction, than for the strain substituted with the 
NADH- dependent gdh-gene (39%: Figure 4.7B) when the biomass formation was constrained at 
the same values as reported in the experiments (0.28 and 0.33 g biomass · (g glucose)-1 for the 
NADPH-dependent strain and NADH-dependent strain respectively). However, the difference was 
lower than it was seen in the experimental work (30% for the NADPH-dependent strain and 18% 
for the NADH-dependent strain). 
 
Figure 4.6: Simulation results maximizing for lysine production constraining biomass formation at different levels. 
Results shown are in silico strains (Black line: NADPH dependent glutamate dehydrogenase (gdh); Grey line: 
NADH dependent gdh) and experimental data from Marx et al. (1999) (square: NADPH-dependent gdh; Triangle: 
NADH-dependent gdh).     
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To eliminate the effect of the different biomass formation that was seen in the 
experimental work, simulations were carried out constraining the biomass at the same rate (0.30 g 
biomass · (g glucose)-1 consumed). The result gave a higher lysine yield (43%) for the NADH 
dependent strain when compared to the NADPH dependent strain (42%). This marginal increase 
was due to a small increase in Ysx for the NADH-dependent strain compared to the NADPH-
dependent gdh-strain, resulting in more carbon being available for lysine synthesis. The simulation 
data showed a decreased NADPH generation for the in silico strain containing the NADH-
dependent gdh when compared to the NADPH-dependent strain (161% and 222%, respectively). As 
expected the moles of NADPH consumed per mole of lysine produced was lowered significantly for 
the NADH-dependent strain. The minimum theoretical requirement for NADPH was lowered from 
4.0 to 3.0 (NADPH per lysine) in the NADH-dependent gdh strain (without any biomass 
production) when compared to the strain with a NADPH-dependent gdh (data not shown). 
Simulations using the same biomass production burdens (0.30 g biomass · g glucose-1 consumed) 
also showed a lower demand for NADPH. The strain with a NADH dependent gdh used 3.8 moles 
of NADPH per mole of lysine produced, whereas the strain with the NADPH-dependent gdh used 
 
 
Figure 4.7: Flux distribution values for genome-scale model simulations (shown in grey boxes) and literature 
values from Marx et al. (1999) found by metabolic flux analysis (shown in red ovals). All fluxes are expressed as 
molar percentage of specific glucose uptake. Upper simulation value biomass production (Ysx) constrained as 
experimental value (0.28 g biomass · (glucose)-1 for 7A) and 0.33 g biomass · (glucose)-1 for 7B)). Lower  
simulation value Ysx constained to 0.30 g biomass · (glucose)-1 for both 7A) and 7B. 7A) Flux distribution values 
for experimental strain or in silico strain with NADPH dependent Glutamate dehydrogenase (GDH). 7B) Flux 
distribution values for experimental strain or in silico strain with NADH dependent GDH. Abbreviations as for 
figure 1.   
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5.6 moles of NADPH per mole of lysine. The experimental data from Marx et al. (1999) showed a 
higher NADPH demand per mole of lysine produced (7.7 moles per lysine and 6.6 moles per lysine 
for the NADH-dependent strain and NADPH-dependent strain, respectively). These higher values 
were due to the relatively low lysine yields as compared to simulations, and the lower NADPH 
demand for the NADPH-dependent strain can be explained by the lower flux of metabolites towards 
biomass formation as compared to the NADH-dependent strain. 
In conclusion a significant redistribution of the central metabolism of the in silico 
organism is observed as an effect of the substitution of the NADPH-dependent gnd with a NADH-
dependent gnd. Although the model is unable to predict the precise change in phenotypic behavior 
(Increased growth and absolute change in carbon flux distributions), the simulation results are 
surprisingly consistent with the results of Marx et al. (1999). In addition the model predicts a higher 
lysine production with the NADH-dependent gdh strain. However, the improvement is only 
marginal when the biomass yield exceeds 15% of glucose consumption and an improvement on 
lysine yield is only seen when this is already high (Ysp> 55%) (Figure 4.6). That NADPH is not 
limiting on lysine production, and that the central carbon metabolism is able to adjust to NADPH 
requirements of the cell is now generally accepted based on experimental studies on the regulation 
of the PPP (Moritz et al., 2000; Vallino and Stephanopoulos, 1994). It would however be interesting 
to see if this is also the case when lysine yields approaches the theoretical maximum, and some 
recent results have in fact indicated that this is the case, as it was seen by Becker et al. (2005) where 
genetic manipulations leading to an increased PPP-flux resulted in increased lysine production. 
 
Growth of C. glutamicum on lactate and acetate 
 
Simulations for growth on lactate and acetic acid were conducted by maximizing for growth as the 
objective function. Simulations were carried out according to what is described in the section 
“simulation details”, except no constraints were made on the two reactions catalyzed by malic 
enzyme and oxaloacetate decarboxylase. In some cases constraints were made on individual 
reactions, which are described in the text. 
C. glutamicum is able to grow on various substrates including a number of organic 
acids such as lactate (Cocaign-Bousquet and Lindley, 1995) and acetate (Wendisch et al., 2000). 
Simulations were carried out using acetate and lactate as carbon source, and the results were 
compared to results found in literature. 
 
Lactate as carbon source 
 
Simulations maximizing for growth was carried out when lactate was used as a carbon source 
(Figure 4.8). As expected the in silico organism could utilize lactate as a carbon source. The 
maximum biomass yield on substrate was 0.54 g biomass · (g lactate)-1, which was lower than when 
glucose was used as a substrate (0.61 g biomass · (g glucose)-1). The difference was due to the lower 
efficiency in ATP- and NADPH synthesis, when the gluconogenetic pathways were included in the 
model. Experimental data for a carbon limited chemostat showed a biomass yield of 0.36 g biomass 
· (g lactate)-1 (D = 0.17 hr-1) whereas the yield increased as dilution rate was increased (Cocaign-
Bousquet and Lindley, 1995). It needs to be emphasized that in the biomass yield calculations made 
by Cocaign-Bousquet and Lindley (1995) the pyruvate produced as a byproduct was subtracted 
from the substrate carbon, so the biomass yield on lactate including pyruvate production in reality 
was lower.  For a dilution rate of 0.28 hr-1 the biomass yield was 0.42 g biomass · (g lactate)-1 (0.3 g 
biomass · (g lactate)-1 when pyruvate production was taken into account). At this dilution rate the 
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chemostat was not carbon limited, and an overflow of pyruvate was seen resulting in excretion of 
this compound. At the organisms maximum growth rate (μ = 0.35 hr-1) a biomass yield of 0.61 g 
biomass · (g lactate)-1 (0.4 g biomass · (g lactate)-1 when pyruvate production was included) was 
seen, and the efflux of pyruvate was further increased. When comparing experimental data with 
simulation data, it was seen that the model data (Figure 4.8; grey boxes) was comparable to the data 
for the carbon-limited chemostat with μ = 0.17 hr-1 (Figure 4.8; red ovals 1st flux from the top), 
whereas for data for the maximum growth rate (μ = 0.35 hr-1), fluxes around phosphoenolpyruvate, 
pyruvate, oxaloacetate and malate were significantly different (Figure 4.8; red ovals 2nd flux from 
top). In addition to this an efflux of pyruvate (21% of lactate uptake), and a reduced flux through 
the TCA was observed (Cocaign-Bousquet and Lindley, 1995). Looking more into details of the 
experimental data at high growth rates, and hence high substrate uptake rates, growth rate 
 
Figure 4.8: Metabolic flux distribution of C. glutamicum growing on lactate and maximizing for growth. All 
fluxes are expressed as molar percentage of the specific uptake rate of lactate. Numbers in red ovals are taken from 
Cocaign-Bousquet and Lindsley (1995). Upper flux μ = 0.17 hr-1; lower flux μ = 0.35 hr-1. Numbers in grey boxes 
are results from simulations with in silico organism. LACex: extracellular lactate; PYRex: extracellular pyruvate. 
Other abbreviations see figure 1. 
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limitations within the central metabolism were observed (Cocaign-Bousquet and Lindley, 1995). 
During these conditions some enzymes became rate limiting, and the organism found alternative 
pathways which could not be predicted by the model. 
One major difference between the model and the experimental data was the operation 
of an alternative NADPH supply by a cyclic operation of pyruvate carboxylase, coupled to a 
reversed flux through malate dehydrogenase, converting oxaloacetate to malate, and then back to 
pyruvate using malic enzyme. The net result of this cycling was the generation of a NADPH using 
an ATP and a NADH. This behavior was not predicted by the in silico model. However, when 
simulations were carried out constraining the flow of pyruvate limiting the flow towards Ac-CoA as 
it was seen in the data of Cocaign-Bousquet and Lindley (1995), the same flux patterns could be 
recognized (data not shown). The maximum biomass yield was decreased to 0.52 g biomass · (g 
lactate)-1 under these conditions. The model could not predict the behavior observed in the 
 
Figure 4.9: Metabolic flux distribution of C. glutamicum growing on acetate and maximizing for growth. All fluxes are 
expressed as molar percentage of the specific uptake rate of acetate. Numbers in red ovals are taken from Wendisch et al. 
(2000).  Numbers in grey boxes are results from model simulations. ACex: extracellular acetate. Other abbreviations see 
figure 1. 
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experiment, because this flux distribution is not the most stoichiometrically efficient for the in silico 
organism. However, in silico model predictions were close to the results obtained in the work of 
Cocaign-Bousquet and Lindley (1995) when no rate limitations were seen. 
 
Acetate as carbon source 
 
Maximization for growth was simulated during growth on either acetate as single carbon source 
(Figure 4.9), or during simultaneous acetate and glucose consumption (data not shown). The 
maximum biomass yield on acetate (0.48 g biomass · (g acetate)-1) was found to be lower than on 
glucose (0.61 g biomass · (g glucose)-1), and the glyoxylate shunt was observed to be active. Both 
observations were consistent with experimental data (Wendisch et al., 2000), although biomass 
yields for the experimental data was lower being 0.24 g biomass · (g acetate)-1 and 0.34 g biomass · 
(g glucose)-1 for acetate and glucose respectively. 
It was observed that no growth was possible for the in silico organism when the 
glyoxylate shunt was shut down (data not shown), which was also observed by Wendisch et al. 
(2000). During optimal growth the model predicted a flux through the glyoxylate cycle 
corresponding to 25% of the substrate uptake (Figure 4.9). This flux was 18% for the experimental 
data of Wendisch et al. (2000). Further investigation of the glyoxylate shunt branch point showed, 
that when the carbon flux through the glyoxylate shunt was constrained to 18% of the acetate 
uptake, the biomass yield was lowered to 0.35 g biomass · (g acetate)-1 (data not shown). When the 
carbon flux through the glyoxylate shunt was increased by constraining this flux, a decrease in the 
biomass yield was seen (data not shown), indicating that the carbon flux predicted by the model is 
truly a maximum for the in silico organism. 
The model predicted that the flux through the PPP was entirely omitted, and NADPH 
needed for biomass was solely generated by the isocitrate dehydrogenase reaction, whereas the data 
of Wendisch et al. (2000) showed a low flux (4%) through the PPP. When PPP-flux was 
constrained to 4% simultaneously with the glyoxylate shunt constrain above, the biomass yield 
further decreased to 0.33 g biomass · (g acetate)-1. The TCA-flux was higher for the experimental 
data as it was the case for the model. 
Simulations for co-metabolism of acetate and glucose were carried out (data not 
shown). Wendisch et al. (2000) found that the glyoxylate cycle was active during co-metabolism of 
these two substrates, which was a surprise since this was not seen for E. coli cells grown under the 
same conditions (Walsh and Koshland, 1985), and since this pathway is not essential when glucose 
is present. The model predicted the same behavior when substrate uptake was constrained at the 
same levels (data not shown). However, when the glyoxylate cycle was removed from the model 
the growth yield of the organism was not altered (data not shown), which in practice means that 
from a stoichiometric point of view it is insignificant which route is used under the given 
conditions. The preferred use of the glyoxylate route in Wendisch et al. (2000) is probably due to 
acetate specific induction, which earlier has been seen for C. glutamicum during these conditions 
(Gerstmeier et al., 2003). Anaplerotic fluxes were higher for the experimental data than for the 
model, and a significant cycling between C3 and C4 was seen (Figure 4.9) resulting in an 
anaplerotic netflux of 54% towards the pyruvate/phosphoenolpyruvate pool which was higher than 
for the model (17%) (Figure 4.9). 
 
Conclusions 
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A validated metabolic network of C. glutamicum ATCC 13032 was constructed, and by using flux-
balance analysis the in silico model was able to predict metabolic fluxes during lysine production 
and growth under various conditions, which were consistent with experimental values. This work 
also showed that genome scale metabolic model simulations needs to be combined with data from 
other sources, i.e. flux data or transciptomic data, in order to improve the prediction power of the 
model. The model was able to predict potential targets for metabolic engineering for improving 
lysine production in C. glutamicum, and hence serves as a useful tool for future directing of 
metabolic engineering strategies resulting in improved lysine production. The model also serves as 
an extensive compendium on C. glutamicum metabolism, and it is our hope that by combining the 
model with datasets from high throughput experimental techniques such as transcriptomics, 
fluxomics and metabolomics, the prediction power of the model can be further improved. 
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Abstract 
Eight different metabolic engineering strategies were evaluated for their ability to 
improve the production of lysine in an industrially relevant Corynebacterium glutamicum 
production strain. The eight stains constructed for this work were evaluated in fed-batch 
fermentations under conditions simulating industrial scale fermentation. Over-expression of the two 
NADPH generating genes present in the pentose phosphate pathway, zwf and gnd, both resulted in 
increased lysine yields of 5% and 6%, respectively, indicating that the co-factor NADPH was 
limiting for lysine synthesis in this stain. Over-expression of the genes lysC and pyc both showed 
negative effects on overall lysine yield with yields of 83% and 89% of the control strain, 
respectively. No significant effects on overall lysine yields were seen for over-expression of four 
genes located in the lysine synthesis pathway, dapA, dapC, dapF and lysE.    
Keywords: Corynebacterium glutamicum; lysine; central carbon metabolism; fed-batch 
fermentation  
 
Introduction 
Corynebacterium glutamicum is a gram-positive bacterium widely used in the 
production of amino acids. The amino acid produced in the largest quantity by this bacterium is L-
lysine of which the annual production today is about 1,100,000 ton L-lysine,HCl with an expected 
increase in demand of 10% per year. For many years production strains have been improved by 
many rounds of undirected mutagenesis followed by screening for increased productivity and yield. 
However, since the arise of readily available genetic manipulation tools and the publication of the 
genome of the C. glutamicum ATCC 13032 type strain (Ikeda and Nakagawa, 2003; Kalinowski et 
al., 2003) considerable efforts have been made to use metabolic engineering in improving lysine 
yields and productivity. A number of succesful examples of metabolic engineering have been 
presented (Cremer et al., 1990; Cremer et al., 1991; Eggeling et al., 1998; Hartmann et al., 2003; 
Koffas et al., 2002; Koffas et al, 2003). Due to large commercial interest in lysine and the use of C. 
glutamicum as a model organism for studying the central metabolism in actinomycetes this 
organism has been intensively investigated. This has led to a quite unique accumulation of 
experimental information and a list of potential bottlenecks towards the synthesis of lysine. 
However, strains used in metabolic engineering studies have in many cases been strains with 
relatively low lysine production compared to commercial production strains. In this study we 
investigate various previously reported metabolic engineering strategies on the commercially 
relevant production strain C. glutamicum KK-11, and evaluated the effect of these strategies under 
relevant production conditions.  
 Based on earlier findings eight different genes were selected for metabolic 
engineering. In all cases the genes were up-regulated. The targets for metabolic engineering were 
selected so different parts of the metabolism were engineered (Figure 5.1). Our primary focus was 
to study the effect of engineering the central carbon metabolism and the first committed step 
towards lysine production, but we also included metabolic engineering targets in the lysine 
pathway. It is known that C. glutamicum has a high demand for NADPH for the overproduction of 
lysine (Moritz et al., 2000; Marx et al., 1999) and a relationship between a high flux through the 
NADPH generating pentose phosphate pathway (PPP) and a high lysine production has been 
identified (Kiefer et al., 2004; Wittmann and Heinzle, 2002). Based on this the two genes, gnd and 
zwf, responsible for the NADPH generating reactions in this pathway were selected for up-
regulation. Pyruvate carboxylase (pyc) has been found to be the main anaplerotic pathway for lysine 
biosynthesis (Park et al., 1997; Peters-Wendisch et al., 1998; Petersen et al., 2000), and increasing 
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the product of this reaction, oxaloacetate, may increase lysine production. Our last primary target 
was the aspartate kinase (lysC), which is the reaction and gene in the lysine pathway that has been 
given most attention in metabolic engineering studies due to its importance in regulation of flux 
towards lysine-, methionine and threonine synthesis. In the wild type strain this reaction is feed 
back inhibited by lysine and threonine, making this reaction a key step in regulation of the synthesis 
of lysine (Kelle et al., 2005). In all known C. glutamicum strains overproducing lysine the lysC-
gene is known to have mutations causing feed back resistance. Over-expression of lysC has shown 
positive effects on lysine production (Cremer et al., 1991; Eggeling et al., 1998). 
In addition to the four key targets another four targets downstream lysC were selected 
 
Figure 5.1: Overview of the L-lysine metabolism in C. glutamicum. Genes up-regulated in this study is marked 
in red. BM: biomass.  
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for metabolic engineering. Dihydrodipicolate synthase (dapA) is another enzyme in the lysine 
synthetic pathway which has received attention due to its presence at the split between lysine and 
homoserine. Up-regulation of this gene has in some cases led to an increase in lysine production 
(Cremer et al., 1991; Eggeling et al., 1998). Succinyl-amino-ketopimelate transaminase (dapC) and 
diaminopimelate epimerase (dapF), two reactions part of the succinylase branch of the lysine 
pathway, have both been shown as rate limiting in the synthesis of lysine since up-regulation of 
each of these genes gave a positive effect on lysine production (Hartmann et al., 2003). The efflux 
of lysine from the cytosol of the bacterium is carried out by the transport protein lysine permerase 
(LysE) (Vrljic et al., 1996). This exporter is tightly controlled in the wild type strain making this an 
obvious candidate for optimization of lysine production.           
 
Materials and methods 
 
Bacterial strains and plasmids 
 
The lysine producing strain used in this study was the industrial strain C. glutamicum KK-11. This 
strain is derived from multiple rounds of mutagenesis and screening from the C. glutamicum wild-
type strain ATCC 13032. KK-11 is prototrophic for all amino acids. Electrocompetent C. 
glutamicum KK-11 cells were produced following the method of Eggeling and Reyes (2005).  
Electro competent Escherichia coli DB10B and chemically competent Mach1™-T1R E. coli cells 
(Invitrogen) were used for initial molecular work. The E.coli – C. glutamicum shuttle vector pEC-
XK99E (Tauch et al., 2003) was used for over-expression of individual genes.   
  
Medium 
All chemicals used were purchased from either Sigma-Aldrich or VWR International. For 
cultivation of E. coli Luria-Bertani (LB) medium (Bertani, 1951) was prepared and added 5 g/L 
glucose after sterilization. Solid plates were prepared adding 1.5% agar before sterilization. When 
needed, kanamycin was added after cooling of the sterilized medium. Medium for pre-cultures of C. 
glutamicum was prepared with brain heart infusion (BHI) broth, and 5 g/L glucose. Glucose and 
BHI broth were sterilized separately (121°C for 15 minutes) and aseptically poured together when 
cooled. When needed kanamycin and Isopropyl β-D-1-thiogalactopyranoside (IPTG) were added by 
sterile filtration. Solid plates were prepared by adding 1.5% agar to the BHI broth before 
sterilization. Fermentation medium (FM-1) for fed-batch lysine fermentations was prepared 
containing (pr kg of medium): 4.36 g corn steep liquor (CSL) (dry weight), 40 g glucose, 2.5 g 
(NH4)2SO4, 15.7 g H3PO4, 0.60 g citric acid, 0.90 g KH2PO4, 1.20 g K2HPO4, 0.63 g MgSO4, 1.13 g 
Na2HPO4, 20 mg FeSO4·7 H2O, 20 mg ZnSO4·H2O, 2.20 mg CuSO4·5 H2O. Medium was sterilized 
at 121°C for 30 minutes. After sterilization and cooling to 30°C vitamins (4.6 mg thiamine, 1.3 mg 
biotin, 11.3 mg calciumpantothenate and 5.7 mg nicotinic acid), 25 mg kanamycin and 0.23 g IPTG 
was added by sterile filtration. Feed medium (FM-2) was prepared containing (pr kg of medium): 
400 g glucose, 4.5 g citric acid, 28.3 g KH2PO4, 4.0 g MgSO4, 4.67 g Na2HPO4, 60 g (NH4)2SO4, 
100 mg FeSO4·7 H2O, 10 mg ZnSO4·H2O, 10 mg CuSO4·5 H2O, 10 mg NiCl2·6 H2O 18.3 mg 
CoCl2, 10 mg (NH4)6Mo7O24·4 H2O, 10 mg MnSO4·H2O. Glucose was sterilized separately (121°C 
for 30 minutes) and the rest was sterilized together (121°C for 30 minutes). After cooling the two 
parts were aseptically poured together and vitamins (4.6 mg thiamine, 1.3 mg biotin, 11.3 mg 
calciumpantothenate and 5.7 mg nicotinic acid), 25 mg kanamycin and 0.23 g IPTG was added by 
sterile filtration. Shake flask medium (SFM-1) for enzymatic assays was prepared contained (pr kg 
of medium): 18 g glucose, 2.5 g CSL (dry weight), 0.45 g H3PO4, 0.61 g citric acid, 1.2 g KH2PO4, 
Comparative analysis of eight metabolic engineering strategies….  
________________________________________________________________________________ 
119 
1.0 g K2SO4, 0.7 g MgSO4, 1.2 g Na2HPO4, 92.4 g MOPS sodium salt, 23.8 mg FeSO4·7 H2O, 15.9 
mg ZnSO4·H2O, 2.3 mg CuSO4·5 H2O. After serilization (121°C for 15 minutes) 10 g (NH4)2SO4, 
4.87 mg thiamine, 11.9 mg calciumpantothenate, 6.0 mg nicotinic acid, 1.3 mg biotin, 0.23 g IPTG 
and 25 mg kanamycin was added by sterile filtration.  
 
Table 5.1: Strains constructed for this work 
Strain Host Plasmid Inserted gene Over-expressed Enzyme 
     
KK11-control KK11 pEC-XK99E - - 
KK11-zwf KK11 pEC-XK99E zwf Glucose-6-phosphate dehydrogenase 
KK11-gnd KK11 pEC-XK99E gnd 6-phosphogluconate dehydrogenase 
KK11-pyc KK11 pEC-XK99E pyc Pyruvate carboxylase 
KK11-lysC KK11 pEC-XK99E  lysC Aspartate kinase 
KK11-dapA KK11 pEC-XK99E dapA Dihydrodipicolate synthase 
KK11-dapC KK11 pEC-XK99E dapC Succinyl-amino-ketopimelate 
transaminase 
KK11-dapF KK11 pEC-XK99E dapF Diaminopimelate epimerase 
KK11-lysE KK11 pEC-XK99E lysE Lysine permerase 
     
 
 
 
Construction of plasmids and C. glutamicum strains  
Standard protocols were used for the construction and analysis of plasmid DNA. Purification of 
chromosomal DNA from C. glutamicum was performed by the following method: 5 mL of 
overnight culture (BHI broth) was harvested by centrifugation. Supernatant was carefully removed 
and discharged using a pipette. Pellet was washed dissolving the pellet in TE-buffer (pH 7.6) 
followed by centrifugation (13,000 g). Supernatant was carefully removed. Pellet was dissolved in 1 
ml TE-buffer (pH 7.6) containing 15 mg/mL lysozyme followed by incubation for 180 minutes at 
37°C. 3 ml TE-buffer (pH 8.2) containing 400 mM NaCl, 220 μL 10% SDS and 3 mg proteinase K 
was added, and tubes were incubated for 300 minutes at 50°C. After ended incubation 1 mL 
saturated NaCl solution (approximately 6 M) was added. Solution was vortexed for 2 minutes 
before it was centrifuged for 15 minutes at 13,000 g. Supernatant was carefully transferred to a 
clean Eppendorf tube and DNA was precipitated adding 0.5 mL 3 M sodium acetate (pH 5.2) and 
16.5 mL 96% ethanol, incubated at -20°C for 30 minutes followed by 30 minutes of centrifugation 
at maximum speed. Supernatant was carefully removed and discarded pellet was air-dried before it 
was dissolved in 200 μL TE-buffer (pH 7.6). For each of the 8 genes selected for this study (Table 
5.1) a PCR was carried out containing: 1x High Fidelity PCR Buffer (Invitrogen), 10 mM dNTP, 2 
mM MgSO4, 0.2 μM of each primer (Table 5.2), 1 μL chromosomal DNA from C. glutamicum KK-
11, 1 unit Platinum® Taq High Fidelity polymerase (invitrogen),  autoclaved distilled water to 50 
μL. PCR was carried out using the following conditions: 95°C 2 min; 95°C 30 s, 64°C 30 s, 68°C 4 
minutes for 5 cycles; 95°C 30 s, 60°C 30 s, 68°C 4 min for 5 cycles; 95°C 30 s, 56°C 30 s, 68°C 4 
min for 10 cycles; 95°C 30 s, 52°C 30 s, 68°C 4 min for 10 cycles; 68°C 10 min. The blunt end 
PCR products were added T-overhangs adding one unit of Taq polymerase (Invitrogen) directly into 
the PCR-tube and incubating for 10 minutes at 72°C. PCR fragments were ligated into a TOPO® 
vector using TOPO pCR®2.1-TOPO® Kit (Invitrogen) and the vector was introduced into 
chemically competent Mach1™-T1R E. coli cells (Invitrogen). Two independent positive colonies 
were selected and grown in LB medium and plasmid DNA was purified using JETstar (Genomed). 
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Plasmid DNA was shipped to sequencing (MWG Biotech, Germany). That no mutations had 
occurred during PCR was confirmed by analyzing two independent clones. PCR fragments were cut 
out and purified using the GFX PCR DNA and Gel Band Purification kit (Amersham Biosciences) 
and ligated into the plasmid pEC-XK99E using T4 DNA ligase (Invitrogen). Transformation was 
carried out using 15 μL electro competent E. coli DB10B (Invitrogen) which was transferred to an 
icecold 0.2 mm cuvette. 10 μL pEC-XK99E ligation-mix was added to the cells and the mix was 
incubated at ice for 5 minutes before electroporation (25 μF, 200Ω, 2500V). Immediately after 
electroporation the cuvette was placed on ice and 0.5 mL LB medium was added. Cells were 
incubated at 37°C for 60 minutes before cells were plated on LB plates with 50 mg/L kanamycin 
and incubated over night at 37°C. Presence of gene-products in plasmids was confirmed by PCR 
using the following method: Cell material from a colony was transferred to a PCR tube before a 
reaction mix was added containing 1 x PCR buffer, 2.5 mM MgCl2, 0.2 mM dNTP, 0.5 μM of each 
primer, 2.5 U Taq Polymerase (Invitrogen) and autoclaved water to a final volume of 100 μl. PCR 
was carried out using the following conditions: 94°C 5 min; 94°C 30 s, 55°C 30 s, 72°C 30 s for 25 
cycles; 72°C 10 min for 1 cycle. Plasmid DNA purification was conducted on transformants 
incubated over night (37°C, 200 rpm) in LB medium with 50 mg/L kanamycin. GFX Micro Plasmid 
Prep Kit (GE Healthcare) was used for the purification. The purified plasmids were introduced to C. 
glutamicum using the following method. 150 μL elektrocompetent C. glutamicum (Eggeling and 
Reyes, 2005) was added 10 μL purified pEC-XK99E from E. coli and the protocol from Eggeling 
and Ryes (2005) was followed. After electroporation cells were plated on BHI agar containing 91 
g/L sorbitol and 15 mg/L kanamycin. Plates were incubated at 30 °C until visible colonies were 
seen. Presence of gene-products in the vector was confirmed by PCR as described earlier.           
 
Table 5.2: Primer sequences designed for amplification of genes from strain KK11, and added nucleotides at the 5’-end 
for convenient restriction sites.  Underlined nucleotides are introduced restriction sites.   
Primer Sequence 
EcoRI-lysC-F 5’-gaattcgtggccctggtcgtacagaaat -3’ 
SmaI-lysC-R 3’-cccgggttagcgtccggtgcctgcataa-5’ 
EcoRI-dapC-F 5’-gaattcatgacctctcgcaccccgcttg-3’ 
SmaI-dapC-R 3’-cccgggttagctcaggcgagaaacaaag-5’ 
EcoRI-dapA-F  5’-gaattcatgagcacaggtttaacagcta-3’ 
SmaI-dapA-R 3’-cccgggttatagaactccagcttttttc-5’ 
EcoRI-gnd-F 5’-gaattcatgccgtcaagtacgatcaata-3’ 
SmaI-gnd-R 3’-cccgggttaagcttcaacctcggagcgg-5’ 
EcoRI-lysE-F  5’-gaattcatggaaatcttcattacaggtc-3’ 
SmaI-lysE-R 3’-cccgggctaacccatcaacatcagtttg-5’ 
MfeI-dapF-F 5’-caattggtgaatttgaccatcccctttg-3’ 
SmaI-dapF-R 3’-cccgggttagatctgcacctcaccgagt-5’ 
MfeI-zwf-F 5’-caattggtgagcacaaacacgaccccct-3’ 
SmaI-zwf-R 3’-cccgggttatggcctgcgccaggtgtga-5’ 
MfeI-pyc-F 5’-caattggtgtcgactcacacatcttcaa-3’ 
EcoRV-pyc-R 3’-gatatcttaggaaacgacgacgatcaag-5’ 
  
  
 
 
 
L-Lysine production in 7 L fermentor 
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Fermentations were carried out with 2.0 kg medium as initial amount; the temperature was kept at 
30°C. During the batch phase agitation was controlled at 800 rpm. The Fed-batch phase was 
initiated when all glucose in the batch medium was consumed.  Agitation and aeration was 
controlled so dissolved oxygen was kept > 20% throughout the whole fermentation. pH was 
controlled at 7.0 by NH4OH (25%) addition. The sugar feeding rate was kept constant and the 
glucose concentrations never exceeded 5 g/kg. Weight of the fermenter, sugar feed and NH4OH 
were monitored online.    
 
Sampling and sample processing  
 
Medium samples were periodically taken for measurement of sugar, lysine and optical density. 
Samples were taken with intervals ranging from 4-6 hours. Sample amount was 20-30 g. Lysine, 
glucose and biomass removed from the bioreactor was taken into account in the yield calculations. 
Biomass concentration was determined by measuring OD620 assuming OD620 ⋅ 3.9-1 g biomass (dry 
cell weight) · kg-1. Culture samples were centrifuged and separated in supernatant and biomass 
samples and stored at -20°C until further analysis.  
 
Glucose  
 
The glucose concentrations in the supernatant were measured by HPLC. Separation of sugars was 
achieved using a CarboPac PA 1 column 4 × 50 mm (Dionex Corporation, USA) as precolumn 
followed by a CarboPac PA 1 column 40 × 250 mm (Dionex , USA) with 160 mM NaOH as mobile 
phase. Detection and quantification was performed with an amperometric impulse-detector 
(Electrochemical detector ED 50 Dionex, Germany). 
 
Lysine 
 
Samples for amino acid analysis were first processed by extraction of 1 g supernatant in 10 mL 0.1 
M HCl for 5 minutes while stirred by a magnetic stirrer. The sample was then added 5 mL 5-
sulfosalicylic acid (6% w/v) and stirred for another 5 minutes before centrifugation at 4000 g in 10 
minutes. An appropriate amount of the supernatant was transferred to a container where pH was 
adjusted to 2.20 ± 0.02 with 1 M NaOH. The sample was transferred to a 25 mL volumetric flask 
which was filled using sodium citrate loading buffer (0.20 M, pH 2.20) (Biochrom Ltd., Cambrigde 
Science Park, England). The sample was filtrated through a 0.22-μm pore size filter, diluted if 
necessary and loaded on a Biochrom 30 (Biochrom, Ltd., Cambrigde Science Park, England). 
Amino acids were separated using a pH gradient on a Oxidised Hydrolysate Column (Biochrom, 
Ltd., Cambrigde Science Park, England) and detection was carried out by a postcolumn derivatized 
with ninhydrin reagent followed by measuring absorbance at 440 (proline) or 570 nm (all other 
amino acids).  
 
Enzyme assays 
The activity of the enzymes glucose-6-phosphate dehydrogenase, 6-phosphogluconate 
dehydrogenase, pyruvate carboxylase and aspartate kinase was determined on cell extracts of 
homogenized cells. Cells were grown in 100 mL medium (SFM-1) in a 500 mL baffled shake-flask 
(30°C, 200 rpm) and harvested at the late exponential phase (~OD620 = 20) by centrifugation. Cells 
were washed twice with Tris-HCl buffer (pH and concentration depending on the assay). Cells were 
resuspended in 5 mL Tris-HCl buffer and transferred to a DT-20 Ultra Turrax tube, and the sample 
was homogenized on an IKA Ultra Turrax Tube Drive (IKA-Werke, Staufen, Germany) for 5 
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minutes. The sample was centrifuged for 10 minutes at maximum speed and the supernatant was 
transferred to a clean tube and immediately cooled on ice. The homogenized cell extract was used 
for enzyme assays. Protein concentrations were determined using the method of Bradford (1976).  
Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase was assayed using a 
method based on Sugimoto and Shiio (1987). A mixture was prepared containing 50 mM Tris/HCl 
(pH 7.5), 1 mM NADP+, 10 mM MgCl2 and crude cell extract. Reaction was initiated by the 
addition of 4 mM glucose 6-phosphate or 1 mM 6-phosphogluconate to a final volume of 0.5 mL. 
Enzyme activity was measured by continuously measuring the increase in absorbance at 340 nm 
while incubating at 30°C. Pyruvate carboxylase was assayed by a method based on Payne and 
Moris (1969). A mixture was prepared containing 90 mM Tris-HCl (pH 8.0), 50 mM NaHCO3, 5 
mM MgCl2, 0.10 mM Acetyl CoA, 0.25 mM DTNB, 5 U citrate synthase, 5 mM ATP, 5 mM 
pyruvate and crude cell extract to a final volume of 1 mL. Assays were incubated at 30°C and 
activity was measured by continuously measuring the increase in absorbance at 412 nm. Aspartate 
kinase was assayed based on the method from Black and Wright (1954). Reaction mixtures were 
prepared with 180 mM Tris-HCl (pH 7.5), 10 mM MgSO4 · 6 H2O, 5 mM L-aspartic acid, 10 mM 
ATP (adjusted to pH 7.0 with NaOH), 160 mM NH2OH · HCl (neutralized with NaOH) and crude 
cell extract to a final volume of 500 μL was mixed and incubated at 60°C. The reaction was stopped 
by the addition of 500 μL 5% (w/v) FeCl3-solution. Enzyme activity was measured as the change in 
absorbance at 540 nm.   
 
Calculations and Statistics 
 
Lysine yields (g lysine · (g glucose)-1) and biomass yields (g biomass · (g glucose)-1) were 
calculated as an average for the whole fermentation (overall yield), and for 2 different phases of the 
fed-batch phase of the fermentation (phase 1 and phase 2). Glucose, lysine and biomass removed by 
sampling were taken into account which was also the case for evaporation. Yields for the two fed-
batch phases was determined from the slope of the curve when plotting glucose consumed vs. lysine 
produced or glucose consumed vs. cell dry weight produced for the whole phase. All yields were 
normalized to the accumulated yield of the control fermentation. Data were analyzed using students 
T-test, and effects was considered significant when P ≤ 0.05.     
 
Results and discussion 
 
Enzyme activities of key enzymes for engineered strains  
 
In order to evaluate whether over-expression resulted in higher enzyme activities for our four 
primary targets, enzyme activities for the two NADPH generating enzymes in the PPP (zwf and 
gnd), the oxaloacetate generating step from pyruvate (pyc) and the first step in the lysine synthetic 
pathway (lysC) were measured by enzymatic assays. From this data it could be seen that in all cases 
enzyme activities were increased when the genes were overexpressed (Figure 5.2). Differences were 
observed for the effect of the metabolic engineering strategy on the increase in enzyme activities. 
For 6-phosphogluconate dehydrogenase and aspartate kinase an increase higher than 4 fold was 
observed, whereas glucose-6-phosphate dehydrogenase activity and pyruvate carboxylase activity 
only increased 1.6 and 1.7 fold, respectively. A decrease in enzyme activity was observed for the 
two PPP enzymes (zwf and gnd) when the opposite gene was upregulated.       
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Table 5.3: Lysine yields for constructed strains. Yields normalized to Ysp-total for the control-strain. Numbers in bold 
are significant different from control strain (P > 0.05)  
Over-expressed gene Ysp (Phase 1) Ysp (Phase 2) Ysp (Overall) 
  [%] [%] [%] 
           
Control  (n = 4) 90 ± 7 111 ± 5 100 ± 2 
           
zwf        (n = 2) 95 ± 1 120 ± 1 105 ± 1 
gnd        (n = 2) 105 ± 2 128 ± 4 106 ± 0 
pyc         (n = 2) 90 ± 2 95 ± 2 89 ± 2 
lysC       (n = 2) 59 ± 5 102 ± 1 83 ± 4 
dapA (n = 2) 90 ± 8 109 ± 0 97 ± 3 
dapC (n = 2) 84 ± 11 111 ± 2 102 ± 6 
dapF (n = 2) 105 ± 0 109 ± 2 102 ± 1 
lysE (n = 2) 93 ± 4 112 ± 6 102 ± 1 
           
 
 
 
Characterization of fed-batch fermentations  
 
Figure 5.2: Enzyme activities relative to protein in cell extract. Values normalized to KK11-control strain. Data 
represent mean values from three determinations.  
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For each constructed strain two independent fed-batch fermentations were carried out, and for the 
control strain carrying an empty plasmid (KK11-control), four independent fermentations were 
conducted. Fermentations were designed to resemble real industrial fermentation conditions. In all 
cases fermentations were run for more than 65 hours, and the lysine titer exceeded 60 g/kg and the 
biomass concentrations exceeded 25 g DCW/kg. Fermentation profiles for a KK11-control- and a 
KK11-gnd fermentation are presented in figure 5.3 (the lysine concentrations are normalized to 100 
for the control strain and data for the engineered strain is related to this). The fermentations were 
carried out with a batch phase until the initial glucose concentration was depleted (batch phase), and 
after this the fed-batch phase was initiated. The fed-batch phase was divided into two different 
phases (phase 1 and phase 2) based on biomass growth, where growth was seen in phase 1 and only 
limited growth was seen in phase 2.                    
 
Influence of genetic manipulations on lysine yield 
 
The different genetically manipulated strains were compared concerning lysine yield (Table 5.3). 
As expected the control strain showed a lower lysine yield in phase 1 of the fermentations (90% of 
the overall yield) and a higher yield in phase 2 with a yield of 111% of the overall yield. The two 
strains with up-regulated PPP-genes, KK11-zwf and KK11-gnd, both showed a positive effect on 
the genetic manipulations responding with a 5% and 6% increase in overall lysine yield, 
respectively, when compared to the total yield of the KK11-control strain. For the two phases of the 
fed-batch phase KK11-zwf showed a significantly higher yield in phase 2 (8% higher). Becker et al. 
(2007) also observed an increase in the lysine yield upon up-regulation of the zwf-gene, but they 
observed improvements of 33%-38% depending on the strategy used. However, the reference strain 
used by Becker et al. (2007) had a much lower productivity compared to the stain used in our study, 
and an improvement in this range would therefore be difficult to achieve by a single change in 
KK11. The strain KK11-gnd was producing lysine at significantly higher yields than the control 
strain in both phase 1 and phase 2 (16% higher and 15% higher respectively). The up-regulation of 
this gene has earlier been reported in patent literature (Duncan et al., 2004), but to our knowledge 
this is the first time the up-regulation of this gene have been evaluated intensively. However, 
Ohnishi et al. (2005) identified this enzyme as important in the regulation of the PPP-flux, and they 
found that a mutation in 6-phosphogluconate dehydrogenase (Ser→361→Phe) lead to an 8% 
increase in PPP-flux, which resulted in improved lysine production. The positive effect on up-
 
 
Figure 5.3: Examples of fermentation profiles for this study. A) KK11-control B) KK11-gnd. The division 
between the different phases of the fermentation is indicated. Triangles: glucose concentration; White squares: 
biomass concentration; Filled squares: lysine titer normalized to KK11-control-data. 
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regulation of both zwf and gnd was unexpected since it could be expected that only one of the 
enzymes was limiting the flux through the PPP.  
 
Table 5.4: Biomass yields for constructed strains. Yields normalized to Ysx-total for the control-strain. Numbers in bold 
are significant different from control strain (P > 0.05) 
Over-expressed 
gene 
Ysx (Phase 1) Ysx (Phase 2) Ysx (Overall) 
  [%] [%] [%] 
           
Control (n = 4) 159 ± 37 60 ± 6 100 ± 5 
           
zwf (n = 2) 168 ± 29 30 ± 1 100 ± 7 
gnd (n = 2) 97 ± 11 55 ± 0 101 ± 9 
pyc (n = 2) 173 ± 14 49 ± 1 98 ± 14 
lysC (n = 2) 178 ± 39 51 ± 12 106 ± 1 
dapA (n = 2) 185 ± 30 46 ± 1 94 ± 0 
dapC (n = 2) 230 ± 60 65 ± 16 112 ± 22 
dapF (n = 2) 169 ± 50 50 ± 5 96 ± 2 
lysE (n = 2) 144 ± 59 57 ± 1 94 ± 2 
           
 
However, it is likely that the changes in metabolite concentrations due to one genetic manipulation 
can cause a flux-change due to transcriptional regulation or allosteric regulation of the enzymes. 
Such an effect has earlier been seen for the genes lysC and dapA in a lysine producing C. 
glutamicum strain, where up-regulation of each of these genes resulted in a similar increase in 
lysine flux (Cremer et al., 1991; Eggeling et al., 1998). The strain KK11-pyc showed a negative 
effect on lysine yield with a decrease to 89% of the yield of the KK11-control on strain. Lysine 
yields for the KK11-pyc strain in phase 1 was not significantly different from the control strain, but 
in phase 2, a decrease of 14 % was seen. The same effect was reported by Koffas et al. (2002) 
where the up-regulation of this gene in the strain C. glutamicum ATCC 21253 resulted in a lower 
lysine yield. In the same study up-regulation of the same gene in another strain (C. glutamicum 
ATCC 21799) had, however, no effect on the final lysine yield, which again shows that the effect 
on lysine production by engineering of the central carbon metabolism can be very strain dependent. 
For KK11-lysC there was also observed a negative effect on the total lysine yield (83% of KK11-
control). For the two phases KK11-lysC had a significantly lower lysine yield in both phase 1 and 
phase 2, i.e. 36% and 9% for phase 1 and phase 2, respectively. The lysC gene-product has earlier 
been identified as a limitation for lysine production (Hua et al., 2000; Jetten et al., 1995), and our 
observed decrease in lysine yield did therefore not match our expectations. Up-regulation of the 
lysC-geneproduct aspartate kinase has earlier been connected with growth restrictions in defined 
minimal media (Koffas et al., 2003), which was also observed for KK11-lysC (Data not shown). 
However, during growth in complex media no difference between this strain and KK11-control 
could be seen (data not shown). The negative effect observed by us may therefore be due to other 
issues such as kinetics or different regulation in our reference strain. 
For the strains KK11-dapA, KK11-dapC, KK11-dapF and KK11-lysE no significant 
changes in overall lysine yield was seen as a result of the genetic manipulations. For dapA similar 
results was found by Hua et al. (2000), while Cremer et al. (1988), Cremer et al. (1991) and 
Eggeling et al. (1998) saw an increase in lysine production up-regulating this gene. Based on the 
results in the present study the dapA gene-product dihydrodipicolinate syntase was not limiting for 
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lysine production in KK11. KK11-dapF showed an increase in lysine yield in phase 1 of 16%, while 
no positive effect was seen for phase 2. The positive effect in phase 1 could be confirmed by the 
data of Hartmann et al. (2003). Here a positive effect of up-regulation of dapF in a shake-flask 
experiment was seen (13% higher lysine titer). That no effect was seen in phase 2 can be connected 
to the lower biomass production in this part of the fermentation (Ysx = 169 for phase 1 and 50 for 
phase 2). When the carbon flux towards growth is decreased drain from the TCA cycle necessary to 
support biomass is lowered. During this phase it can be expected that the TCA flux is lowered, as 
seen for simulations with an in silico model of C. glutamicum (Kjeldsen & Nielsen, 2008), and the 
availability of succinyl-CoA, an intermediate in both the TCA cycle and in the succinylase branch 
of the lysine synthesis pathway, is decreased. In this case another reaction in the lysine pathway 
becomes limiting and the effect of overexpression of dapF is abolished. For the dapC gene 
Hartmann et al. (2003) saw a positive effect on lysine production on up-regulation of this gene in a 
lysine producing strain. Such an effect was not seen in KK11 on up-regulation of dapC, which is 
also part of the succinylase branch suggesting that this step is not limiting in the succinylase branch 
in KK11. No effect was seen on lysine yields on up-regulating lysE indicating that the lysine export 
capacity of KK11 is sufficient under the conditions in this study.       
 
Influence of genetic manipulations on biomass yield 
 
The biomass yield for KK11-control showed a higher yield for phase 1 (159%) than for phase 2 
(60%) when compared to the biomass yield for the whole fermentation (Table 5.4). This was a 
general observation for all the strains except for KK11-gnd, for which the biomass yield in phase 1 
and the total biomass yield were similar. For the biomass yield for the whole fermentation no 
significant differences were seen between the strains in which enzymes had been up-regulated and 
the reference strain KK11-control. For the two phases of the fermentation a lower biomass yield 
was seen for KK11-gnd in phase 1 (39% lower than KK11-control). In phase 2 the biomass yields 
of the strains KK11-zwf, KK11-pyc and KK11-dapA were significant lower than the KK11-control 
strain (59%, 18% and 23% lower, respectively). The low biomass yield in phase 1 for strain KK11-
gnd could indicate a higher flux towards PPP, limiting growth due to a lower TCA flux. This same 
effect was not seen in phase 1 when zwf was up-regulated, but instead it was observed in phase 2 
where the biomass yield was lower compared to KK11-control. A similar effect was observed by 
Becker et al. (2007) when zwf was up-regulated. An up-regulation of dapA has earlier been seen to 
decrease the flux towards biomass due to a decreased flux towards threonine and methionine 
(Eggeling et al., 1998). A decrease in biomass yield in the later phase of the fermentation could be 
recognized in the present study when dapA was up-regulated. This decrease was not followed by an 
significant increase in lysine yield. An increased level of the pyc gene-product pyruvate carboxylase 
has in some cases shown higher biomass levels (Koffas et al., 2002; Koffas et al., 2003). This was 
not the case when pyc was up-regulated in KK11-control. Instead a decrease was seen in the later 
phase of the fermentation. No effect on biomass yield was seen for KK11-lysE.  
 
Correlation between biomass yield and lysine yield  
 
A clear correlation between the biomass yield and the lysine yield was seen for the data of all the 
fermentations (Figure 5.4). It could be recognized that the biomass yield was decreasing when the 
lysine yield was increasing, which indicates that carbon was redirected from biomass synthesis to 
lysine production. A similar correlation was predicted by simulations of a genome scale metabolic 
model (Kjeldsen and Nielsen, 2008), and interestingly the slope of the linear regression of the data 
of the present work is almost the same as that predicted by the genome scale model simulations. 
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Experimental data fitted best to the simulations where the succinylase variant of the lysine synthetic 
pathway was used, which could indicate that this pathway is the dominant one in KK11. In the 
present study the two different fed-batch phases of the fermentation (Phase 1 and Phase 2) were 
clearly separated. Data for phase 1 had a higher variation than data from phase 2. Especially the 
biomass yields varied more in phase 1, but in most cases the biomass yield correlated well with the 
lysine yield indicating that differences in lysine yields in most cases were growth related. As 
discussed earlier KK11-lysC showed a significant lower lysine yield in phase 1, and the data for this 
strain is also quite clearly an outlier on the plot in this phase, indicating that the low lysine yield 
was not entirely due to increased biomass formation. Data for KK11-dapF is also an outlier from 
the regression line, but data for this strain are placed above the regression line indicating better 
carbon utilization in this part of the fermentation for this mutant. The significant increased lysine 
yield of KK11-gnd on the other hand showed a quite clear correlation to biomass yield. Phase 2 is 
from an industrial point the most interesting part since this is the longest part of the fermentation 
process, and also here the largest part of the carbon source is used. Data for KK11-pyc and KK11-
lysC were both below the regression line, confirming that neither of the metabolic engineering 
strategies used in the construction of these strains were good. As discussed earlier up-regulating 
both NADPH generating steps in the PPP (gnd and zwf) resulted in significant higher lysine yields 
which strongly indicates that this part of the metabolism is in fact limiting for lysine production in 
KK11. For KK11-zwf the improved lysine yield was correlated with a lower biomass yield, whereas 
this was not the case for KK11-gnd. 
 
 
Figure 5.4: Normalized biomass yields plotted against normalized lysine yields. The division between the two 
phases is indicated by a vertical line. The linear regression is made based on all yield data from table 3 and table 4 
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 In conclusion we find that even though metabolic engineering strategies are reported 
to be successful for improving lysine production, many of these strategies can not be transferred 
directly to industrial strains. However, through comparative analysis of several different strategies 
our results points to that supply of the co-factor NADPH may in fact be a limitation for high-
producing strains, which probably mainly are derived based on mutations in the lysine pathway. 
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Abstract 
 
Two L-lysine producing strains of Corynebacterium glutamicum, a high producing strain KK-11 
and a low producing strain ATCC 21253, were compared during growth and lysine production 
during fed-batch fermentaions using a complex medium. Using [U-13C6]glucose the uptake of nine 
different amino acids present in the complex medium was estimated during batch fermentation. 
Alanine, isoleucine, leucine, phenylanaline, proline, threonine and valine were taken up by both 
strains, although the ratio between de novo synthesis and uptake was different for the two strains. 
Glycine and serine were not taken up by any of the strains. Estimations of flux distributions in the 
batch- and fed-batch phase were carried out using [1-13C]glucose. A comparison of the two strains 
was made both in the batch phase and in the fed-batch phase of the fermentations. In the batch 
phase the pentose phosphate pathway and the anaplerotic netflux was higher in the high producing 
strain, whereas the TCA flux was lower. Finally, a significant ATP-consuming futile cycle 
involving anaplerotic reactions was identified in the low producing strain. The data from the 
production phase of the fed-batch fermentation showed an increased flux through the pentose 
phosphate pathway for both strains.   
 
Introduction 
 
Amino acid production by the gram positive bacteria Corynebacterium glutamicum is one of the 
major processes in industrial biotechnology. The amino acid produced in the largest quantity by this 
bacterium is L-lysine of which the annual production today is about 1,100,000 ton L-lysine,HCl 
with an expected increase in demand of 8% per year. Optimization of cultivation strategies and 
producer strains has led to increased yields and productivities. Much of this improvement has been 
achieved by random mutagenesis strategies followed by intensive screening programs. Recent years 
more direct methods have been applied using metabolic engineering.  In order to improve the 
performance of a production organism by metabolic engineering a detailed knowledge of 
intracellular fluxes in the central metabolism may be useful for predicting strategies for direct 
modifications of the organism by genetic engineering. Metabolic network analysis combining 
metabolite balancing and 13C-labeling patterns (Christensen and Nielsen, 1999b) can be used as a 
tool in this respect.  
Throughout the last decade the metabolic network of C. glutamicum has been thoroughly 
investigated using methods based on 13C-labeled substrates (Kiefer et al., 2004; Krömer et al., 
2004; Marx et al., 1996; Petersen et al., 2000; Wittmann and Heinzle, 2002). This has led to a 
unique knowledge about the central metabolism of this organism under various conditions. 
In commercial production of lysine a complex medium containing various carbon sources such as 
corn steep liquor (CSL), is normally used, and the metabolic fluxes in this type of media may be 
different from the fluxes in a defined minimal medium. However, conducting metabolic network 
analysis using 13C-labeled substrate in complex media is challenging since uptake of non-labeled 
substrate influences both the metabolite balancing and the labeling patterns of the biomass 
components. Therefore sophisticated methods need to be used in order to deal with these 
challenges. Amino acids from the macromolecular pool of the biomass protein are often chosen for 
analysis in metabolic network analysis using 13C-labeled substrates (Christensen and Nielsen, 
1999a; Christiansen et al., 2002; Marx et al., 1996). The labeling patterns of the amino acids reflect 
the labeling of the intermediates in the central carbon metabolism and thereby the fluxes of the 
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metabolic network. In order to make an accurate metabolic network analysis it is therefore required 
to know the precise amino acid uptake to be able to take the contribution of unmarked carbon into 
account when the flux model is made.  
Labeling patterns of amino acids have been determined from continuous cultures in steady state 
(Christensen and Nielsen, 2000; Marx et al., 1996) or in the exponential growth phase of batch 
cultures (Pedersen et al., 2000), which also represents a physiological steady state. However, since 
the batch phase of commercial lysine production only represents a part of the fermentation, it is of 
great interest to be able to determine the metabolic fluxes in the fed-batch phase following the batch 
phase. However, when a metabolic shift occurs during a batch or fed-batch fermentation the 
labeling patterns of the amino acids do not reflect the in vivo fluxes at a given time. However, they 
give an integral value of the metabolic fluxes, which allow us to identify fluxes affected by the 
physiological change based on the tendencies seen in the labeling patterns of the biomass. This can 
be used to elucidate metabolic changes in the central metabolism during non balanced growth.           
In this study metabolic network analysis on two lysine producing C. glutamicum strains grown in 
complex media containing CSL was conducted. Amino acid uptake was determined in a parallel 
study where 32%[ U-13C6]glucose was used as carbon source.                        
 
 
Materials and Methods 
 
Strains 
Two L-lysine producing strains of Corynebacterium glutamicum was used in this study. Both 
strains were obtained by sequential random mutagenesis by UV radiation and by the use of 
chemical mutagens. The strain ATCC 21253 was obtained from the American Type Culture 
Collection (Manassas, Va.), whereas the strain KK-11 was kindly donated by Agro&Ferm A/S. 
 
Propagation 
A frozen culture of C. glutamicum was used to inoculate agar plates containing (per litre distilled 
water): 37 g brain heart broth (Merck), 15 g agar, 5 g glucose. The plates were inoculated for 36 hr 
at 30 °C, and a single colony was used to inoculate a 500 mL baffled Erlenmeyer flask containing 
100 mL media containing (per kg distilled water): 5 g glucose, 2.4 g corn step liquor (49% DW), 
5.2 g H3PO4 (85 % (wt/wt)), 0.075 g Na2-EDTA, 1.2 g KH2PO4, 1 g K2SO4, 0.7 g MgSO4, 1.2 g 
NaHPO4, 92.4 g 3-morpholinopropanesulforic acid (MOPS) sodium salt, 0.15 g threonine, 0.10 g 
leucine, 0.04 g methionine, 12.4 mg FeSO4 · 7 H2O, 8.26 mg ZnSO4 · H2O, 1.21 mg CuSO4 · 5 H2O 
and 26 mg citric acid. After sterilization (121 °C, 20 minutes) and vitamins and ammonium sulphate 
was added by sterile filtration so the concentration was (per kg distilled water): 4.87 mg thiamine, 
HCl, 11.92 mg calcium pantothenate, 6.03 mg nicotinic acid, 1.32 mg D-biotin and 10 g (NH4)2SO4. 
Cultures were inoculated and incubated in a rotary shaker at 30 °C and 250 rpm for 48 hours before 
they were used to make freeze stocks by mixing 667 μL 50 % (w/v) glycerol with 1000 μL culture 
and transferred to a -80 °C freezer where they were stored until used as inoculum for the tracer 
experiment. 
 
Batch medium 
A batch medium was prepared containing (per kg distilled water): 2.4 g corn step liquor (49% DW), 
5.2 g H3PO4 (85 % (m/m)), 0.075 g Na2-EDTA, 1.2 g KH2PO4, 1 g K2SO4, 0.7 g MgSO4 , 1.2 g 
NaHPO4, 0.15 g threonine, 0.10 g leucine, 0.04 g methionine, 12.4 mg FeSO4 · 7 H2O, 8.26 mg 
ZnSO4 · H2O, 1.21 mg CuSO4 · 5 H2O and 26 mg citric acid, 4.87 mg thiamine, HCl, 11.92 mg 
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calcium pantothenate and 6.03 mg nicotinic acid. The vitamins were sterile filtrated into the 
medium together with (NH4)2SO4 and glucose after the rest of the components had been sterilized 
(121 °C, 20 minutes) and the medium had been cooled to 30 °C. For batch cultivations the initial 
glucose concentrations were 17 g · L-1 and (NH4)2SO4 concentrations were 10 g · L-1. The glucose 
used was either 99% [1-13C] (Omicron Biochemicals, Inc.) or a mixture of 32% [U-13C6] (Isotech, 
Inc.) and 68% naturally labeled glucose. For fed-batch operations a feed-medium was prepared 
containing (per kg distilled water): 17 g glucose 99% [1-13C] and 10 g (NH4)2SO4. The two 
components was sterilized separately and mixed after cooling.  
 
Bioreactors and cultivation conditions 
The cultivations were carried out in a small scale bioreactor with a working volume of 250 ml 
designed and made in house. Cultivations were carried out at 30 °C and pH was kept constant at 7.0 
using 5 % (v/v) NH4OH. Bioreactor was aerated with 2 VVM and agitated with 700 rpm to ensure 
aerobic conditions. Feed medium, NH4OH and fermenter were all placed on balances and the 
changes in weight was monitored online.  
 
Biomass measurements 
Dry cell weight (DCW) content of the medium was determined by OD620 measurements followed 
by a calculation using a preciously determined OD620:DCW-ratio. The OD620:DCW-ratio was 
obtained in fermentations identical to the fermentations used for 13C flux analysis. At specified time 
points samples taken and OD620 was measured. In addition samples were centrifuged and washed 
twice with distilled water followed by drying at 105 °C until constant weight. A OD620:DCW-ratio 
was determined using data from 6 independent fermentations.  
 
Sampling procedure 
Samples were immediately put on ice and centrifuged. Pellet and a supernatant were separated, and 
the supernatant was filtrated through a 0.22-μm pore size filter before both parts were stored at -
20°C until further analysis.  
 
Amino acids analysis 
Samples for amino acid analysis were first processed by extraction of 1 g sample in 10 mL 0.1 M 
HCl for 5 minutes while stirred by a magnetic stirrer. The sample was then added 5 mL 5-
sulfosalicylic acid (6% w/v) and stirred for another 5 minutes before centrifugation at 4000 g in 10 
minutes. An appropriate amount of the supernatant was transferred to a container where pH was 
adjusted to 2.20 ± 0.02 with 1 M NAOH. The sample was transferred to a 25 mL volumetric flask 
which was filled using sodium citrate loading buffer (0.20 M, pH 2.20) (Biochrom Ltd., Cambrigde 
Science Park, England). The sample was filtrated through a 0.22-μm pore size filter, diluted if 
necessary and loaded on a Biochrom 30 (Biochrom, Ltd., Cambrigde Science Park, England). 
Amino acids were separated using a pH gradient on a Oxidised Hydrolysate Column (Biochrom, 
Ltd., Cambrigde Science Park, England) and detection was carried out by a postcolumn derivatized 
with ninhydrin reagent followed by measuring absorbance at 440 (proline) or 570 nm (all other 
amino acids).  
 
Glucose measurement 
Separation of sugars was achieved using a CarboPac PA 1 column 4 × 50 mm (Dionex Corporation, 
USA) as precolumn followed by a CarboPac PA 1 column 40 × 250 mm (Dionex , USA) with 160 
mM NaOH as mobile phase. Detection and quantification was performed with an amperometric 
impulse-detector (Electrochemical detector ED 50 Dionex, Germany).   
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Organic acids measurement 
The concentration of organic acids in the supernatant was determined by HPLC. A Dionex ICS-
1000 ion chromatography system with a IonPac ICE-AS6 (250 × 9 mm) column (Dionex, USA) 
together with an anionic micromembrane suppressor AMMS ICE (Dionex, USA) were used for 
detection of organic acids. The eluent used was 0.4 mM heptaflurobutyric acid and 12 mM 
tetrabutylamonium hydroxide was used as reagent. The operation conditions used were as follows: 
sample volume 20 μL; system backpressure 800 psi; background conductance 14~16 μS; effluent 
flow rate 1 mL/min and reactant flow rate 1 mL/min. Samples were measured for the presence of 
lactate, acetate, malate and succinate.   
 
Analysis of the 13C-labeling patterns  
The labeling patterns of the amino acids incorporated into the biomass were analyzed by GC-MS, 
and the labeling patterns of the central metabolites were subsequently deduced from the knowledge 
of the biochemical relationship between precursors and amino acids (Christensen and Nielsen, 
1999a; Marx et al., 1996). The biomass used for analysis was harvested by centrifugation and 
washed twice with 50 mM Na2HPO4 buffer containing 0.9% (w/w) NaCl, pH adjusted to 7.0 with 
HCl. Approximately 15 mg biomass (dry) was hydrolyzed using 600 μL 6 M HCl at 105°C for 16 h. 
After hydrolyzation the sample was centrifuged and the supernatant was transferred into vials and 
dried at 105°C. The dried sample was dissolved in 1 mL dH2O, and the sample was extracted by 
solid phase extraction adding the entire sample to a Dowex cation exchange column containing 100 
mg dowex exchange resin (50W x 8 – 400) dissolved in 50% (w/w) glycerol. The sample was 
slowly allowed to pass through the resin allowing the resin to dry out. After this the resin was 
washed with 1 mL 50% ethanol followed by 200 μL 1 M NaOH. The sample was extracted by 
adding 1 mL extract solution (33.3% ethanol (v/v), 6.7% pyridine and 60% (v/v) of a solution 
containing 1% NaOH (wt/v) in saline (0.9% NaCl (wt/v)). The amino acid extract was divided into 
two and used for derivatization by ethylchloroformate or (N,N)-dimethylformamide dimethylacetal.  
 
Ethylchloroformate (ECF) derivatization 
The amino acid extract was added 50 μL ECF. After the formation of carbon dioxide had ceased the 
derivatives was extracted adding 200 μL propyl acetate and mixing followed by adding 50 μL 1 M 
HCl. The oraganic phase was collected for GC-MS analysis. 
 
(N,N)-dimethylformamide dimethylacetal (DMFDMA) derivatization 
The amino acid extract was added 200 μL 1 M HCl and dried at 105°C. The dried sample was 
added 200 μL DMFDMA and 200 μL acetonnitril and vortexed. The samples was derivatized at 
100°C for 20 min, and the sample was transferred to -20°C for 10 min. Sample was used for GC-
MS analysis.     
 
GC-MS parameters 
GC-MS analysis was done on an Agilent (palo Alto, CA, USA) HP 6890 gas chromatograph 
coupled to a HP 5973 quadruple mass selective detector in positive electron impact ionization (EI+) 
using an electron energy of 70 eV. The GC was equipped with a 4.0 mm i.d. Siltek gooseneck 
splitless deactivated liner (Restek, Bellefonte, PA, USA), and a Supelco (Bellefonte, PA, US) SLB-
5 MS column, 15 m, 0.25 mm i.d., 0.25 µm film. Helium of a purity of 99.999% was used as carrier 
gas at a constant linear gas velocity 35 cm/ s. Transfer line temperature was 280ºC, quadruple 
temperature 150ºC and MS source 200ºC. The GC-MS system was controlled from Agilent MSD 
Chemstation v. D.01.02.16.  
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For ECF derivatives the following method was used: The oven temperature was initially held at 
75°C for one min. Hereafter the temperature was raised with a gradient of 40°C min-1 until 165°C. 
Then 4°C until 190°C and 40°C upto 240°C. At the end, temperature was increased to 260°C with a 
gradient of 4°C min-1 and held constant for 4 minutes. The flow through the column was held 
constant at 1.3 mL He min-1. Temperature of the inlet, 200°C. Interface temperature, 
280°C.Quadrupole temperature, 105°C. 
  
DMFDMA derivatives was measured using the following method: The oven temperature was 
initially held at 60°C for one min. Hereafter the temperature was raised with a gradient of 20°C 
min-1 until 130°C. Then 4°C until 150°C and 40°C upto 260°C and held constant for 4.25 minutes. 
The flow through the column was held constant at 1 mL He min-1. Temperature of the inlet, 230°C. 
Interface temperature, 270°C.Quadrupole temperature, 105°C. 
For all the above methods, samples of 1 µL were injected in the splitless (30 sec, split 1:20) mode at 
200ºC using hot needle.  
 
In the mass spectrometer, the derivatives were ionized and subsequently fragmented, and the mass 
distribution of each individual fragment was measured (Christensen and Nielsen, 1999a). From the 
abundance of the measured peaks in the mass spectrum, the summed fractional labelling (SFL) of 
each fragment was calculated using (eq. 1), where mi is the abundance of the (m+i)-mass 
isotopomer and n is the total number of carbon atoms in the fragment. The calculated SFL was 
corrected for the occurrence of naturally labeling from other atoms (Wittmann and Heinzle, 1999).   
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The calculated SFLs were used to analyze the metabolic network. 
 
Amino acid uptake 
The amino acid uptake from the complex medium was measured using the concept of reciprocal 
labeling (Christensen, 2001). Here the 32%[U-13C6]glucose and 68% naturally labeled glucose was 
used as substrate. The fraction of amino acids taken up from the complex medium could be 
calculated from eq. 2.  
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Here n is the number of carbon atoms in the fragment measured. The labeling from naturally 
labeled sugar is 1.11%, so the labeling of a carbon atom completely synthesized de novo from 
glucose is 32.75%.   
 
Table 6.1: Medium and yield coefficients for cultivations in this study 
Strain Phase Substrate μ (h-1) Ysp (g g-1) Ysx (g g-1) 
ATCC 21253 Batch [1-13C]glucose 0.51 0 0.51 
ATCC 21253 Fed-Batch [1-13C]glucose 0 0.24 0.04 
ATCC 21253 Batch [U-13C6]glucose 0.50 0 0.50 
KK-11 Batch [1-13C]glucose 0.28 0.21 0.31 
KK-11 Fed-Batch [1-13C]glucose 0.03 0.37 0.21 
KK-11 Batch [U-13C6]glucose 0.28 0.21 0.31 
 
 
Estimation of metabolic fluxes 
The flux distribution of the metabolic network was estimated from metabolite and 13C balancing 
(Christensen and Nielsen, 1999a; Marx et al., 1996). The inputs to the model included biomass 
yield (see table 6.1), lysine yield (see table 6.1), biomass composition (Wittmann and de Graaf, 
2005), and the labeling patterns of amino acids not taken up from the medium (see table 6.2). The 
complete metabolic network is given in figure 6.1.      
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Figure 6.1: Metabolic network of C. glutamicum, including uptake of lactic acid and excretion of lysine. 
Abbreviations:  GLUCOSEEX: external glucose; G6P: glucose-6-phosphate; F6P: fructose-6-phosphate; P5P: 
pentose-5-phosphate; E4P: erythose-4-phosphate; S7P: sedoheptulose-7-phosphate; FDP: fructose-1,6-
bisphosphate;G3P: glyceraldehyde phosphate; 3PG: 3-phosphoglycerate; PEP: phosphoenolpyruvate; PYR: 
pyruvate; Ac-CoA: acetyl CoA; ICIT: isocitrate; AKG: α-ketogluterate; SUCC: succinate; FUM: fumerate; MAL: 
malate; OA: oxaloacetate; LYSINEEX: external lysine; LACTATEEX: external lactic acid; BM: biomass drain.   
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Table 6.2: Percentage of amino acids taken up from the medium and amino acids available in medium of total amino 
acids in biomass during exponential growth in complex medium 
Amino acid Ion cluster and derivatives ATCC 
21253 
 KK-11 KK-11 
  Uptake 
(%) 
Available in 
medium (%)* 
Uptake (%) Available in 
medium (%)* 
Alanine ECF: Ala 116; DMFDMA: Ala 99, 
Ala 158 
7.2 ± 3.2 32 7.7 ± 1.5 20 
Aspartate ECF: Asp 188; DMFDMA: Asp 
115, Asp 216 
2.6 ± 1.6 0 0.1 ± 1.1 0 
Glutamate DMFDMA: Glu 143, Glu 230  2.5 ± 1.5 1 0.8 ± 1.6 0 
Glycine ECF: Gly 175; DMFDMA: Gly 
144, Gly 85 
0 6 1.8 ± 2.5 6 
Isoleucine ECF: Ile 158 64.6 11 27.8 7 
Leucine ECF: Leu 158 100 94 41.4 58 
Lysine ECF: Lys 156  2.8 1 0 1 
Phenylalanine ECF: Phe 192; DMFDMA: Phe 143 12.2 ± 23 21 13.0 ± 17 13 
Proline ECF: Pro 142 24.4 46 14.8 28 
Serine ECF: Ser 132 0 8 0 5 
Threonine ECF: Thr 146, Thr 175 94.9 ± 6.8 201 31.7 ± 3.8 124 
Valine ECF: Val 144; DMFDMA: Val 
127, Val 143, Val 186 
18.0 ± 1.0 15 6.1 ± 1.3 9 
*: Available amino acid in medium = ((mg amino acid available in the medium)⋅(mg amino acid incorporated in 
biomass)-1)⋅100% 
  
Results 
 
Cultivation of C. glutamicum ATCC 21253 and KK-11 
The cultivation profiles of lysine fermentation with C. glutamicum ATCC 21253 and C. glutamicum 
KK-11 is displayed in figure 6.2 and growth rates and yield coefficients are shown in table 6.1. The 
fermentations were divided into two phases: A batch phase with high growth and low lysine 
production, and a fed-batch phase with low growth and high lysine production. The two phases are 
separated by a black line (Figure 6.2). Growth for both strains was exponential in the first part of 
the fermentation, and for KK-11 exponential growth was seen for the entire batch phase with a 
growth rate of 0.28 hr-1. For ATCC 21253 two distinct growth phases were observed in the batch 
phase, where a maximum growth (μ = 0.51 hr-1) was seen from start to around 10 hours. After this a 
significant decrease in growth was seen as the growth rate in this period was 0.08 hr-1. The change 
in growth correlated with the depletion of leucine, methionine and threonine from the medium (data 
not shown). The continuing growth after the depletion of these essential amino acids can be 
explained by the use of endogenous threonine and methionine for growth (Vallino and 
Stephanopoulos, 1993). For KK-11 the biomass concentration decreased slowly from 4.8 g DCW ⋅ 
kg-1 to 2.5 g DCW ⋅ kg-1 during the fed-batch phase due to dilution. When the data were corrected 
for dilution, a specific growth rate of 0.03 hr-1 was observed. For ATCC 21253 the biomass 
concentration was lowered from 5.8 g DCW ⋅ kg-1 to 2.5 g DCW ⋅ kg-1 in the fed-batch phase, which 
approximately corresponded to the dilution, and hence there was no significant growth in this 
period. In this period leucine, threonine and methionine was depleted which could explain the low 
growth in this phase. Lysine excretion was seen for the whole fermentation for the KK-11-
cultivation, and the final lysine,HCl titer reached 4.3 g ⋅ kg-1, which corresponded to a lysine yield 
of 0.31 g lysine, HCl ⋅ g glucose-1. For the ATCC 21253-cultivation lysine excretion was first 
initiated when leucine was depleted from the medium after 10 hours. Lysine excretion was 
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increased when the fed-batch phase was started, and the final lysine,HCl titer reached 2.5 g ⋅ kg-1 
corresponding to a lysine yield of 0.16 g lysine, HCl ⋅ g glucose-1 at the end of the fermentation. No 
significant byproduct formation was observed during the cultivations, and lactic acid present in the 
batch medium (0.4 g ⋅ kg-1) was depleted during the exponential phase for both strains (data not 
shown).   
                   
 
Amino acid uptake in complex medium  
Amino acids taken up from the medium during the batch phase were identified in cultivations using 
32%[U-13C6]glucose and 68% naturally labeled glucose was as substrate. From the calculated 
 
 
Figure 6.2: Fermentation profile for fed-batch cultivations with the high producing strain C. glutamicum KK-11 
(A) and the low producing strain C. glutamicum ATCC 21253. Black squares: Glucose concentration (g/kg); Grey 
squares: Biomass concentration (g DCW/kg); White squares: lysine,HCl concentration (g/kg).   
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labeling patterns (eq. 1) the uptake of twelve amino acids could be calculated using eq. 2, and the 
results are shown in table 6.2. To account for the differences in availability of the different amino 
acids it was calculated how much of each individual amino acid was taken up normalized to the 
availability of the amino acid (Table 6.2).Most amino acids present in significant amounts were 
taken up by both strains although it was seen that the different amino acids were taken up at 
different ratios. The three amino acids aspartate, lysine and glutamate were not taken up by any of 
the strains. This was expected since these amino acids were not present in significant amounts in the 
medium (Table 6.2). Glycine and serine were both present in small amounts in the medium, but no 
uptake of these amino acids was seen. The uptake of valine and phenylalanine corresponded with 
the available amino acids in the medium for both stains, indicating that these amino acids were fully 
utilized. For the two amino acids alanine and proline, only part of the proteinoic amino acid pool 
originated from the complex medium, 20% and 35% of alanine and 52% and 53% of proline 
originated from the medium for ATCC 21253 and KK-11, respectively. One possible explanation 
could be that both amino acids can serve as nitrogen donors for C. glutamicum (Burkovski, 2005) 
i.e. the amino acids can be metabolized via a transaminase reactions yielding ammonia and pyruvate 
or α-ketogluterate. If this was the case we would expect to see changes in the labeling patterns of 
pyruvate and α-ketogluterate due to the contribution of unmarked carbon from the breakdown 
products. Such changes could not be recognized from the data since glutamate (originated from α-
ketogluterate) and lysine (originated from pyruvate) were completely synthesized from 13C-glucose. 
For ATCC 21253 all proteinoic leucine and threonine was taken up from the medium, which was 
expected since these amino acids are essential for this strain. For the same strain isoleucine uptake 
was 587% of the available isoleucine in the medium. This very high uptake of isoleucine in this 
strain could be explained by the fact that isoleucine in C. glutamicum is synthesized from threonine 
by the incorporation of a pyruvate molecule (Möckel et al., 1992). This way most proteinoic 
isoleucine originated from unlabelled threonine and labeled pyruvate originating from the 13C-
labeled glucose. The high producing strain KK-11 partly synthesized (68%) and partly took up 
(32%) threonine, although this amino acid was present in high amounts in the medium. This was 
also the case for leucine and isoleucine where 41% of the leucine pool of the biomass was taken up 
from the medium. For isoleucine a significant amount originated from unlabeled threonine, however 
the majority of the proteinoic isoleucine was synthesized de novo from glucose.  
 
Table 6.3: Summed fractional labelling of biomass components in batch culture of ATCC 21253 and KK-11 grown on 
[1-13C]glucose in CSL based complex medium. 
  ATCC 21253 KK-11 
Ion Cluster Precursor Measured SFL Estimated SFL Measured SFL Estimated SFL 
Lysine 156 OAA{2,3,4}; 
PYR{2,3} 
83.4 85.5 73.6 74.7 
Aspartate 188 OAA{2,3,4} 51.3 52.7 45.3 48.7 
Aspartate 216 OAA{1,2,3,4} 58.7 61.7 55.3 56.0 
Aspartate 115 OAA{2} 11.1 10.9 11.5 11.2 
Glycine 144 G3P{1,2} 4.4 4.7 4.4 4.4 
Glycine 175 G3P{2} 5.3 4.7 - - 
Glycine 85 G3P{2} - - 1.8 1.7 
Serine 132 G3P{2,3} 34.5 34.3 28.4 27.9 
Glutamate 230 AKG{1,2,3,4,5} 85.1 85.5 76.6 74.7 
Glutamate 143 AKG{1,2} 42 41.8 40.2 37 
 
 
Flux distribution during exponential growth in complex medium               
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The metabolic network applied contains the glycolysis, the pentose phosphate pathway and the 
TCA cycle. The anaploresis is represented by pyruvate carboxylase, phosphoenolpyruvate 
carboxylase and phosphoenolpyruvate carboxykinase. In addition to these anaplerotic reactions 
malic enzyme and oxaloacetate decarbyxylase have also been reported in C. glutamicum, however 
based on biochemical evidence the activity of these reactions during growth on glucose are low or 
absent (Petersen et al., 2000) why these reactions were not included in the network. The metabolic 
flux distributions in the batch phase of fermentations using 99% [1-C13]glucose in complex medium 
were estimated from SFLs of fragments of aspartate, glutamate, lysine, serine and glycine (Table 
6.3). These amino acids were not taken up in significant amounts by any of the strains used in this 
study, and therefore they were synthesized de novo from the labeled glucose. The lactic acid 
contribution from the CSL was also included in the model. Lactic acid is entering the central 
metabolism of C. glutamicum as pyruvate, and an irreversible flux from lactic acid to pyruvate was 
therefore included into the model taking the contribution of unlabelled pyruvate into account. That 
all SFLs were based on samples in isotopic steady state was ensured by analyzing three independent 
samples in the exponential phase. For all SFL-data used for the flux estimation deviations were 
found to be lower than 0.5% (absolute)(data not shown) indicating the presence of an isotopic 
steady state. The estimated flux distributions are given in figure 6.3. All fluxes are given relative to 
100 mol of glucose taken up. The standard deviation for the SFLs was set to 0.05 in the model, and 
most estimations were within the range of this standard deviation. The estimated SFLs from the 
glycine ioncluster were in some cases not within the standard deviation. These values were low why 
an experimental error can not be excluded. The sensitivity of these values were tested and it was 
concluded that flux distributions only were changed marginally (1-2% absolute) when the SFLs 
were changed ±10% (Data not shown). Estimated and measured SFLs for the glutamate 143 and 
aspartate 188 ion clusters were also found to differ for KK-11 cultivations. Sensitivity test showed 
that ±10% (relative) of these fragments did not change the flux distributions significantly (data not 
shown).  
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Figure 6.3: Carbon flux distributions in the central part of C. glutamicum KK-11 and C. glutamicum ATCC 
21253 (displayed in that order from top to bottom) during low lysine production and high specific growth of 
the batch phase. Results are estimated from the best fit to experimental data for combined metabolite 
balancing and isotope balancing using metabolite data in table 1 SFL-data in table 3, and biomass 
requirement data from Witmann and de Graff (2005). Flux estimations are normalised to glucose uptake 
(1.10 mmol glucose ⋅ g DCW-1 and 0.66 1.10 mmol glucose ⋅ g DCW-1).  For abbreviations see figure 6.1.  
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Fluxes at the glucose-6-phosphate node into glycolysis and pentose phosphate pathway 
As shown in figure 6.3 a significant difference in flux distribution around the glucose-6-phosphate 
node was seen between the two C. glutamicum strains KK-11 and ATCC 21253. For the high 
producing strain KK-11 the flux through the pentose phosphate pathway was 83% and the 
glycolytic flux was 15%. The pentose phosphate pathway flux reported here is significantly higher 
than what is generally reported in literature. Wittmann and Heinzle (2002) reported pentose 
phosphate fluxes between 57% and 64% for various lysine producing strains, and Wittmann and 
Heinzle (2001) reported a pentose phosphate flux of 71% for ATCC 21253 in the lysine producing 
phase. The higher pentose phosphate pathway flux reported here may be explained by lack of, or 
reduced control of, the pentose phosphate pathway flux in this highly mutagenized strain. In the 
wild type the activity of both NADPH generating enzymes glucose-6-phosphate dehydrogenase and 
6-phosphogluconate dehydrogenase are inhibited by NADPH (Moritz et al., 2000). Mutations 
reducing this inhibition resulting in a increased flux through the pentose phosphate pathway have 
earlier been identified for both glucose-6-phosphate dehydrogenase (Becker et al., 2007) and 6-
phosphogluconate dehydrogenase (Ohnishi et al., 2005). For ATCC 21253 the pentose phosphate 
pathway flux was 37% and the flux through the glycolysis was 61%. ATCC 21253 have been 
studied earlier and pentose phosphate pathway fluxes have been observed to be 56% (Wittmann and 
Heinzle, 2002) and 71% (Wittmann and Heinzle, 2001a) under lysine production. In the present 
study samples were taken just before the lysine production phase had initiated and when growth rate 
was at maximum, and the lysine yield was therefore low compared to the studies mentioned above. 
Using the same technique as applied here pentose phosphate pathway fluxes of 40% and 36% have 
been reported in the C. glutamicum wild type strain ATCC 13032 (Sonntag et al., 1995) and the 
non-excreting strain C. glutamicum LE4 strain (Marx et al., 1997) corresponding well with the 
values found here. In both strains the carbon flux into the pentose phosphate pathway was much 
higher than the anabolic demands of the pentose phosphate pathway intermediates erythose-4-
phosphate and ribose-5-phosphate. Most of the carbon was therefore redirected back into the 
glycolytic pathway at the level of fructose-6-phosphate and glycaldehyde-3-phosphate. Although a 
significant difference was observed at the upper level of the glycolysis it was seen that at the lower 
part of the glycolysis between 3-phosphoglycerate and phosphoenolpyruvate the two strains 
revealed very similar fluxes with 152% and 155% for KK-11 and ATCC 21253, respectively.                             
 
Fluxes around the pyruvate node 
As pyruvate is one of the key metabolites in C. glutamicum the fluxes around this compound is 
important when analyzing the metabolic network. Pyruvate connects glycolysis, the TCA cycle, 
anaplerosis, anabolic reactions and lysine synthesis. The pyruvate yielding fluxes included in this 
model were lactate uptake (v36 – figure 6.1) and the two phosphoenolpyruvate converting reactions 
pyruvate kinase (v7 – figure 6.1) and the PTS glucose uptake system (v1). The major difference 
between the two strains was a significant higher flux from phosphoenolpyruvate to pyruvate, 101% 
for the ATCC 21253 strain compared to 50% for KK-11, mediated by the pyruvate kinase flux. The 
higher flux was connected to an ATP-consuming futile cycle, where pyruvate was converted to 
oxaloacetate (83%) and oxaloacetate was further converted to phosphoenolpyruvate (51%) 
corresponding to the difference seen for pyruvate kinase flux. Such a futile cycle have been reported 
for numerous lysine producing and non-producing strains (Krömer et al., 2004; Marx et al., 1996; 
Wittmann and Heinzle, 2001a; Wittmann and Heinzle, 2001b). Surprisingly the flux of this cycle 
was much lower for the high producing strain, where only a decarboxylating flux of 4% was 
observed. As a result the anaplerotic netflux for KK-11 was higher (41+3-4 = 40%) than it was the 
case for ATCC 21253 (83+0-51 = 32%). It is generally accepted that there is a correlation between 
a high anaplerotic netflux and a high lysine production (Kjeldsen and Nielsen, 2008), a correlation 
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which is also seen when these two strains are compared. For both strains the major carboxylating 
reaction was pyruvate carboxylase (v13 – figure 6.1) contributing to more than 90% of the 
carboxylation for KK-11 and 100% for ATCC 21253. This is in agreement with earlier findings for 
this organism (Petersen et al., 2000). 
 
TCA cycle 
The low producing strain ATCC 21253 exhibited a flux of 79% entering the TCA cycle, whereas 
the high producing strain KK-11 showed a significant lower value of 67% (figure 6.3). The reduced 
growth for the high producing strain KK-11 compared to the low producing strain is reflected in the 
lower TCA flux, thus adapting to the lower anabolic- and ATP-demand. Instead a higher 
oxaloacetate demand for lysine synthesis mediated a higher anaplerotic netflux.        
 
NADPH balancing    
From the obtained information on the metabolic flux distribution a balance for NADPH formation 
and consumption can be set up. As previously shown there are three major NADPH generating 
reactions in C. glutamicum during cultivation on glucose: glucose-6-phosphate dehydrogenase 
(Sugimoto and Shiio, 1987a), 6-phosphogluconate dehydrogenase (Sugimoto and Shiio, 1987b) and 
isocitrate dehydrogenase (Eikmanns et al., 1995). This leads to a NADPH formation of 83 + 83 + 
67 = 233% for the high producing strain KK-11, and 37 + 37 + 79 = 153% for the low producing 
stain ATCC 21253. NADPH is required for growth and for lysine production. With a demand of 
16.429 mmol NADPH ⋅ (g biomass)-1 (Wittmann and de Graaf, 2005) and biomass yields of 54.3 g ⋅ 
(mol glucose)-1 and 90.5 g ⋅ (mol glucose)-1 for KK-11 and ATCC 21253, respectively and with a 
demand of four NADPH for one molecule of lysine the NADPH demand for KK-11 is 176% and 
for ATCC 21253 it is 156%. This leads to a NADPH excess of 57% for the high producing strain 
KK-11. Similar findings have been reported in other lysine producing strains (Krömer et al., 2004; 
Wittmann and Heinzle, 2001a; Wittmann and Heinzle, 2002). For ATCC 21253 the NADPH 
balance almost closed with a deficit of only 3%.              
 
Flux estimation during fed-batch fermentation 
The labeling patterns of the proteinoic amino acids of the biomass are used for flux estimations. 
Since the labeling patters of the protein pool changes relatively slowly compared to physiological 
responses of the cells, an error occurs when making flux estimations on non-steady state cultures 
with non-constant physiological behavior. However, the labeling patterns of the proteinoic amino 
acids formed after a metabolic shift due to changes in physiological behavior will be reflected in the 
labeling patterns of the combined pools of “old” and “new” protein. Using the generally applied 
method for flux estimations as used earlier for the batch cultivations, samples taken at different 
parts of the fed-batch phase were analyzed. As samples taken in the fed-batch phase are not steady 
state samples, the in vivo fluxes estimated do not represent the real fluxes, but they do point to 
trends in changes in the metabolism. Flux estimations using this strategy have earlier been termed 
“integrated fluxes” (Jonsbu et al., 2001).  
 
Integrated fluxes through the central carbon metabolism  
Three integrated fluxes related to central carbon metabolism were analyzed to see the effect of the 
change from high specific growth and low lysine production to low specific growth and high lysine 
production as seen in table 6.1. The fluxes evaluated were the pentose phosphate pathway, the 
anaplerotic netflux, and the flux through the TCA cycle (Figure 6.4A and Figure 6.4B). For the 
fluxes presented here a smooth development in the fluxes was generally observed indicating that the 
metabolic changes due to the physiological change were constant. For the high producing strain 
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KK-11 a 1.1-fold increase in the pentose phosphate pathway flux was seen so the integrated flux 
was 91% at the last part of the fed-batch phase (Figure 6.2A). For the low producing strain ATCC 
21253, a 1.4 increase in the pentose phosphate pathway flux was seen as a consequence of the 
physiological change of the culture so an integrated flux of 51% was seen at the end of the fed-
batch phase (Figure 6.4B). The TCA cycle flux for KK-11 was decreased 1.2-fold so the flux at the 
end of the fed-batch phase was 72%, and the anaplerotic netflux increased 1.1-fold. For ATCC 
21253 the TCA flux increased 1.2 fold and the anaplerotic netflux decreased 1.3 fold. The increase 
in the pentose phosphate pathway flux as a consequence of the change in physiological state of the 
culture seen for both strains was thought to be a consequence of the decreased growth rate lowering 
the requirement for ATP and precursors for biomass synthesis. Earlier work on profiling lysine 
fermentations has shown results which are inconsistent with our findings. Batch-cultures of ATCC 
21253 was analyzed throughout a fermentation by metabolite balancing (Vallino and 
Stephanopoulos, 1993), and fluxes were found to fluctuate throughout the fermentation, so the 
pentose phosphate pathway flux increased from 25% when no lysine was produced to 69% when 
the lysine production phase had just initiated and then dropped to 40% at the later lysine production 
phase. In another study batch cultures of C. glutamicum ATCC 13237 was analyzed by metabolite 
balancing and isotopomer modeling throughout a lysine fermentation (Krömer et al., 2004). They 
found that the pentose phosphate pathway flux decreased from 72% to 52% when the fermentation 
changed from high growth and no lysine production to low specific growth and lysine production. 
Further, they found that the TCA cycle flux decreased from 70% to 53%, and from 69% to 46% and 
 
Figure 6.4: Integrated fluxes through the central carbon metabolism of two C. glutamicum strains. A) C. 
glutamicum KK-11. B) C. glutamicum ATCC 21253. Squares: Pentose phosphate pathway flux; Triangles: TCA 
flux; Diamonds: Anaplerotic netflux.  
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back to 70% in the study of Vallino and Stephanopoulos (1993). The major differences between the 
data of Krömer et al. (2004) and Vallino and Stephanopoulos (1993) and the data presented in this 
paper are the different fermentation strategies applied, and the use of complex medium. In this 
paper carbon limited fed-batch is applied to avoid the production of byproducts often seen under 
batch cultivations, which is expected to change the in vivo flux distribution. In addition to this the 
use of complex medium is likely to affect the metabolic fluxes. Both factors may explain the 
differences seen between earlier published data and the data in this paper. Another explanation for 
the inconsistence between data presented here and earlier findings could be that the data presented 
here are integrated fluxes, and is therefore an average of the whole fermentation and not a snapshot 
of the present in vivo fluxes at a given time as seen for the data of Vallino and Stephanopoulos 
(1993) and Krömer et al. (2004). When comparing the two strains KK-11 and ATCC 21253 the 
development in the TCA flux and anaplerotic netflux were found to be different. For KK-11 the 
development was expected since an increase in lysine production is generally known to decrease 
TCA cycle flux and increase the anaplerotic netflux (Kjeldsen and Nielsen, 2008). However, for 
ATCC 21253 this was not the case under these conditions. Previously a rigid regulation of the 
carbon flux at the oxaloacetate node in a lysine producing ATCC 21253 strain in continuous culture 
was observed, demanding a higher TCA flux under conditions where oxaloacetate demand was 
increased (Kiss and Stephanopoulos, 1991). The oxaloacetate demand was in fact increased 1.1-fold 
through for the cultivations in this study. Later work on batch cultures of ATCC 21253 and related 
strains did not show a rigid oxaloacetate node (Wittmann and Heinzle, 2002). However, as pointed 
out by Wittmann and Heinzle (2002) the metabolic regulation in C. glutamicum might be different 
under the conditions of reduced growth in batch cultures compared to that of continuous culture. 
And this may also be the case when compared to data from fed-batch cultures. When evaluating the 
significant differences between the integrated fluxes of the two strains compared in this study, it 
needs to be taken into account that it seems possible that different mutations affecting metabolic 
regulation have been introduced to the two strains during random mutagenesis. 
 
Conclusion 
Two strains of C. glutamicum, a low producing strain ATCC 21253 and a high producing strain 
KK-11, were evaluated under batch and fed-batch lysine production in complex medium. The flux 
distribution values found for the low producing strain were in some cases inconsistent with what 
have been reported earlier for this strain in batch cultivations in defined medium. This emphasizes 
the importance of developing methods for in vivo flux estimation to be able to understand industrial 
processes. We were able to identify changes in the central metabolism as a result of the change in 
physiological state mediated by the change from batch to fed-batch fermentation, changing the 
culture from high growth-low lysine excretion to low growth-high lysine excretion. Methods for in 
vivo flux estimations in unbalanced systems such as fed-batch or repeated fed-batch systems are 
needed in order to fully understand these systems. The method presented here can be used to 
identify tendencies in such systems. The results presented here for an industrial production strain 
illustrates that significant differences can be seen between industrial production strains and low 
producing strains.                  
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Chapter 7 
Conclusion and discussion 
 
 
In the present PhD project various strategies have been applied in order to pursue the overall goal of 
improving an industrial L-lysine producing Corynebacterium glutamicum strain. The experimental 
part of the project can be divided into three separate parts all of which are described below. 
 
Reconstruction and analysis of C. glutamicum metabolic network 
A mathematical model of the metabolic network of C. glutamicum based on genomic information, 
and based on the wealth of biochemical information which is available for this organism due to its 
long history as a commercial relevant organism was constructed and validated against earlier 
published data. The in silico model constructed in this study is described in detail in chapter 4, and 
was made based on the annotated genome of the wild type strain of C. glutamicum (ATCC 13032) 
and published biochemical information on C. glutamicum. The model was validated against data 
from a series of well recognized scientific papers, and the model predictions were found to fit well 
with experimental data. The model was used to analyze the metabolic network during lysine 
production, and based on this a number of biological hypotheses were suggested to improve lysine 
production in C. glutamicum. The first prediction made by the model was that a high ATP 
production under high lysine production resulted in a limitation in lysine production. This was the 
case at high lysine yield (>55%) and low growth. When ATP was in excess under these conditions 
the model had to handle this excess energy burning up excess ATP in futile cycles suboptimal for 
lysine synthesis. Secondly, the model predicted a limitation in lysine production when the 
succinylase branch of the lysine synthetic pathway was preferred over the dehydrogenase branch. 
The result was a decrease in maximal theoretical lysine yield from 0.75 mmol lysine ⋅ (mmol 
glucose)-1 to 0.57 mmol lysine ⋅ (mmol glucose)-1 due to a relatively higher activity of the TCA 
cycle because of the involvement of the TCA intermediate Succinyl-CoA. The higher TCA cycle 
activity was suboptimal for lysine production because of a loss of carbon due to CO2 –production. 
Thirdly, the model predicted a correlation between a high pentose phosphate pathway flux and high 
lysine production. This correlated well with earlier published data, and increasing the flux through 
the pentose phosphate pathway by metabolic engineering was chosen as a metabolic engineering 
strategy. The fourth prediction made from the analysis of the in silico model was the correlation 
between increasing anaplerotic netflux and increasing lysine production. This correlation could also 
be confirmed from a large number of scientific papers, why this strategy also was chosen for 
metabolic engineering. 
 
The in silico model constructed and presented in this thesis is made from data from various sources 
based on data from different strains including both lysine producing and non-producing strains. To 
improve the prediction power of the model and to fit the predictions to a specific strain (i.e. a highly 
mutagenized production strain) the model needs to be adjusted and improved with data from the 
specific strain. The data in this respect could be in vivo flux data or transkriptomic data made under 
production relevant conditions. It is believed that by implementing this type of data from the high 
producing strain used in this study the prediction power will be improved, when the metabolic 
network is analyzed and when biological hypotheses are tested in silico. In this study in vivo flux 
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estimations on the high producing strain was conducted, but, these data were not implemented in 
the model presented in this thesis as they were first obtained at the end of the PhD study.  
 
Comparison of various metabolic engineering strategies in a high 
producing C. glutamicum strain 
Various metabolic engineering strategies were tested in a high producing C. glutamicum strain as 
described in chapter 5. Based on the findings in the metabolic network reconstruction and based on 
results reported in literature three parts of the metabolism were selected for metabolic engineering. 
As predicted by the in silico model the pentose phosphate pathway was selected to increase the 
NADPH formation. The two NADPH generating enzymes glucose-6-phosphate dehydrogenase 
(zwf) and 6-phosphogluconate dehydrogenase (gnd) was up-regulated, and both modifications were 
seen to have a positive effect on lysine yield of 5% and 6%, respectively, indicating that NADPH 
was in fact limiting under high lysine producing conditions. The enzyme pyruvate carboxylase (pyc) 
was also selected for up-regulations to increase the anaplerotic netflux which is believed to be 
beneficial for lysine production based on findings in literature and predictions by the in silico 
model. This modification resulted in a decrease in lysine production and did not fit our initial 
expectations. Five enzymes in the lysine synthetic pathway were selected for up-regulation based on 
results found in literature. The enzymes were aspartate kinase (lysC), dihydrodipicolate syntase 
(dapA), succinylaminoketopimelate transaminase (dapC), diaminopimelate epimerase (dapF) and 
lysine permerase (lysE). Only the strain with an up-regulated aspartate kinase activity showed a 
significant effect on the overall lysine yield, and this effect was negative. In this study it was seen 
that although metabolic engineering strategies had earlier been shown to be beneficial for lysine 
production in C. glutamicum strains, many of these strategies could not be transferred directly to a 
high producing industrial strain. 
 
In vivo flux estimations under industrial relevant conditions 
Estimations of in vivo fluxes under growth and lysine production in complex medium and during 
batch and fed-batch fermentation were conducted. These results are presented in detail in chapter 6. 
For the industrial strain, C. glutamicum KK-11, a higher flux through the pentose phosphate 
pathway was seen compared to earlier published data. This high flux may be explained by the fact 
that this highly mutagenized strain can be expected to have mutations not present in low producing 
strains. In addition to this the role of the complex medium components can affect metabolic fluxes. 
In addition to flux estimations during balanced growth present in the batch phase of the 
fermentation, the method was employed on samples from the fed-batch phase of the fermentation. 
These results were used to identify metabolic changes when the physiological state of the cells was 
changed. The tendencies identified employing this method was an increase in the pentose phosphate 
pathway flux, a decrease in the TCA flux, and a increase in the anaplerotic net flux. Another C. 
glutamicum strain, ATCC 21253, earlier used in flux estimation studies was also included in the 
flux estimation study. This strain was found to have lower pentose phosphate pathway fluxes 
compared with the industrial strain. And during the change from batch to fed-batch fermentation the 
tendencies were different than what was seen for the industrial strain. The pentose phosphate 
pathway flux was increased as seen for the industrial strain, but TCA flux was increased and 
anaplerotic netflux decreased. These differences are discussed more in detail in chapter 6. 
 
The idea of making metabolic flux estimations under production relevant conditions is quite 
appealing seen from an industrial point of view, because this will give a true picture of what is 
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going on in the industry scale fermentation. On the other hand it is not trivial at all to get reliable 
flux estimation results due to a number of practical challenges. First of all industrial fermentations 
are typically carried out in complex medium containing complex components such as corn steep 
liquor, molasses, protein hydrolysates etc. Many of these components will affect the results of the 
measurements making the basis of the flux estimation, and this needs to be taken into account. In 
the present study some of these challenges were met by excluding data which were affected by the 
complex components. However, this limits the number of inputs to the flux model which may affect 
the accuracy of the flux estimations. Another problem is the fact that flux balance estimations are 
made during balanced growth which is seen during exponential growth. However, for an industrial 
scale lysine production process the exponential growth phase is only a small part of the 
fermentation, and measurements in this phase does not represent the production phase which is the 
most interesting part from an industrial point of view. In this study the effects of the physiological 
changes made when the fermentation was changed from batch to fed-batch was analyzed by looking 
at the integrated fluxes which gave a clear indication on these changes based on the tendencies seen 
in the development in flux distributions. This approach of course has some limitations since the 
results reflect an average of the “old” biomass produced before the physiological change and the 
“new” biomass. The results can therefore not be used to identify the absolute fluxes at a given time-
point. Even though there have recently been developed concepts and methods for flux quantification 
during dynamic growth conditions through measurements of labeling patterns in intracellular 
metabolites, this is still quite complex due to the turn over of both protein and transaminase reaction 
involving amino acids and keto-acids. 
 
The in vivo flux distribution estimations found for the industrial production strain can be used to 
improve the C. glutamicum in silico metabolic model presented in this study to fit the industrial 
production strain used in this study. 
 
Industrial relevance of project 
In this industrial PhD-project a number of industrial relevant problems have been addressed. The 
main purpose of the project was to improve a C. glutamicum industrial production strain. To pursue 
this goal the above mentioned methods were applied. Each of these methods has earlier been 
applied on C. glutamicum or other organism. In this study the three methods has been unified to 
form a strategy for strain improvement (Figure 7.1). Using the constructed in silico metabolic model 
biological hypotheses can be tested and predictions can be used to propose metabolic engineering 
strategies. These strategies can be tested using metabolic engineering followed by an evaluation of 
the effects on lysine production of the metabolic engineering strategies making fermentations, 
simulating production scale fermentation conditions. In addition to this the development of a 
method for estimating in vivo metabolic fluxes under production-like conditions gives a direct 
measure for the effect of the introduced modification on the metabolic flux distribution, and these 
results can be used to improve the in silico model. As seen in figure 7.1 all three parts are connected 
and it is the idea that by continuing this process the metabolic model will be improved, the 
predictions will be improved and at the end an improved production strain will be the result. 
 
Another challenge which has been addressed is the use of complex medium, which is generally 
applied in industry scale fermentations. As mentioned above a number of problems can be 
identified using complex based medium. In this study metabolic flux estimations were conducted in 
complex medium, and this represents a major new contribution to the field of flux analysis of lysine 
producing strains. 
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Furthermore, in this study the organism used in most experiments was an industrial relevant 
production strain with yields and productivities significantly higher than what is generally reported 
in literature. The use of an organism with these characteristics makes the results much more 
interesting from an industrial point of view. In particular it is interesting to note that many of the 
different metabolic engineering strategies that have shown to be successful for laboratory strains are 
found not to have a positive effect on an industrial strain, which points to that industrial strains are 
already highly optimized and that it is therefore not always possible to transfer metabolic 
engineering strategies from laboratory strains to industrial strains. 
 
 
 
Figure 7.1: Strategy for continuous production strain improvement 
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 # 1. SUBSTRATES UTILISATION
  # 1.1 CARBON SOURCES
 #Glycerol
Q8NLP9 2.7.1.30  glpK  ATP + GL <-> ADP + GL3P
 #Ethanol
Q8NLX9 1.1.1.1  adhA  ACAL + NADH <-> ETH + NAD
Q8NLZ0 1.2.1.3  dhaS_1  ACAL + NAD -> NADH + AC
 #Glycerate
Q8NNV1 2.7.1.31  glxK  ATP + GLYR <-> ADP + 3PG
 #N-acetyl-D-glucosamine-6-phosphate
3.1.2.5 r3.1.2.5  NAGA6P -> GA6P + AC
 # C5 compounds
 # L-arabinose, D-arabitol, D-lyxose, D-ribose, D-xylose, L-lyxose, L-xylitol, 
Q8NN81 2.7.1.15  rbsK1  ATP + RIB <-> ADP + R5P
Putative-ARA  R5P + UTP -> UDPARA + PI
Q6M8P0 2.7.1.17  xylB  ATP + XYL -> ADP + X5P
 # Hexoses
 #Fructose
Q8NTZ3 2.7.1.4  iolC  FRU + ATP -> F6P + ADP
#Glucose
Q6M788 5.4.2.2  pmmB  G1P <-> G6P
 #Mannose
Q8NSC8 5.3.1.8  manA  MAN6P <-> F6P
Q8NSD0 5.4.2.8  pmmA  MAN6P <-> MAN1P
Q6M738 2.7.7.22  rmlA2  GTP + MAN1P <-> PPI + GDPMAN
 #Galactose
Q8NNH0 2.7.1.6 r2.7.1.6  ATP + GLAC <-> GAL1P + ADP 
5.1.3.2  galE  UDPG <-> UDPGAL
2.7.7.9  galU1  UTP + G1P <-> PPI + UDPG
 # D-gluconate
Q8NLD4 2.7.1.12  gntK  ATP + GLUC <-> ADP + D6PGC
 # Disaccharides
 # sucrose
Q8NMD5 3.2.1.26  scrB  SUC6P -> FRU + G6P Yokota & Lindley (2005)
 # celobiose
 #Trehalose
 treY  POLYGLC <-> MLTTRE Tzvetkov et al (2003)
 treZ  MLTTRE <-> TRE Tzvetkov et al (2003)
 otsA  G6P + UDPG <-> UDP + TRE6P Tzvetkov et al (2003)
 otsB  TRE6P <-> TRE+ PI Tzvetkov et al (2003)
 treS   MLT <-> TRE Tzvetkov et al (2003)
 
 # organic acids
 
# acetate
P77845 2.7.2.1  ackA  ATP + AC -> ADP + ACETYLP Reinsheid et al (1999)
P77844 2.3.1.8  pta  COA + ACETYLP <-> ACCOA + PI Reinsheid et al (1999)
 # propionate
 prpDBC  PROPIONATE + OA -> PYR + SUCC Claes et al (2002)
 # fumerate
Q6M7L9 1.2.1.2  fdhF  FOR + NAD -> CO2 + NADH
 # lactate
 # Amino acids
#Alanine
 
Appendix I: Reaction list for genome-scale reconstruction of 
C. glutamicum 
Apendix I: Reaction list genome scale model 3 / 24
 D-Ala_degrade  DALA + FAD -> FADH2 + PYR + NH3
Q8NT35 2.6.1.19  bALA_degrade  bALA + AKG -> GLU + MALONATES  
Q8NSX1 1.2.1.27  msmA
 #Aspargine
Q8NNP5 3.5.1.1  asp   ASN -> ASP + NH3
 #Serine
Q8NQ09 4.3.1.17  sdaA  SER -> PYR + NH3
 # Glutamate family (glutamate, glutamine, arginine, proline)
 # glutamate
Q8NT35 2.6.1.19  gabT  GABA + AKG <-> SUCCSAL + GLU
 gabD2 SUCCAL + NADP <-> NADPH + GLU
# 1.2 SULPHATE METABOLISM
 
Q8NLX1
2.7.7.4  cysND  SLF + ATP + GTP <-> APS + PPI + GDP + PI Lee (2005)
Q6M242 1.8.4.8  cysH_1  APS + RTHIO -> OTHIO + H2SO3 + AMP Lee (2005)
  cysI  H2SO3 + 3 NADPH <-> H2S + 3 NADP Lee (2005)
  cysC  APS + ATP <-> ADP + PAPS + PI Lee (2005)
Q8NLX0 1.8.4.8  cysH_2  PAPS + RTHIO -> OTHIO + H2SO3 + PAP Lee (2005)
#added model in order to balance PAP
 unk_34  PAP -> AMP + PI Added reaction
  # 1.3 NITROGEN METABOLISM
Q9RHM6
3.5.1.5  ureA  UREA -> CO2 + 2 NH3 Siewe et al (1998); 
Beckers et al (2004)
NH3/NH4-eq.  NH3 <-> NH4 Added reaction
 # 1.4 PHOSPHOROUS METABOLISM
Pyrophosphate PPI <-> PI + PI Added reaction - Artificial 
for balancing
  # 2. CARBOHYDRATE METABOLISM
 # 2.1 GLYCOLYSIS/GLUCONEOGENESIS
 #Reactions prior EMP
Q8NS31 5.3.1.9  pgi  G6P <-> F6P Marx et al (2003)
Q8NR14 2.7.1.11  pfkA  ATP + F6P <-> ADP + FDP Sugimoto et al (1989)
Q8NP81 2.7.1.11  pfkB  ATP + F1P -> ADP + FDP Sugimoto et al (1989)
Q6M4B1 2.7.1.2  glk  ATP + GLC -> ADP + G6P Park et al (2000)
3.1.3.11  fbp FDP -> F6P + PI Rittmann et al (2003)
 #Glycolysis
P19537
4.1.2.13  fda  FDP <-> DHAP + G3P von der Osten et al (1989)
P19583 5.3.1.1  tpiA  G3P <-> DHAP Eikmanns (1992)
Q01651
1.2.1.12  gapA  G3P + PI + NAD <-> NADH + 13PDG Eikmanns (1992); Bathe 
et al (1996)
 #gapB  G3P + PI + NADP <-> NADPH + 13PDG
Q6M6L3 1.2.1.12  gapB  NADPH + 13PDG -> G3P + PI + NADP Eikmanns (1992)
Q01655 2.7.2.3  pgk  ADP + 13PDG <-> ATP + 3PG Eikmanns (1992)
Q8NTA5 5.4.2.1  pgm  3PG <-> 2PG Yokota & Lindley (2005)
Q8NRS1 4.2.1.11  eno  2PG <-> PEP Yokota & Lindley (2005)
Q46078
2.7.1.40  pyk  PEP + ADP -> PYR + ATP Jetten et al (1994); Netzer 
et al (2004)
Q8NSW3 2.7.9.2  pps  ATP + PYR -> AMP + PEP + PI Jetten et al (1994b)
 # 2.2 CITRATE CYCLE (TCA CYCLE)
 #TCA Cycle
Q8NNF6 1.2.4.1  aceE  PYR + LIPO -> ACLIPO + CO2 kalinowski et al (2003)
##aceF not found so far
2.3.1.12  aceF  ACLIPO + COA -> ACCOA + DLIPO
Q8NSI4 1.8.1.4  lpd  DLIPO + NAD -> LIPO + NADH Schwinde et at (2001)
P42457 2.3.3.1  gltA  ACCOA + OA -> CIT + COA Eikmanns et al (1994)
Q8NQ98 4.2.1.3  acn  CIT <-> ICIT Krug et al (2005)
P50216 1.1.1.42  icd  ICIT + NADP -> AKG + CO2 + NADPH Eikmanns et al (1995)
P96746 1.2.4.2  odhA  AKG + LIPO -> SDLIPO + CO2 Usuda et al (1996)
Q8NNJ2 2.3.1.61  sucB  SDLIPO + COA -> DLIPO + SUCCOA Zhao & Lin (2002)
Q8NMK8
6.2.1.5  sucD  ADP + PI + SUCCOA -> ATP + SUCC + COA Zhao & Lin (2002)
Q8NMK7 1.3.5.1  sdhCAB  SUCC + MK -> FUM + MKH2 Bott & Niebisch (2003)
 #sdhA_1  SUCC + FAD -> FUM + FADH2
 #sdhA_2  FUM + FADH2 -> SUCC + FAD
 MALONATES + COA + NAD -> CO2 + 
ACCOA + NADH
##gapB more active when AC is used as carbon source (Eggeling and Bott (2005, pp 224), gapB 
reversibel acording to literature. However, NADPH generation if not constrained to be ireversibel
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Q8NRN8 4.2.1.2  fumC  FUM <-> MAL Zhao & Lin (2002)
##Precence of mdh2 is uncertain
Q8NSK9 1.1.1.82  mdh2  MAL + NADP -> OA + NADPH
Q8NN33 1.1.1.37  mdh  MAL + NAD -> NADH + OA Molenaar et al (2000)
  #Glycosylate shunt
P42449 4.1.3.1  aceA  ICIT <-> SUCC + GLX Reinsheid et al (1994)
4.1.3.2  aceB  ACCOA + GLX -> MAL + COA Reinsheid et al (1994b)
 #Anaplerotic reactions
P12880 4.1.1.31  ppc  PEP + CO2 -> PI + OA Eikmanns et al (1989)
O54587
6.4.1.1  pyc  ATP + PYR + CO2 -> ADP + PI + OA Peters-Wendisch et al 
(1998)
##pckG mainly glucogenic enzyme
4.1.1.32  ##pckG  GTP + OA <-> GDP + PEP + CO2 Riedel et al (2001)
Q9AEM1 4.1.1.32  pckG GTP + OA -> GDP + PEP + CO2 Riedel et al (2001)
##mez mainly glucogenic enzyme
 
1.1.1.40  ##mez MAL + NADP <-> CO2 + NADPH + PYR Vallino & 
Stephanoupoulos (1993)
Q8NLD5
1.1.1.40  mez  MAL + NAD <-> CO2 + NADPH + PYR Vallino & 
Stephanoupoulos (1993)
4.1.1.3  Odx  OA -> PYR + CO2 Jetten & Sinskey (1995)
 # 2.3 PENTOSE PHOSPHATE PATHWAY
Q6M517 1.1.1.49 zwf&opcA  G6P + NADP -> 6PG + NADPH Moritz et al (2000)
Q8NQI2 1.1.1.44  gnd  6PG + NADP -> Ru5P + CO2 + NADPH Moritz et al (2000)
Q8NQ49 5.1.3.1  rpe  Ru5P <-> X5P Yokata & Lindley (2005)
Q8NMZ0 5.3.1.26  rpi  Ru5P <-> R5P Yokata & Lindley (2005)
Q6M519 2.2.1.1  tkt_1  R5P + X5P <-> G3P + S7P Yokata & Lindley (2005)
Q8NQ64 2.2.1.2  tal  G3P + S7P <-> E4P + F6P Yokata & Lindley (2005)
Q8NQ65 2.2.1.1  tkt_2  E4P + X5P <-> F6P + G3P Yokata & Lindley (2005)
  #3.Respiratory Energy Metabolism
Q79VG1 1.6.99.3  ndh  NADH + MK -> MKH2 + NAD Bott & Niebisch (2003)
Q6M7Z1 1.3.5.1  sdhCAB  SUCC + MK -> FUM + MKH2 Bott & Niebisch (2003)
O69282
1.1.99.16 mqo  MAL + MK -> OA + MKH2 Bott & Niebisch (2003); 
Molenaar et al (2000)
Q8NMG5 1.2.2.2  poxB PYR + MK -> AC + CO2 + MKH2 Bott & Niebisch (2003)
Q8NRY8 1.1.1.28  dld2  LAC + MK -> PYR + MKH2 Bott & Niebisch (2003)
Q8NLN0 1.1.1.27  lldD  LLAC + MK -> PYR + MKH2 Bott & Niebisch (2003)
Q6M4X2 1.1.99.5  glpD  GL3P + MK -> DHAP + MKH2 Bott & Niebisch (2003)
Q8NU48 1.5.1.12  putA  PRO + MK -> P5C + MKH2 Bott & Niebisch (2003)
#Electron transfer from Menaquinol to Oxygen
 #(1H+/e-); Eggeling and Bott (2005) pp 325
 cyto-bd-complex MKH2 + 0.5 O2 + 2 H_PO -> MK + 2 H_POxt Bott & Niebisch (2003)
#(3H+/e-); Eggeling and Bott (2005) pp 325
bc1-aa3-complex  MKH2 + 0.5 O2 + 6 H_PO -> MK + 6 H_POxt Bott & Niebisch (2003)
 #3.3 Electron tranfer from Menaquinol to Nitrate
 narGHIJ  NO3 + MKH+ 2 H_PO -> NO2 + MK + 2 
H_POxt
Bott & Niebisch (2003)
#3.4 F1F0.ATP Syntase
## (observed values for Protons/ATP is between 3-4 → P/O = 1.5-2 (Bott & Niebisch (2003))
 ATPase-complex  ADP + PI + 4 H_POxt -> ATP + 4 H_PO Bott & Niebisch (2003)
 #3.4 Hydrogenperoxide
Q6M8A6 1.11.1.6  katA  2 H2O2 -> O2  
 #3.2 Heme Biosynthesis and cytocrome c Maturation
 NCgl0233+NCgl1244  GLU + ATP -> AMP + GLUTAMYLTRNA Bott & Niebisch (2003)
 hemA  GLUTAMYLTRNA + NADPH -> NADP + GSA Bott & Niebisch (2003)
 hemL  GSA -> 5AL Bott & Niebisch (2003)
 hemB  2 5AL <-> PORIII Bott & Niebisch (2003)
 hemC  4 PORIII -> 4 NH3 + HYDROXYMEBI Bott & Niebisch (2003)
 hemD  HYDROXYMEBI -> UROPORIII Bott & Niebisch (2003)
 hemE  UROPORIII -> 4 CO2 + COPPIII Bott & Niebisch (2003)
 hemN  COPPIII -> 2 CO2 + PROIX Bott & Niebisch (2003)
 hemG  PROIX -> PROPORIX Bott & Niebisch (2003)
 hemH  PROPORIX -> PROTOHEMEIX Bott & Niebisch (2003)
 Heme c  PROTOHEMEIX <-> HEMEC Bott & Niebisch (2003)
## Maximal P/O ratio can be set by changing the amount of protons consumed per one ATP synthesis, 
 here P/O ratio is 6/3=2
##reversibel iaccording to literature. However a cycle with mqo is made so menaquinol electrontransport 
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 ctaB  PROTOHEMEIX <-> HEMEO Bott & Niebisch (2003)
 ctaA  HEMEO <-> HEMEA Bott & Niebisch (2003)
 #3.3 Menaquinone Biosynthesis
 menF  CHOR -> ICHOR Bott & Niebisch (2003)
 menD  ICHOR + AKG -> PYR + CO2 + SHCHC Bott & Niebisch (2003)
 menC  SHCHC -> OSB Bott & Niebisch (2003)
 menE  ATP + OSB + COA -> AMP + PPI + OSBCOA Bott & Niebisch (2003)
 menB  OSBCOA -> COA + DHN Bott & Niebisch (2003)
 menA  DHN -> CO2 + DMK Bott & Niebisch (2003)
 menG  DMK + SAM -> SAH + MK Bott & Niebisch (2003)
# 4. BIOMASS BIOSYNTHESIS
 # 4.1 AMINO ACID BIOSYNTHESIS
 # Glutamate family (glutamate, glutamine, arginine, proline)
 # Glutamate/glutamine biosynthesis
Q79VE3 6.3.1.2  glnA  ATP + GLU + NH3 -> ADP + PI + GLN Jacoby et al (1997)
Q8NTW7 1.4.1.13  gltBD  GLN + AKG + NADPH -> 2 GLU + NADP Burkowski (2003)
P31026 1.4.1.4  gdh  AKG + NH3 + NADPH -> GLU + NADP Burkowski (2003)
 # Proline synthesis
P46546 2.7.2.11  proB  GLU + ATP -> ADP + GLUP Ankri et al (1996)
Q8NU48 1.5.1.12  putA1  P5C + NAD -> GLU + NADH  
P45638
1.2.1.41  proA  GLUP + NADPH -> NADP + PI + GLUGSAL Serebrijski et al (1995)
Spontane
ous
rGLUGSAL  GLUGSAL <-> P5C Serebrijski et al (1995)
Q6M511 4.3.1.12  ocd  ORN -> PRO + NH3 Serebrijski et al (1995)
Q6M511 2.6.1.13 r2.6.1.13  ORN + AKG -> GLU + P5C Serebrijski et al (1995)
P46540 1.5.1.2  proC  P5C + NADPH -> PRO + NADP Serebrijski et al (1995)
 # Arginine synthesis
2.3.1.1  argR  GLU + ACCOA <-> NAGLU + COA Serebrijski et al (1995)
Q59281 2.7.2.8  argB  ATP + NAGLU <-> ADP + NAGLUP
Q59279
1.2.1.38  argC  NAGLUP + NADPH <-> NAGLUS + NADP + 
PI 
Q59282 2.6.1.11  argD   NAGLUS + GLU <-> NAORN + AKG
Q59280 2.3.1.35  argJ  NAORN + GLU -> ORN + NAGLU
Q59283 2.1.3.3  argF  CAP + ORN -> PI + CITR
P58893
6.3.5.5  carA  2 ATP + GLN + CO2 -> 2 ADP + PI + GLU + 
CAP
O85176 6.3.4.5  argG  ATP + CITR + ASP -> AMP + PPI + NAS
O88101 4.3.2.1  argH  NAS -> FUM + ARG
 # The branched chain amino acids (isoleucine, valine, leucine)
 # Valine biosynthesis (ilv-genes shared between VAL and ILE pathway!!)
P42463 2.2.1.6  ilvBN_val  2 PYR -> ACLAC + CO2 Radmacher et al (2002)
Q57179 1.1.1.86  ilvC_val  ACLAC + NADPH -> DHMVA + NADP Radmacher et al (2002)
Q8NQZ9 4.2.1.9  ilvD_val  DHMVA -> OIVAL Radmacher et al (2002)
Q79VE5 2.6.1.42  ilvE_val  OIVAL + GLU -> VAL + AKG Radmacher et al (2002)
 # Isoleucine biosynthesis
Q04513 4.3.1.19  ilvA_ile  THR -> OBUT + NH3 Möckel et al (1992)
P42463
2.2.1.6  ilvBN_ile  OBUT + PYR -> ABUT + CO2 Keilhauer et al (1993); 
Leyval et al (2003)
Q57179
1.1.1.86  ilvC_ile  ABUT + NADPH -> DHMV + NADP Keilhauer et al (1993); 
Leyval et al (2003)
Q8NQZ9
4.2.1.9  ilvD_ile  DHMV -> OMVAL Keilhauer et al (1993); 
Leyval et al (2003)
Q79VE5 2.6.1.42  ilvE_ile  OMVAL + GLU -> ILE + AKG Leyval et al (2003)
 # leucine biosynthesis
P42455 2.3.3.13  leuA  OIVAL + ACCOA -> IPPMAL + COA Paték et al (1998)
P58946 4.2.1.33  leuCD  IPPMAL -> CBHCAP Willis et al (2005)
P94631
1.1.1.85  leuBP  CBHCAP + NAD -> 2OMOP + NADH + CO2 Paték et al (1998)
Q79VE5 2.6.1.42  ilvE  2OMOP + GLU -> LEU + AKG Groeger & Sahn (1987)
 # The aspartate family (aspartate, asparagine, threonine, lysine, methionine)
 # Aspartate biosynthesis
Q6M8B5 2.6.1.1  aspB  OA + GLU -> ASP + AKG Cremer et al (1991)
Q59200 4.3.1.1  aspA  ASP -> FUM + NH3  
 # Asparagine biosynthesis
Q8NNK1
6.3.5.4  ltsA  ATP + ASP + GLN -> AMP + PPI + ASN + 
GLU
 6.3.1.1 NCgl2116  ATP + ASP + NH3 -> PPI + AMP + ASN
# Threonine biosynthesis
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P08499 1.1.1.3  hom  ASPSA + NADPH -> HSER + NADP Reinsheid et al (1991)
P07128 2.7.1.39  thrB  ATP + HSER -> ADP + PHSER Miyajima et al (1968)
P23669 4.2.3.1  thrC  PHSER -> THR + PI Malumbres et al (1994)
 # Lysine biosynthesis
P26512 2.7.2.4  lysC  ATP + ASP -> ADP + AP Cremer et al (1991)
P26511 1.2.1.11  asd  AP + NADPH + H -> ASPSA + PI + NADP Cremer et al (1991)
P19808 4.2.1.52  dapA  ASPSA + PYR -> DEHYDRODIPICOLINAT Cremer et al (1991)
P40110
1.3.1.26  dapB DEHYDRODIPICOLINATE + NADPH -> 
PIPER26DC + NADP
Cremer et al (1990)
2.3.1.26  dapD  PIPER26DC + SUCCOA -> SDAAKP + COA Cremer et al (1990)
Q6M8B5 2.6.1.1  dapC  SDAAKP + GLU -> SDAPIM + AKG Cremer et al (1991)
Q59284 3.5.1.18  dapE  SDAPIM -> SUCC + DAPIM Wehrmann et al (1995)
Q8NP73 5.1.1.7  dapF  DAPIM -> MDAPIM Cremer et al (1991)
P04964
1.4.1.16  ddh  PIPER26DC + NH3 + NADPH -> MDAPIM + 
NADP
Schrumpf et al (1991)
P09890 4.1.1.20  lysA  MDAPIM -> LYS + CO2 Cremer et al (1991)
 # Methionine biosynthesis
O68640 2.3.1.31  metX  ACCOA + HSER -> COA + OAHSER Park et al (1998)
Q79VI4 2.5.1.49  metY  OAHSER + H2S -> HCYS + AC Hwang et al (2002)
Q79VD9
2.5.1.48  metB  OAHSER + CYS -> LLCT + AC Lee & Hwang (2003); 
Rückert et al (2003)
Q93QC6
4.4.1.8  metC  LLCT -> PYR + NH3 + HCYS Lee & Hwang (2003); 
Rückert et al (2003)
Q93PM7 2.1.2.1  glyA SER + THF <-> GLY + METHF Simic et al (2002)
Q8NNM2
1.7.99.5 metF  METHF + NADPH -> MTHF + NADP Lee & Hwang (2003); 
Rückert et al (2003)
Q6M580
2.1.1.13  metH  MTHF + HCYS <-> MET + THF Lee & Hwang (2003); 
Rückert et al (2003)
Q9K5E4
2.5.1.6  metK  ATP + MET -> PPI + SAM Lee & Hwang (2003); 
Rückert et al (2003)
Q8NSC4
3.3.1.1  ahcY  SAH <-> HCYS + ADENOSINE Lee & Hwang (2003); 
Rückert et al (2003)
 # The pyruvate family (alanine)
2.6.1.66 NCgl0388  VAL + PYR -> ALA + OIVAL
Q8RSU9 5.1.1.1  alr  ALA <-> DALA
  # The serine family (serine, glycine, cysteine)
 # Serine biosynthesis
Q8NQY7
1.1.1.95  serA  3PG + NAD -> NADH + PHP Peters-Wendisch et al 
(2002)
Q8NS51
2.6.1.52  serC  PHP + GLU -> AKG + 3PSER Peters-Wendisch et al 
(2005)
Q6M2V2
3.1.3.3  serB  3PSER -> PI + SER Peters-Wendisch et al 
(2005)
 # Glycine biosynthesis
##See glyA in methionine synthesis
 # Cysteine biosynthesis  
Q6M2R8 2.3.1.30  cysE  ACCOA + SER -> COA + OASER Wada et al (2002)
Q6M2R9 2.5.1.47  cysKM  OASER + H2S -> AC + CYS Wada et al (2004)
 # The histidine family  
 # Histidine biosynthesis
Q9Z472 2.4.2.17  hisG  PRPP + ATP -> PPI + PRBATP Alifano et al (1996)
Q9Z471 3.6.1.31  hisI_1  PRBATP -> PPI + PRBAMP Alifano et al (1996)
Q8NNT9 3.5.4.19  hisI_2  PRBAMP -> PRFP Alifano et al (1996)
O68602 5.3.1.16  hisA  PRFP -> PRLP Jung et al (1998)
Q9Z472 2.4.2.17  hisFH  PRLP + GLN -> GLU + AICAR + DIMGP Jung et al (1998)
Q9KJU3 4.2.1.19  hisB_1  DIMGP <-> IMACP Alifano et al (1996)
Q9KJU4 2.6.1.9  hisC  IMACP + GLU <-> HISOLP + AKG Alifano et al (1996)
3.1.3.15  hisB_2  HISOLP -> PI + HISOL Alifano et al (1996)
Q8NNT5 1.1.1.23  hisD  HISOL + 2 NAD -> HIS + 2 NADH Alifano et al (1996)
 # The aromatic family
# The shikimate pathway
P35170 2.5.1.54  aroG  PEP + E4P -> 3DDAH7P + PI Linn et al (2001)
Q9X5D2 4.2.3.4  aroB  3DDAH7P -> DQT + PI Ideka (2005)
O52377 4.2.1.10  aroQ  DQT -> DHSK Ideka (2005)
Q9X5C9 1.1.1.25  aroE  DHSK + NADPH -> SME + NADP Ideka (2005)
Q9X5D1 2.7.1.71  aroK  ATP + SME -> ADP + SME3P Ideka (2005)
Q9Z470 2.5.1.19  aroA  PEP + SME3P -> 5EPS3P + PI Ideka (2005)
Q9X5D0 4.2.3.5  aroC  5EPS3P -> CHOR + PI Ideka (2005)
# Tryptophan biosynthesis
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P06557 4.1.3.27 trpE&trpG  CHOR + GLN -> AN + PYR + GLU Sugimoto & Shiio (1977)
P06559 2.4.2.18  trpD  AN + PRPP -> NPRAN + PPI Sugimoto & Shiio (1977)
P06560 4.1.1.48  trpC  NPRAN -> CPAD5P Sugimoto & Shiio (1977)
P06562 4.2.1.20 trpA&trpB  SER + CPAD5P -> TRP + G3P + CO2 Sugimoto & Shiio (1977)
# Tyrosine and phenylalanine biosynthesis
5.4.99.5  csm  CHOR -> PHEN Ideka (2005)
Q6M8C9 1.3.1.12  tyrA  PHEN + NAD -> NADH + PRETYR + CO2 Fazel & Jensen (1979)
2.6.1.57 r2.6.1.57  PRETYR + GLU -> AKG + TYR Fazel & Jensen (1979)
P10341
4.2.1.51  pheA  PHEN -> PHPYR + CO2 Follettie & Sinskey (1986)
2.6.1.5  NCgl0215&NCgl2020  PHPYR + GLU -> PHE + AKG Fazel & Jensen (1979)
 # 4.2 NUCLEOTIDE BIOSYNTHESIS
#PURINE
Q8NRU9 2.7.6.1  prs  ATP + R5P -> AMP + PRPP
Q8NMI9 2.4.2.14  purF  PRPP + GLN -> PPI + GLU + PRAM
Q8NMH3 6.3.4.13  purD  ATP + PRAM + GLY <-> ADP + PI + GAR
Q6M6S8 2.1.2.2  purN GAR + FTHF <-> THF + FGAR
Q8NMI5
6.3.5.3  purL  ATP + FGAR + GLN <-> ADP + PI + FGAM + 
GLU
Q8NMJ0 6.3.3.1  purM  FGAM + ATP -> ADP + PI + AIR
Q6M768 4.1.1.21  purK  AIR + CO2 + ATP <-> CAIR + ADP + PI
Q8NMH6
6.3.2.6  purC  CAIR + ATP + ASP <-> ADP + PI + SAICAR
Q8NMH5 4.3.2.2  purB_1  SAICAR <-> FUM + AICAR
Q8NS21 2.1.2.3  purH AICAR + FTHF <-> THF + PRFICA
Q8NS21 3.5.4.10 r3.5.4.10  PRFICA <-> IMP
Q8NM16 6.3.4.4  purA  GTP + IMP + ASP <-> GDP + PI + ASUC
Q8NMH5 4.3.2.2  purB_2  ASUC <-> FUM + AMP
Q8NM99 1.1.1.205  guaB1  IMP + NAD -> XMP + NADH
Q8NSR1
6.3.5.2  guaA  ATP + XMP + GLN <-> AMP + PPI + GMP + 
GLU
#PYRINE
Q8NM11 2.4.2.10  pyrE_1  OROA + PRPP -> PPI + OMP
P58893
6.3.5.5 NCgl1547&NCgl1548  CO2 + 2 ATP + GLN -> GLU + CAP + 2 ADP 
+ PI
Q8NQ38 2.1.3.2  pyrB  CAP + ASP -> CAASP + PI
Q8NQ39 3.5.2.3  pyrC  CAASP -> DOROA
Q8NQC0 1.3.3.1  pyrD  DOROA + O2 -> OROA + H2O2
Q8NQ40 4.1.1.23  pyrF  OMP -> UMP + CO2
Q8NMI5
6.3.5.3  pyrG_2  ATP + UTP + GLN -> GLU + ADP + PI + CTP
 #pyrE_2  DOROA + NAD -> OROA + NADH
Q8NS38 2.1.1.45  thyA  METTHF + DUMP -> DTMP + DHF
P40111
2.1.1.148 thyX METHF + DUMP + FADH2 <-> FAD + DUMP + 
THF 
Q8NQL7 6.3.4.2  pyrG_1  ATP + UTP + NH3 -> ADP + PI + CTP
Q8NLT9 3.5.4.13 dcd_1 CTP -> UTP + NH3
Q8NLT9 3.5.4.13 dcd_2 DCTP -> DUTP + NH3
#Nucleotide Salvage Pathways
P49973 2.7.4.3  adk_1  ATP + AMP <-> ADP + ADP
P49973 2.7.4.3  adk_2  ATP + DAMP <-> ADP + DADP
Q8NQK7 2.7.4.14 cmk_1  ATP + UMP <-> ADP + UDP
Q8NQK7 2.7.4.14 cmk_2 ATP + CMP <-> ADP + CDP
Q8NQK7 2.7.4.14 cmk_3 ATP + DCMP <-> ADP + DCDP
Q8NSC3 2.7.4.9  tmk  DTMP + ATP <-> ADP +  DTDP
Q8NSC3 2.7.4.9 umk DUMP + ATP -> ADP + DUDP
Q8NN43 2.7.4.6 ndk_4 ATP + ADP <-> ATP + ADP
Q8NN43 2.7.4.6  ndk_10  ATP + UDP <-> UTP + ADP
Q8NN43 2.7.4.6  ndk_11  ATP + CDP <-> CTP + ADP
Q8NN43 2.7.4.6  ndk_2  ATP + GDP <-> ADP + GTP
Q8NN43 2.7.4.6  ndk_3  ATP + DGDP <-> ADP + DGTP
Q8NN43 2.7.4.6  ndk_12  ATP + DTDP <-> ADP + DTTP
Q8NN43 2.7.4.6  ndk_1  ATP + DADP <-> ADP + DATP
Q8NN43 2.7.4.6 ndk_4 ATP + DUDP <-> ADP + DUTP
Q8NN43 2.7.4.6 ndk_5 ATP + DCDP <-> ADP + DCTP
Q8NQ42 2.7.4.8  gmk_1  ATP + GMP <-> ADP + GDP
Q8NQ42 2.7.4.8  gmk_2  ATP + DGMP <-> ADP + DGDP
2.7.4.22 r2.7.4.22 ATP + UMP <-> ADP + UDP
Q8NL59 1.8.1.9  trxB  OTHIO + NADPH -> NADP + RTHIO 
Q6M2U5 1.17.4.1  nrdF_10  CDP + RTHIO -> DCDP + OTHIO
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Q79VD6 1.17.4.1  nrdF_4  UDP + RTHIO -> DUDP + OTHIO
Q6M2U5 1.17.4.1  nrdD_1  ATP + RTHIO -> DATP + OTHIO
Q79VD6 1.17.4.1  nrdD_2  GTP + RTHIO -> DGTP + OTHIO
Q8NUB7 3.1.3.5  nucA_1  AMP -> ADENOSINE + PI
Q8NUB7 3.1.3.5  nucA_2  IMP -> INOSINE + PI
Q8NUB7 3.1.3.5  nucA_3  XMP -> XANTHOSINE + PI
Q8NUB7 3.1.3.5  nucA_4  GMP -> GUANOSINE + PI
Q8NUB7 3.1.3.5  nucA_5  CMP -> CYTIDINE + PI
Q8NUB7 3.1.3.5  nucA_6  UMP -> URIDINE + PI
Q8NUB7 3.1.3.5  nucA_7  DTMP -> THYMIDINE + PI
Q8NUB7 3.1.3.5  nucA_8  DUMP -> DEOXYURIDINE + PI
Q8NUB7 3.1.3.5  nucA_9  DCMP -> DEOXYCYTIDINE + PI
Q8NUB7 3.1.3.5  nucA_10  DAMP -> DEOXYADENOSINE + PI
Q8NUB7 3.1.3.5  nucA_11  DGMP -> DEOXYGUANOSINE + PI
Q8NLV1 3.2.2.1 r3.2.2.1_1 ADENOSINE -> ADENINE + RIB
Q8NQR2 3.2.2.1 r3.2.2.1_2 INOSINE -> HXAN + RIB
Q8NLV1 3.2.2.1 r3.2.2.1_3 XANTHOSINE -> XHANTHINE + RIB
Q8NQR2 3.2.2.1 r3.2.2.1_4 GUANOSINE -> GUANINE + RIB
Q6M2E9 2.4.2.8 r2.4.2.8_1 HXAN + PRPP -> XMP + PPI
Q6M2E9 2.4.2.8 r2.4.2.8_2 GUANINE + PRPP -> GMP + PPI
Q6M2E9 2.4.2.8 r2.4.2.8_3 ADENINE + PRPP -> AMP + PPI
O87330 2.4.2.7 r2.4.2.7_1 ADENINE + PRPP -> AMP + PPI
O87330 2.4.2.7 r2.4.2.7_2 GUANINE + PRPP -> GMP + PPI
3.1.5.1 r3.1.5.1 DGTP -> DEOXYGUANOSINE + PI + PI + PI
Q6M8C7 3.5.4.1 r3.5.4.1 CYTOSINE -> URA + NH3
Q6M8Q7 3.2.2.4 amn AMP -> R5P + ADENINE
Q8NPA9 3.6.1.23 dut DUTP -> DUMP + PPI
P59011 2.4.2.9  pyrR  URA + PRPP <-> UMP + PPI
Q8NTH9 3.6.1.45  ushA  UDPG -> UMP + G6P Wendisch & Bott (2005)
 # 4.3 LIPIDS BIOSYNTHESIS
 # Fatty acids biosynthesis (Path I)
Q6M6V5
6.4.1.2  accDA  ATP + ACCOA + CO2 <-> ADP + PI + 
MALCOA
Q6M2X6 2.3.1.85 fas-IB_1  MALCOA + ACP -> MALACP + COA
Q6M6V0 2.3.1.85 fas-IA_1  ACCOA + ACP -> ACACP + COA
2.3.1.85; 1  FASC140  ACACP + 6 MALACP + 12 NADPH -> 12 
NADP + C140ACP + 6 CO2 + 6 ACP
2.3.1.85; 1  FASC150  ACACP + 6.5 MALACP + 13 NADPH -> 13 
NADP + C150ACP + 6.5 CO2 + 6.5 ACP
2.3.1.85; 1  FASC160  ACACP + 7 MALACP + 14 NADPH -> 14 
NADP + C160ACP + 7 CO2 + 7 ACP
2.3.1.85; 1  FASC161  ACACP + 7 MALACP + 13 NADPH -> 13 
NADP + C161ACP + 7 CO2 + 7 ACP
2.3.1.85; 1  FASC180  ACACP + 8 MALACP + 16 NADPH -> 16 
NADP + C180ACP + 8 CO2 + 8 ACP 
2.3.1.85; 1  FASC181  ACACP + 8 MALACP + 15 NADPH -> 15 
NADP + C181ACP + 8 CO2 + 8 ACP
 # Fatty acids biosynthesis (Path II) (no encoding genes for this system) (Eggeling and Bott, (2005) pp 134)
 #Mycolic acid Biosynthesis
Q6M1Y6
6.2.1.3 fas-IA_MA  0.071 C140ACP + 0.332 C150ACP + 0.408 
C160ACP + 0.189 C161ACP -> ACP + 
FREEMYCOLICACID
Q8NTG4
2.3.1.122  cmt FREEMYCOLICACID + TRE + ATP <-> TMCM 
+ ADP
Brand et al (2003)
Q6M6M6
2.3.1.122  cmt_3 TMCM + TRE + ATP <-> TDCM + ADP Daffé (2005); Brand et al 
(2003)
 # Phospholipids biosynthesis
 gpsA  DHAP + NADH <-> GL3P + NAD Nampoothiri et al (2002)
# synthesis of phosphatidylglycerol (80% of all phospholidids (Eggeling and Bott. 2005)
Phospholipid-step  GL3P + 0.004 C140ACP + 0.438 C160ACP + 
0.004 C161ACP + 0.010 C180ACP + 0.544 
 C181ACP -> AGL3P + ACP
Hoischen & Krämer 
(1990)
 plsC  AGL3P + 0.004 C140ACP + 0.438 C160ACP 
+ 0.004 C161ACP + 0.01 C180ACP + 0.544 
 C181ACP -> PA + ACP
Hoischen & Krämer 
(1990)
 cdsA_1  PA + CTP <-> CDPDG + PPI Nampoothiri et al (2002)
 cdsB  CDPDG + SER <-> CMP + PS Nampoothiri et al (2002)
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 pgsA2  CDPDG + GL3P <-> CMP + PG Nampoothiri et al (2002)
 #synthesis of cardiolipin
r2.7.8.a  PG -> PI + CL + GL Nampoothiri et al (2002)
 #synthesis of phosphatidyl inositol
r2.7.8.b  CDPDG -> PIT Nampoothiri et al (2002)
 #synthesis of phosphatidyl inositol mannosides
r2.7.8.c  PIT -> PIM Nampoothiri et al (2002)
 # synthesis of phosphatidylethanolamine
  cdsA  CTP + PA <-> PPI + CDPDG Nampoothiri et al (2002)
 # 4.4 PEPTIDOGLYCAN PRECURSORS BIOSYNTHESIS
 # D-glutamate synthesis
Q9XDZ7
5.1.1.3  murI  DGLUTAMATE <-> GLU Ingraham et al (1983); 
Daffé (2005)
 # D-alanyl-D-alanine synthesis
Q8NQL7
6.3.4.2  ddl  ATP + 2 DALA <-> ADP + PI + ALAALA Ingraham et al (1983); 
Daffé (2005)
 # NAG and NAM biosynthesis
Q8NND3
2.6.1.16  glmS  GLN + F6P -> GLU + GA6P Ingraham et al (1983); 
Daffé (2005)
Q8NMD4
3.5.99.6  pmmB_1  GA6P -> F6P + NH3 Ingraham et al (1983); 
Daffé (2005)
Q6M788
5.4.2.2  pmmB_2  GA6P -> GA1P Ingraham et al (1983); 
Daffé (2005)
2.3.1.57 r2.3.1.157  ACCOA + GA1P -> NAGA1P + COA Ingraham et al (1983); 
Daffé (2005)
Q8NRU8
2.7.7.23  glmU  UTP + NAGA1P -> UDPNAG + PPI Ingraham et al (1983); 
Daffé (2005)
Q8NML5
2.5.1.7  murA  UDPNAG + PEP -> UDPNACVG + PI Ingraham et al (1983); 
Daffé (2005)
Q8NTF4
1.1.1.158  murB  UDPNACVG + NADPH -> UDPNAM + NADP Ingraham et al (1983); 
Daffé (2005)
 # 4.5 COFACTORS BIOSYNTHESIS
 # Nicotinamide nucleotides (NAD+, NADP+) biosynthesis
3.5.1.19 r3.5.1.19  NAM -> NIC + NH3
2.4.2.11  r2.4.2.11  NIC + ATP + PRPP -> NACN + ADP + PI + 
PPI
Added reaction
Q8NN57 2.7.7.18  r2.7.7.18  NACN + ATP -> PPI + NAAD
Q8NMN7 6.3.1.5  nadE  ATP + NAAD + NH3 -> AMP + PPI + NAD
6.3.5.1  r6.3.5.1  ATP + NAAD + GLN -> AMP + PPI + NAD + 
GLU
Q8NQM1 2.7.1.23  ppnK  NAD + ATP <-> NADP + ADP
 # Riboflavin (vitamin B2), FMN and FAD biosynthesis
Q8NQ52 3.5.4.25  ribA  GTP -> D6RP5P + FOR + PPI
Q8NQ50 3.5.4.26  ribG  D6RP5P -> A6RP5P + NH3
1.1.1.193 NCgl1535  A6RP5P + NADPH -> A6RP5P2 + NADP
Q8NQ53 2.5.1.9  ribH  A6RP5P2 -> A6RP5P + PI
Q8NQ51 2.5.1.9  rib_1  R5P -> FOR + DHB4P
Q8NQ53 2.5.1.9  rib_2  A6RP5P + DHB4P -> O2 + PI + D8RL
Q8NQ51 2.5.1.9  rib_3  D8RL -> A6RP5P + RIBFLAV
Q8NP47 2.7.1.26  ribF  ATP + RIBFLAV -> ADP + FMN
2.7.7.2  rib_4   ATP + FMN -> FAD + PPI
 # Coenzyme-A biosynthesis
Q8NRQ2 2.7.1.33  coaA  ATP + PNTO -> ADP + 4PPNTO
6.3.2.5;4.1  coaD  4PPNTO + CYS + ATP -> PPI + DPCOA + 
CO2 + AMP
Added reaction
P58897 2.7.1.24  coaE  DPCOA + ATP -> ADP + COA + PI 
Q8NMS4 2.7.8.7  acpS  COA -> PAP + ACP
 # Folate biosynthesis  
Q8NM84 3.5.4.16  folE  GTP -> FOR + AHTD
Q6M3H3 3.1.3.1  phoD  AHTD -> DHP + 3 PI
Q8NMV7 3.1.3.1  phoB  AHTD -> DHP + 3 PI
Q8NM86 4.1.2.25  folX  DHP -> AHHMP
2.7.6.3  folK  AHHMP + ATP -> AMP + AHHMD
6.3.5.8 r6.3.5.8 CHOR + GLN -> GLU + PYR + 4A4DOCHOR
4.1.3.38 r4.1.3.58 4A4DOCHOR -> PABA
P11744 2.5.1.15  sulI  PABA + AHHMD -> PPI + DHPT
6.3.2.12  folC  ATP + DHPT + GLU -> DHF + ADP + PI
Q8NS39 1.5.1.3  folA  DHF + NADPH -> NADP + THF
Q8NS39 1.5.1.3  fol_1  FOL + NADPH <-> DHF + NADP
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 3.5.4.9  folD_1  METTHF <-> FTHF 
Q8NSM0 1.5.1.5  folD_2  METHF + NADP <-> METTHF + NADPH
 1.5.1.20 r1.5.1.20 METHF + NADPH -> MTHF + NADP
 2.3.2.17  fol_2  THF + ATP + GLU <-> ADP + PI + THFG
Q8NTC5 3.5.1.10 r3.5.1.10 FTHF -> THF + FOR
 # Biotin biosynthesis
##Lack of bioF (Eggeling and Bott (2005, p 46)
 #bio_F  ALA -> KAPA
P46395 2.6.1.62  bioA  KAPA + SAM -> DAPA + SAH
P46397
6.3.3.3  bioD  DAPA + ATP + CO2 <-> DTBIOTIN + ADP + 
PI
P46396 2.8.1.6  bioB  DTBIOTIN + SLF <-> BIOTIN
 # Pantotheate Synthesis
Q9X712 2.1.2.11  panB  OIVAL + METHF -> AKP + THF Sahn & Eggeling (1999)
1.1.1.169 1.1.1.169  panE  AKP + NADPH -> PANT + NADP Sahn & Eggeling (1999)
Q9X4N0 4.1.1.11  panD  ASP -> bALA + CO2 Sahn & Eggeling (1999)
Q9X713
6.3.2.1  panC  ATP + PANT + bALA -> AMP + PPI + PNTO Sahn & Eggeling (1999)
#Protein is in mmol of amino acids for protein to 1 g DW Biomass
PROTEIN_Ass 0.666 ALA + 0.190 ARG + 0.194 ASN + 0.194 
ASP + 0.044 CYS + 0.342 GLN + 0.548 GLU + 
0.353 GLY + 0.067 HIS + 0.189 ILE + 0.351 
LEU + 0.187 LYS + 0.076 MET + 0.128 PHE + 
0.159 PRO + 0.245 SER + 0.273 THR + 0.028 
TRP + 0.078 TYR + 0.273 VAL + 19.7 ATP -> 
19.7 ADP + 19.7 PI + PROTEIN
DNA_Ass
RNA_Ass
ARABINOGALACTAN_Ass
 PEPTIDOGLYCAN_Ass 1.106 UDPNAM + 1.106 UDPNAG + 1.106 ALA 
+ 1.106 MDAPIM + 1.106 DGLUTAMATE + 
1.106 GLY + 2.052 ALAALA + 4.426 ATP -> 
PEPTIDOGLYCAN + 4.426 ADP + 4.426 PI + 
1.106 UDP + 1.106 UMP + 1.126 ALA          
 FREEMYCOLICACID_Ass 0.007 C140ACP + 0.014 C150ACP + 0.437 
C160ACP + 0.012 C161ACP + 0.009 C180ACP 
+ 0.521 C181ACP -> ACP + 
FREEMYCOLICACID
MYCOLICACID_Ass 0.061 TMCM + 0.043 TDCM + 1.875 
FREEMYCOLICACID -> MYCOLICACID
 PHOSPHOLIPID_Ass 0.033 PA + 1.133 PG + 0.007 CL + 0.042 PIT + 
0.065 PIM -> PHOSPHOLIPID
biomass_ass PROTEIN + 0.010 DNA + 0.05 RNA + 0.028 
PHOSPHOLIPID + 0.095 PEPTIDOGLYCAN + 
0.095 ARABINOGALACTAN + 0.102 
MYCOLICACID + 29.2 ATP + 18.5 ATP -> 
BIOMASS + 29.2 ADP + 29.2 PI + 18.5 ADP + 
18.5 PI
Cougain & Bouchet 
(1996)
 # 6. MAINTENANCE
# 4.6 MACROMOLECULES BIOSYNTHESIS (mmoles used for the synthesis of 1 g of macromolecule, exc
0.69 ATP + 1.01 GTP + 0.70 CTP + 0.70 UTP + 
1.24 ATP -> 1.24 ADP + 1.24 PI + RNA + 3.10 
PPI 
0.498 UDPGAL + 4.650 UDPARA -> 5.148 
UDP + ARABINOGALACTAN
# The energy for polymerisation of building blocks into macromolecules is included in the reactions. For 
0.748 DAMP + 0.871 DCMP + 0.748 DTMP + 
0.871 DGMP + 4.44 ATP -> 4.44 ADP + 4.44 PI 
 + 3.238 PPI + DNA
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 #maintenance  ATP -> ADP + PI
# 7. TRANSPORT REACTIONS
 # 7.1 FREE DIFFUSSION
 UREA_diffusion  UREAxt <-> UREA Siewe et al (1998); 
Beckers et al (2004)
 CO2_diffusion  CO2xt <-> CO2
 NO3_diffusion  NO3xt <-> NO3
 SLF_diffusion  SLFxt <-> SLF 
 O2_diffusion  O2xt <-> O2
 THR_diffusion  THRxt <-> THR Palmieri et al (1996)
 PHE_diffusion  PHExt <-> PHE Burkowski & Krämer 
(2002)
 TYR_diffusion  TYRxt <-> TYR Burkowski & Krämer 
(2002)
 ILE_diffusion  ILExt <-> ILE Burkowski & Krämer 
(2002)
 NH3_diffusion  NH3xt <-> NH3 Siewe et al (1998)
 # 7.2 PEP-dependent Transporters
Q8NP80 2.7.1.69  FRU_in_PEP  FRUxt + PEP -> PYR + F6P Yokota & Lindley (2005)
Q45298 2.7.1.69  GLC_in_PEP  GLCxt + PEP -> PYR + G6P Yokota & Lindley (2005)
Q46072 2.7.1.69  MAN_in_PEP  MANxt + PEP -> PYR + MAN6P Yokota & Lindley (2005)
Q8NMD6 2.7.1.69  SUC_in_PEP  SUCxt + PEP -> PYR + SUC6P Yokota & Lindley (2005)
Q6M488 2.7.1.69  TRE_in_PEP  TRExt + PEP -> PYR + TRE6P Yokota & Lindley (2005)
 # 7.3 ATP-driven Transporters
Q8NMK1 3.6.3.27 pstB_ATP  ATP + PIxt -> ADP + PI + PI
GLU_ATP  GLUxt + ATP -> GLU + ADP + PI Kronenmeyer et al (1995)
  RIB_ATP  RIBxt + ATP -> RIB + ADP + PI
 XYL_ATP  XYLxt + ATP -> XYL + ADP + PI
 URA_ATP  URAxt + ATP -> URA + ADP + PI
 BET_ATP  BETxt + ATP -> BET + ADP + PI
 amt_ATP  NH4xt + ATP -> NH4 + ADP + PI Burkowski & Krämer 
(2002)
 SLF_ATP SLFxt + ATP -> SLF + ADP + PI
3.6.3.17  GLC_in GLCxt + ATP -> GLC + ADP + PI
THR_ATP  THR + ATP -> THRxt + ADP + PI
aroP1_ATP  TRPxt + ATP -> TRP + ADP + PI Burkowski & Krämer 
(2002)
aroP2_ATP  TYRxt + ATP -> TYR + ADP + PI Burkowski & Krämer 
(2002)
aroP3_ATP  PHExt + ATP -> PHE + ADP + PI Burkowski & Krämer 
(2002)
 MET_ATP  METxt + ATP -> MET + ADP + PI Burkowski & Krämer 
(2002)
ILE_ATP  ILE + ATP -> ILExt + ADP + PI Burkowski & Krämer 
(2002)
ORN_ATP  ORNxt + AT <-> ORN + ADP + PI Burkowski & Krämer 
(2002)
UREA_ATP UREAxt + ATP -> UREA + ADP + PI Beckers et al (2004)
# 7.4 PROTON-LINKED ACTIVE TRANSPORT
Proton_ATP  H_transport_xt + ADP + PI <-> H_transport + 
ATP
 CIT_H  CITxt + H_transport_xt -> CIT + H_transport
Phosphate_H  PIxt + H_transport_xt -> PI + H_transport Wendisch & Bott (2005)
 ARG_H  ARG + H_transport -> ARGxt + 
H_transport_xt
 LysE  LYS + 2 H_transport_xt -> LYSxt + 2 
H_transport
 NO3_H  NO3xt + H_transport_transport_xt -> NO3 + H
 GLU_H  GLUxt + H_transport_xt -> GLU + H_transport
 GLUC_H  GLUCxt + H_transport_xt -> GLUC + 
H_transport
 GABA_H  GABAxt + H_transport_xt -> GABA + 
H_transport
 UREA_H  UREAxt + H_transport_xt <-> UREA + 
H_transport
Siewe et al (1998)
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AC_H Acxt + H_transport_xt <-> AC + H_transport Ebbighausen et al (1991)
 # 7.6 OTHER TRANSPORT
# Sodium associated transport
Na-transporter  Na + H_transport_xt <-> Naxt + H_transport
 # Symport  
ILE_S  ILExt + Naxt -> ILE + Na Ebbighausen et al 
(1989b)
 VAL_S  VALxt + Naxt -> VAL + Na Ebbighausen et al 
(1989b)
 LEU_S  LEUxt + Naxt -> LEU + Na Ebbighausen et al 
(1989b)
 ALA_S  ALAxt + Naxt -> Na + ALA
 PRO_S  PROxt + Naxt <-> Na + PRO
 nptA_S  PIxt + Naxt -> Na + PI Wendisch & Bott (2005)
 SER_S  SER + Na -> SERxt + Naxt Somic et al (2001)
 GLU_S  GLUxt + Naxt -> GLU + Na
 THR_S  THR + Na -> THRxt + Naxt Palmieri et al (1996)
 # Antiport
 GLN_S  GLNxt + Na <-> Naxt + GLN Siewe et al (1995)
 #Transporters of unknown Mechanisms
 NAM_in  NAMxt -> NAM
Nitrate_in  NO3xt -> NO3
Nitrite_in  NO2xt -> NO2
 Met_out  MET -> METxt
 PANT_in  PANTxt -> PANT
BIOTIN_in  BIOTINxt -> BIOTIN
 Lys_in1  LYSxt + ALA -> LYS + ALAxt Burkowski & Krämer 
(2002)
 Lys_in2  LYSxt + VAL -> LYS + VALxt Burkowski & Krämer 
(2002)
 Lys_in3  LYSxt + LEU -> LYS + LEUxt Burkowski & Krämer 
(2002)
VAL_in VALxt -> VAL Ebbighausen et al 
(1989b)
ILE_in ILExt -> ILE Ebbighausen et al 
(1989b)
LEU_in LEUxt -> LEU Ebbighausen et al 
(1989b)
 #Putative transportsystems
GL_in_out  GLxt <-> GL
ETH_in_out  ETHxt <-> ETH
#AC_in_out  ACxt + H_transport_xt <-> AC + H_transport
#LLAC_in_out  LLACxt + H_transport_xt <-> LLAC + 
H_transport
LLAC_in_out  LLACxt <-> LLAC
AC_in_out  ACxt <-> AC
GLAC_in_out  GLACxt <-> GLAC
T3_in_out  T3xt <-> T3
GLYR_in_out  GLYRxt <-> GLYR
Propionate_in_out  PROPIONATExt + H_transport_xt <-> 
PROPIONATE + H_transport
Formate_in_out  FORxt + H_transport_xt <-> FOR + 
H_transport
LAC_in_out  LACxt + H_transport_xt <-> LAC + 
H_transport
ASN_in_out  ASNxt <-> ASN
ASP_in_out  ASPxt <-> ASP
GLY_in_out  GLYxt <-> GLY
CYS_in_out  CYSxt <-> CYS
HIS_in_out  HISxt <-> HIS
PPI_in_out  PPIxt <-> PPI
PYR_transport  PYRxt <-> PYR
 FRU_out  FRU -> FRUxt
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Abbreviation Metabolite
13PDG 3-Phospho-D-glyceroyl phosphate
2OMOP 2-oxo-4-methyl-3-carboxypentenanoate
2PG 2-Phospho-D-glycerate
3DDAH7P 3-deoxy-D-arabino-heptonate 7-phosphate 
3PG 3-Phospho-D-glycerate
3PSER 3-Phosphoserine
4A4DOCHOR 4-Amino-4-deoxychorismate
4PPNTO D-4'-Phosphopantothenate
5AL 5-aminolevulinate
5EPS3P 5-enolpyruvylshikimate 3-phosphate
6PG 6-Phosphogluconate
A6RP5P 5-Amino-6-(5'-phosphoribosylamino)uracil
A6RP5P2 5-Amino-6-(5'-phosphoribitylamino)uracil
ABUT 2-Aceto-2-hydroxybutanoate
AC Acetate
ACACP Acyl-[acyl-carrier protein]
ACAL Acetaldehyde
ACCOA Acetyl Co-A
ACETYLP Acetyl-P
ACLAC 2-Acetolactate
ACLIPO S-acetyldihydrolipoamide
ACP Acyl-carrier protein
ADENINE Adenine
ADENOSINE Adenosine
ADP ADP
AGL3P Acyl-sn-glycerol 3-phosphate
AHHMD 2-Amino-7,8-dihydro-4-hydroxy-6-(diphosphooxymethyl)pteridine
AHHMP 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine
AHTD 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate
AICAR 1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide
AIR Aminoimidazole ribotide: (1-(5-phosphoribosyl)-5-aminoimidazole)
AKG 2-Oxoglutarate
AKP 2-Dehydropantoate
ALA L-Alanine
ALAALA D-alanyl-D-alanine
AMP AMP
AN Anthranilate
AP L-4-aspartyl phosphate
APS Adenylylsulfate
ARABINOGALACTAN Arabinogalactan (cell wall component)
ARG L-Arginine
ASN L-Asparagine
ASP L-Aspartate
ASPSA L-Aspartate 4-semialdehyde
ASUC N6-(1,2-Dicarboxyethyl)-AMP; Adenosylosuccinate
ATP ATP
bALA beta-Alanine
BET Betaine
BIOMASS Biomass
BIOTIN biotin
C140ACP Myristoyl-[acyl-carrier protein]
Appendix I: List of metabolites for genome-scale 
model
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C150ACP Pentadecanoyl-[acyl-carrier protein]
C160ACP Hexadecanoyl-[acyl-carrier protein]
C161ACP Palmitoyl-[acyl-carrier protein]
C180ACP Stearoyl-[acyl-carrier protein]
C181ACP Oleoyl-[acyl-carrier protein]
CAIR 1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate
CAP Carbamoyl phosphate
CBHCAP 3-Isopropylmalate
CDP CDP
CDPDG CDP-diacylglycerol
CHOR Chorismate
CIT Citrate
CITR L-Citrulline
CL Cardiolipin (biomass component)
CMP CMP
CO2 CO2
COA CoA
COPPIII Coproporphyrinogen III
CPAD5P 1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate
CTP CTP
CYS L-Cysteine
CYTIDINE Cytidine  
CYTOSINE Cytosine
CAASP N-Carbamoyl-L-aspartate
D6PGC 6-Phospho-D-gluconate
D6RP5P 2,5-Diamino-6-hydroxy-4-(5'-phosphoribosylamino)-pyrimidine
D8RL 6,7-Dimethyl-8-(1-D-ribityl)lumazine
DADP dADP
DALA D-alanine
DAMP dAMP
DAPA 7,8-aminopelargonic acid
DAPIM L,L-2,6-Diaminopimelate
DATP dATP
DCDP dCDP
DCMP dCMP
DCTP dCTP
DEHYDRODIPICOLINAT Dehydrodipicolinate
DEOADENOSINE Deoxyadenosine
DEOXYCYTIDINE Deoxycytidine
DEOXYGUANOSINE Deoxyguanosine
DEOXYURIDINE Deoxyuridine
DGDP dGDP
DGDP dGDP
DGLUTAMATE D-Glutamate
DGMP dGMP
DGTP dGTP
DHAP Glycerone phosphate
DHB4P 3,4-dihydroxy-2-butanone-4-P
DHF Dihydrofolate
DHMV 2,3-dihydroxy-3-methylvalerate
DHMVA (R)-2,3-dihydroxy-3-methylbutanoate
DHN 1,4-dihydroxy-2-naphthoate
DHP 2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-dihydropteridine
DHPT Dihydropteroate
DHSK 3-Dehydroshikimate
DIMGP D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate
DLIPO Dihydrolipoamide
DMK 2-Demethylmenaquinone
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DNA DNA (biomass component)
DOROA (S)-Dihydroorotate
DPCOA Dephospho-CoA
DQT 3-Dehydroquinate
DTBIOTIN Dethiobiotin
DTDP dTDP
DTMP dTMP
DTTP dTTP
DUDP dUDP
DUMP dUMP
DUTP dUTP
E4P D-Erythrose 4-phosphate
ETH Ethanol
F1P D-Fructose 1-phosphate
F6P beta-D-Fructose 6-phosphate
FAD FAD
FADH2 FADH2
FDP beta-D-Fructose 1,6-bisphosphate
FGAM 2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine
FGAR 5'-Phosphoribosyl-N-formylglycinamide
FMN FMN
FOL Folate
FOR Formate
FREEMYCOLICACID Free Mycolic acids and Mycolic acids bonded to Arabinogalactan 
FRU D-Fructose
FTHF 10-Formyltetrahydrofolate
FUM Fumarate
G1P D-Glucose 1-phosphate
G3P D-Glyceraldehyde 3-phosphate
G6P alpha-D-Glucose 6-phosphate
GA1P D-Glucosamine 1-phosphate
GA6P D-Glucosamine 6-phosphate
GABA 4-Aminobutanoate
GAL1P D-Galactose 1-phosphate
GAR 5'-Phosphoribosylglycinamide
GDP GDP
GDPMAN GDPmannose
GL Glycerol
GL3P sn-Glycerol-3-phosphate
GLAC D-Galactose
GLC alpha-D-Glucose
GLN L-Glutamine
GLU L-Glutamate
GLUC D-Gluconate
GLUGSAL L-Glutamate 5-semialdehyde
GLUP alpha-D-Glutamyl phosphate
GLUTAMYLTRNA GLUTAMYLTRNA
GLX Glyoxylate
GLY Glycine
GLYR (R)-glycerate
GMP GMP
GSA Glutamate-1-semialdehyd
GTP GTP
GUANINE Guanine
GUANOSINE Guanosine   
H_PO Protons assosiated with electron transport chain
H_transport Protons assosiated with transport reactions over the membrane
H2O2 H2O2
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H2S Hydrogen sulfide
H2SO3 Sulfite
HCYS Homocysteine
HEMEA Heme a
HEMEC Heme c
HEMEO Heme o
HIS L-Histidine
HISOL L-Histidinol
HISOLP L-Histidinol phosphate
HSER L-Homoserine
HXAN Hypoxhantine
HYDROXYMEBI hydroxymethylbilane
ICHOR Isochorismate
ICIT Isocitrate
ILE L-Isoleucine
IMACP 3-(Imidazol-4-yl)-2-oxopropyl phosphate
IMP IMP
INOSINE Inosine
IPPMAL 2-Isopropylmalate
KAPA 7-keto-8-aminopelargonic acid
LAC (R)-Lactate, D-Lactate
LEU L-Leucine
LIPO Lipoamide
LLAC (S)-Lactate, L-Lactate
LLCT L-Cystathionine
LYS L-Lysine
MAL Malate
MALACP Malonyl-[acyl-carrier protein]
MALCOA Malonyl-CoA
MALONATES Malonate semialdehyde
MAN Mannose
MAN1P alpha-D-Mannose 1-phosphate
MAN6P D-Mannose 6-phosphate
MDAPIM meso-2,6-Diaminopimelate
MET L-Methionine
METHF 5,10-Methenylenetetrahydrofolate
METTHF 5,10-Methenyltetrahydrofolate
Mg Magnesium
MK menaquinone
MKH2 menaquinol
MLT Maltose
MLTTRE Maltooligosyl trehalose
MTHF 5-Methyltetrahydrofolate
MYCOLICACID Mycolic acid
Na Sodium (assoiated in transport reactions)
NACN Nicotinate D-ribonucleotide
NAD NAD+
NADH NADH
NADP NADP+
NADPH NADPH
NAGA1P N-Acetyl-D-glucosamine 1-phosphate
NAGA6P N-Acyl-D-glucosamine 6-phosphate
NAGLU N-Acetyl-L-glutamate
NAGLUP N-Acetyl-L-glutamate 5-phosphate
NAGLUS N-Acetyl-L-glutamate 5-semialdehyde
NAM Nicotinamide
NAORN N2-Acetyl-L-ornithine
NAS (Nomega-L-arginino)succinate
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NH3 NH3
NH4 NH4
Ni Nickel
NIC Nicotinate 
NIC Nicotinate
NO2 nitrite
NO3 nitrate
NPRAN N-(5-Phospho-D-ribosyl)anthranilate
NAAD Deamido-NAD+
O2 Oxygen
OA Oxaloacetate
OAHSER O-Acetyl-L-homoserine
OASER O-Acetyl-L-serine
OBUT 2-Oxobutanoate
OIVAL (R)-2-Oxoisovalerate
OMP Orotidine 5'-phosphate
OMVAL 3-Methyl-2-oxobutanoate
ORN L-Ornithine
OROA Orotate
OSB O-succinylbenzoate
OSBCOA O-succinylbenzoate-CoA
OTHIO Oxidized thioredoxin
P5C (S)-1-Pyrroline-5-carboxylate
PA Phosphatidate
PABA 4-Aminobenzoate
PANT (R)-Pantoate
PAP Adenosine 3',5'-bisphosphate
PAPS 3'-Phosphoadenylylsulfate
PEP Phosphoenolpyruvate
PEPTIDOGLYCAN Peptidoglycan (biomass component)
PG Phosphatidylglycerol
PHE L-Phenylalanine
PHEN Prephenate
PHOSPHOLIPID Phospholipids (biomass component)
PHP 3-Phosphonooxypyruvate
PHPYR Phenylpyruvate
PHSER O-Phospho-L-homoserine
PI Orthophosphate
PIM Phosphatidyl inositol mannosides
PIPER26DC L(delta-1)-Piperideine-2,6-dicarboxylate
PIT Phosphatidyl inositol
PNTO (R)-Pantothenate
POLYGLC Glucose Polymers
PORIII Porphobilinogen III
PPI Pyrophosphate
PRAM 5-Phosphoribosylamine
PRBAMP N1-(5-Phospho-D-ribosyl)-AMP
PRBATP N1-(5-Phospho-D-ribosyl)-ATP 
PRETYR Pretyrosine
PRFICA 1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide
PRFP
5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-
carboxamide
PRLP
N-(5'-Phospho-D-1'-ribulosylformimino)-5-amino-1-(5"-phospho-D-ribosyl)-4-
imidazolecarboxamide
PRO L-Proline
PROIX Protoporphyringen IX
PROPIONATE Propionate
PROPORIX Protopotphyrin IX
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PROTEIN Proteins (biomass component)
PROTOHEMEIX Protoheme IX
PRPP 5-Phospho-alpha-D-ribose 1-diphosphate
PS Phosphatidylserine
PYR Pyruvate
R1P D-Ribose 1-phosphate
R5P D-Ribose 5-phosphate
RIB D-Ribose
RIBFLAV Riboflavin
RNA RNA (biomass component)
RTHIO Reduced thioredoxin
Ru5P Ribulose-5-phosphate
S7P Sedoheptulose 7-phosphate
SAH S-Adenosyl-L-homocysteine
SAICAR 1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole
SAM S-Adenosyl-L-methionine
SDAPIM N-Succinyl-L-2,6-diaminopimelate
SDLIPO S-Succinyldihydrolipoamide
SDAAKP Succinyl-2,6-amino-6-ketopimelate
SER L-Serine
SHCHC 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate
SLF Sulfate
SMALL MOLECULES Small molecules pool (biomass component)
SME Shikimate
SME3P Shikimate 3-phosphate
SUC Sucrose
SUC6P Sucrose 6-phosphate
SUCC Succinate
SUCCOA Succinyl-CoA
SUCCSAL Succinate semialdehyde
T3 D-Glyceraldehyde
TDCM Trehalose Decorynemycolate
THF Tetrahydrofolate
THFG Tetrahydrofolyl-[Glu](n)
THR L-Threonine
THYMIDINE Thymidine
TMCM Trehalose Monocorynemycolate
TRE alpha,alpha-Trehalose
TRE6P alpha,alpha'-Trehalose 6-phosphate
TRP L-Tryptophan
TYR L-Tyrosine
UDP UDP
UDPARA UDP-L-Arabinose
UDPG UDPglucose
UDPGAL UDP-D-galactose
UDPNACVG UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine
UDPNAG UDP-N-acetyl-D-glucosamine
UDPNAM UDP-N-acetylmuramate
UMP UMP
URA Uracil
UREA Urea
URIDINE Uridine 
UROPORIII Uroporphyrinogen III
UTP UTP
VAL L-Valine
X5P D-Xylulose-5-phosphate
XANTHOSINE Xanthosine   
XHANTHINE Xhanthine
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XMP Xanthosine 5'-phosphate
XYL D-Xylose
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Table 1. Macromolecular composition:
g·g-1 DCW
0.580
0.520 Cocaign-Bousquet et al (1996) C. glutamicum ATCC 17965 Batch; Exponential phase
0.010 Cocaign-Bousquet et al (1996) C. glutamicum ATCC 17965 Batch; Exponential phase
0.050 Cocaign-Bousquet et al (1996) C. glutamicum ATCC 17965 Batch; Exponential phase
0.130 Cocaign-Bousquet et al (1996) C. glutamicum ATCC 17965 Batch; Exponential phase
0.102
Eggeling and Bott (2005) pp 125, 
Purch et al  (2001)
Rest after 
Phospholipids were 
substracted from 
lipid fraction - 
Literature values 7.5-
8%
C. glutamicum CGL2005 + CGL2022 Exponential Phase
0.028
Hoichen & Cremer (1990) Estimated from data 
of Hoichen & 
Cremer (1990) using 
an average 
molecular weight of 
895 g/mol calculated 
in lipid-section
C. glutamicum ATCC 13032 Early glutamate production phase
0.190 Cocaign-Bousquet et al (1996) C. glutamicum ATCC 17965 Batch; Exponential phase
     Peptidoglycan 0.095
Keddie and Cure (1978);           
Integram et al.  (1983)
50 % of cell wall 
carbohydrates 
(estimation)
C. glutamicum  ATCC 13032  
0.095
 50 % of cell wall 
carbohydrates 
(estimation)
C. glutamicum ATCC 13032  
0.100  Cocaign-Bousquet et al (1996) C. glutamicum ATCC 17965 Batch; Exponential phase
1.000
  
 
 
Protoplast
Component Conditions  
Cell wall Carbohydrates
     Arabinogalactan
     Protein
     DNA
     RNA
Lipids
An overall cellular composition of Corynebacterium glutamium  was found in Cocaign-Bousquet et al.  (1996).  
Biomass biosynthesis equation for synthesis of 1 g biomass:
PROTEIN + 0.010 DNA + 0.05 RNA + 0.028 PHOSPHOLIPID + 0.095 PEPTIDOGLYCAN + 0.095 ARABINOGALACTAN + 0.102 MYCOLICACID + 29.2 ATP + 18.5 ATP   -> BIOMASS + 
29.2 ADP + 29.2 PI + 18.5 ADP + 18.5 PI
     Phospholipids
Reference Comments Organism
     Mycolic acids
Ash
SUM
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Table 2.1. Averaged protein composition:
μmol/g 
DW
MW MWa 
substract
ed water
mg/g 
DCW
mg/g protein μmol/g 
protein
666 89.09 71.09 47.31 96.0 1268
190 175.21 157.21 29.79 60.5 361
387 132.6 114.6 44.29 89.9 736
44 121.15 103.15 4.54 9.2 84
423 147.13 129.13 54.62 110.9 806
317 146.2 128.15 40.56 82.3 603
125 147.13 129.13 16.14 32.8 238
25 146.2 128.15 3.14 6.4 47
353 75.07 57.07 20.12 40.8 671
67 156.16 138.16 9.26 18.8 128
189 131.17 113.17 21.33 43.3 359
351 131.17 113.17 39.72 80.6 669
187 146.19 128.19 23.91 48.5 355
76 149.21 131.21 9.91 20.1 144
128 165.19 147.19 18.84 38.2 244
159 115.13 97.13 15.44 31.3 303
245 105.09 87.09 21.34 43.3 467
273 119.12 101.12 27.56 55.9 519
28 204.23 186.23 5.12 10.4 52
78 181.19 163.19 12.65 25.7 148
273 117.14 99.14 27.07 54.9 520
 492.65 1000.0
19.71
a water is substracted from MW to account for water excretion during peptide bond formation
Table 2.2 Protein composition (Marx et al . (1996):
μmol/g 
DW
MW MWa 
substract
ed water
mg/g 
DCW
mg/g protein mmol/g 
protein
606 89.09 71.09 43.08 83.7 1143
189 175.21 157.21 29.71 57.8 357
399 132.6 114.6 45.73 88.9 753
87 121.15 103.15 8.97 17.4 164
360 147.13 129.13 46.49 90.4 679
147 146.2 128.15 18.84 36.6 277
250 147.13 129.13 32.28 62.8 472
49 146.2 128.15 6.28 12.2 92
361 75.07 57.07 20.60 40.0 681
71 156.16 138.16 9.81 19.1 134
202 131.17 113.17 22.86 44.4 381
440 131.17 113.17 49.79 96.8 830
202 146.19 128.19 25.89 50.3 381
146 149.21 131.21 19.16 37.2 275
133 165.19 147.19 19.58 38.1 251
170 115.13 97.13 16.51 32.1 321
225 105.09 87.09 19.60 38.1 425
275 119.12 101.12 27.81 54.1 519
54 204.23 186.23 10.06 19.5 102
Threonine
Tyrosine
Valine
Energy requirement for polymerisation 
Glycine
Histidine
Isoleucine
Tryptophan
Leucine
Lysine
Methionine
Phenylalanine
Proline
Serine
Tryptophan
Phenylalanine
Proline
Serine
Threonine
Isoleucine
Leucine
Lysine
Methionine
Glutamate-intra
Glutamine-intra
Glycine
Histidine
Asx (asp + asn)
Cysteine
Glutamate
Glutamine
Asx (asp + asn)
Amino acid
Alanine
Arginine
The amino acids composition determined for C. glutamicum MH 20-22B (Continuous culture)  is 
taken from Marx et al. (1996) Energy requirement for polymerisation was taken as for E. coli 
( Neidhardt et al. (1987).
Cysteine
Glutamate
Glutamine
Glutamate-intra
Glutamine-intra
Average amino acids composition determined for C. glutamicum MH 20-22B (Continuous 
culture) (Marx et al . (1996)) and C. glutamicum ATCC 17965 (Cocaign-Bousquet et al. (1996)). 
The pool of intracellular glutamate and glutamine was also included in the protein fraction. 
Energy requirement for polymerisation was taken as for E. coli (Neidhardt et al.  (1987).
Amino acid
Alanine
Arginine
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81 181.19 163.19 13.22 25.7 153
284 117.14 99.14 28.16 54.7 536
 514.42 1000.0
20.37
a water is substracted from MW to account for water excretion during peptide bond formation
Table 2.3 Protein composition (Cocaign-Bousquet et al . (1996):
μmol/g 
DW
MW MWa 
substract
ed water
mg/g 
DCW
mg/g protein mmol/g 
protein
725 89.09 71.09 51.54 109.5 1394
190 175.21 157.21 29.87 63.4 365
374 132.6 114.6 42.86 91.0 719
1 121.15 103.15 0.10 0.2 2
486 147.13 129.13 62.76 133.3 935
486 146.2 128.15 62.28 132.3 935
0 147.13 129.13 0.00 0.0 0
0 146.2 128.15 0.00 0.0 0
344 75.07 57.07 19.63 41.7 662
63 156.16 138.16 8.70 18.5 121
175 131.17 113.17 19.80 42.1 337
262 131.17 113.17 29.65 63.0 504
171 146.19 128.19 21.92 46.6 329
5 149.21 131.21 0.66 1.4 10
123 165.19 147.19 18.10 38.4 237
148 115.13 97.13 14.38 30.5 285
265 105.09 87.09 23.08 49.0 510
270 119.12 101.12 27.30 58.0 519
1 204.23 186.23 0.19 0.4 2
74 181.19 163.19 12.08 25.6 142
262 117.14 99.14 25.97 55.2 504
 470.88 1000.0
19.05
a water is substracted from MW to account for water excretion during peptide bond formation
Protein biosynthesis equation is therefore (in mmol for synthesis of Protein for 1 g Biomass DW):
0.666 ALA + 0.190 ARG + 0.194 ASN + 0.194 ASP + 0.44 CYS + 0.342 GLN + 0.548 GLU + 0.353 GLY + 0.067 HIS + 
0.189 ILE + 0.351 LEU + 0.187 LYS + 0.76 MET + 0.128 PHE + 0.159 PRO + 0.245 SER + 0.273 THR + 0.028 TRP + 
0.078 TYR + 0.273 VAL + 19.71 ATP -> 19.71 ADP + 19.71 PI + PROTEIN
Methionine
Phenylalanine
Proline
Serine
Energy requirement for polymerisation 
Threonine
Tryptophan
Tyrosine
Valine
Amino acid
Alanine
Arginine
Asx (asp + asn)
Isoleucine
Cysteine
Glutamate
Glutamine
Glutamate-intra
Leucine
Lysine
Tyrosine
Valine
Energy requirement for polymerisation 
The amino acids composition determined for  C. glutamicum  ATCC 17965 is taken from 
(Cocaign-Bousquet et al. (1996)) Energy requirement for polymerisation was taken as for E. 
coli (Neidhardt et al . (1987).
Glutamine-intra
Glycine
Histidine
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Table 3. DNA composition:
0.231 313.2 0.748
0.269 289.2 0.871
0.231 304.2 0.748
0.269 329.2 0.871
4.44
DNA biosynthesis equation is therefore (in mmol for synthesis of 1 g DNA):
0.748 DAMP + 0.871 DCMP + 0.748 DTMP + 0.871 DGMP + 4.44 ATP -> 4.44 ADP + 
4.44 PI + 3.238 PPI + DNA
dGMP
Energy requirement for polymerisation (ATP):  
a the molecular weight is the weight of the nucleotide monophosphate substracted 1 water, 
which is lost during esterification
The composition of DNA was calculated from the genomic sequence of C. glutamium 
ATCC 13032, Biedefeld. Energy requirement for polymerisation of triphosphates was from 
Neidhardt et al ., (1987).
dAMP
dCMP
dTMP
Nucleotide mol/mol DNA MW
a, g/mol mmol/g 
DNA
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Table 4. RNA composition:
mRNA rRNA tRNA
5% 75% 20%
0.231 0.227 0.197 329.2 0.221 0.69 0.221
0.269 0.334 0.314 345.2 0.327 1.01 0.327
0.231 0.211 0.272 305.2 0.224 0.70 0.224
0.269 0.227 0.217 306.2 0.227 0.70 0.227 3.10
1.24 1.000 1.00
a the molecular weight is the weight of the nucleotide monophosphate substracted 1 water, which is lost during esterification
 
Energy requirement for polymerisation (ATP):  
RNA biosynthesis equation is therefore (in mmol for synthesis of 1 g RNA):
0.69 ATP + 1.01 GTP + 0.70 CTP + 0.70 UTP + 1.24 ATP -> 1.24 ADP + 1.24 PI + RNA + 3.10 PPI
AMP
GMP
CMP
UMP
It was assumed that RNA consisted of 5% mRNA, 75% rRNA and 20% tRNA (molar). The nucleotide composition of 
mRNA was taken as for genomic DNA. The nucleotide composition of rRNA was calculated from the sequences of 
16S, 23S and 5S ribosomal RNA units. tRNA composition was found from sequences of tRNAs. All the sequences 
were obtained from GenBank (http://www.ncbi.nlm.nih.gov). Energy requirement for polymerisation of triphosphates 
was from Neidhardt et al. , (1987).
Nucleotide
mol/mol RNA MWa, 
g/mol
mol/mol 
RNA
mmol/g RNA   
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Table 5.1 Composition of total fatty acids in C. glutamicum:
Fatty acid g/g total fatty 
acids
MWa, g/mol mmol/g 
total 
fatty 
acids
mol/mol total 
fatty acids
C14 0.005 227 0.02 0.006
C15 0.010 241 0.04 0.011
C16 0.415 255 1.63 0.437
C16:1 0.010 255 0.04 0.011
C18 0.010 281 0.04 0.010
C18:1 0.550 281 1.96 0.526
269 SUM: 1.00
Table 5.2 Phospholipids composition:
Phosphatidyllinositol (PI)
Phosphatidyllinositol mannoside (PIM)
SUM:
Table 5.3 Molecular weights of phospholipids components:
Phosphatidyllinositol (PI)
Phosphatidyllinositol mannoside (PIM)
Average molecular weight:
332
200
200
The two major lipids in C. glutamicum  are phospholipids and mycolic acids. The ratio between the two were 
estimated using the data of Puerch et al . (2001) (22% phospholipids and 78% mycolic acids  of total lipid 
fraction).
Data for the composition of phospholipids was taken from Hoichen & Krämer (1990). Biosynthesis of 
phospholipids components is included in the reaction set. Fatty acids for the biosynthesis are supplied in an 
activated form - conjugated to acyl-carrier protein (ACP), so no additional ATP was included in the reaction.
MW, g/mol
backbone # of fatty acids total
756
The composition of fatty acids was taken from Collins et al (1982)
Average molecular weight:
768
1444
756
756
896
2Phosphatic acid (PA)
Phosphatidylglycerol (PG)
Cardiolipin (DPG)
2
4
2
2
200
212
Phospholipids biosynthesis equation is therefore (in mmol for synthesis of 1 g phospholipids):
0.033 PA + 1.133 PG + 0.007 CL + 0.042 PIT + 0.065 PIM -> PHOSPHOLIPID
0.99
Constituent
0.032 0.042
0.049 0.065
Phosphatidylglycerol (PG) 0.87 1.133
Cardiolipin (DPG) 0.01 0.007
mmol/g 
Phosphatic acid (PA) 0.03 0.033
Component g/g phospholipids
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Table 5.4 Composition of fatty acids in phospholipids:
Fatty acid g/g          
total 
phospholipid
MWa    g/mol
C14 0.003 227
C15 0.000 241
C16:0 0.402 255
C16:1 0.004 253
C18:0 0.010 283
C18:1 0.550 281
SUM 0.969
Average molecular weight: 278 SUM:
a molecular weight without a proton
22%
Fatty acid g/g total fatty 
acids
MWa, g/mol
C14 0.004 227
C15 0.010 241
C16 0.327 255
C16:1 0.009 255
C18 0.008 281
C18:1 0.429 281
341 SUM:
Table 5.6. Mycolic acid composition:
 
0.04
0.03
1.53
0.007 C140ACP + 0.014 C150ACP + 0.437 C160ACP + 0.012 C161ACP + 0.009 C180ACP + 0.521 
C181ACP -> ACP + FREEMYCOLICACID
Free mycolic acid biosynthesis equation is therefore (in mmol for synthesis of 1 g free mycolic acid):
0.521
1.00
mmol/g total fatty acids
0.02
0.04
1.28
0.010
0.544
1.000
mmol/g                   total 
fatty acids
0.01
0.00
1.58
0.02
0.04
1.96
0.004
0.000
0.438
0.004
mol/mol              total 
fatty acids
Mycolic acid biosynthesis equation is therefore (in mmol for synthesis of 1 g mycolic acid):
0.061 TMCM + 0.043 TDCM + 1.875 FREEMYCOLICACID -> MYCOLICACID
No exact data on fatty acid composition of mycolic acids could be found. The composition of fatty acids in 
mycolic acids were considered to be the same as for total fatty acid composition minus fatty acids used for 
phospholidids.
MYCOLIC ACID Free 0.90 480 1.875
Trehalose dicyrynomycolate (TDCM) 0.05 1164 0.043
Trehalose monocyrynomycolate (TMCM) 0.05 822 0.061
Component g/g mycolic acid MW g/mol mmol/g Mycolic 
Table 5.5 Mycolic acids
Average molecular weight:
Data for the composition of mycolic acids was  estimated from from Purch et al . (2001). 
mol/mol total 
fatty acids
0.007
0.014
0.437
0.012
0.009
Phospholipid fraction of total lipid fraction: 
CDPDG + SER <-> CMP + PS
PS -> PE + CO2
Example: phosphatidylethanolamine biosynthesis equations are therefore (in mol):
PA + CTP <-> CDPDG + PPI
GL3P + 0.004 C140ACP + 0.438 C160ACP + 0.004 C161ACP + 0.010 C180ACP + 0.544 C181ACP -> 
AGL3P + ACP
AGL3P + 0.004 C140ACP + 0.438 C160ACP + 0.004 C161ACP + 0.01 C180ACP + 0.544 C181ACP -> PA 
+ ACP
Data for the composition of fatty acids in phospholipids was taken from (Houchen & Krämer (1990)
Molecular weight (mycolic acid with C32) 480
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Table 6.1. Peptidoglycan composition:
Average
MWa, 
g/mol
mmol/g 
peptidogl
ycan
1.0 275 1.026  
1.0 203 1.026
1.0 71 1.026
1.0 154 1.026
1.0 129 1.026
2.0 71 2.052
5.129  
a the molecular weight is substracted water to account for the bond formation
Table 6.2. Arabinogalactan composition:
MWa, 
g/mol
203
162
183
a the molecular weight is substracted water to account for the bond formation
Peptidoglycan is one of the main components of the bacterial cell wall. Its composition is the same as for E. coli , and data was 
taken as from Integram et al.  (1983). This data was corrected so data was for the synthesis of 1 g peptidoglycan. The blocks of 
the glycan chain are supplied in the activated form (UDP-NAG and UDP-NAM), therefore energy is needed only for the 
pentapeptide formation (ATP -> ADP per mol of amino acid joined). Half of the alanine in the peptidoglycan was assumed to be 
D-alanine. D-alanine joins the growing amino acids chain as D-alanyl-D-alanine. The fifth D-alanine residue is cleaved 
extracellularly to allow bond formation between diaminopimelinic acid and the fourth residue (Integram et al.  (1983)). 
Component
molar ratio in peptidoglycan:
  
N-acetylmuramic acid 1   
N-acetylglucosamine 1   
L-Alanine 1   
Diaminopimelinic acid 1   
D-glutamate 1   
D-Alanine 2   
4.650
0.498
Energy requirement for polymerisation (ATP):  
Peptidoglycan biosynthesis equation is therefore (in mmol for synthesis of 1 g peptidoglycan):
1.106 UDPNAM + 1.106 UDPNAG + 1.106 ALA + 1.106 MDAPIM + 1.106 DGLUTAMATE + 2.052 ALAALA +  
4.426 ATP -> PEPTIDOGLYCAN + 4.426 ADP + 4.426 PI + 1.106 UDP + 1.106 UMP + 1.026 ALA
The cell wall carbohydrates composition was assumed to be identical to C. glutamicum  CGL2005 (Puech et al 
(2001)). The polysaccharide is made from activated building blocks, therefore there is no need for additional ATP 
during polymerisation.
5.147
Arabinogalactan biosynthesis equation is therefore (in mmol for synthesis of 1 g Arabinogalactan):
0.498 UDPGAL + 4.650 UDPARA -> 5.148 UDP + ARABINOGALACTAN
Molar ratio
9
1
Component
Arabinose
Galactose
mmol/g 
carbohydrate
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Table 7.1. Energy requirement for polymerisation of macromolecules:
Process Energy reqirement
Protein synthesis and processing (mmol ATP ⋅  (mmol aminoacid) -1 )
Activation and incorporation 4.0
mRNA synthesis 0.2
Proofreading 0.1
Assembley and modification 0.006
SUM 4.306
RNA synthesis and processing (mmol ATP ⋅  (mmol RNA) -1 )
Discharging segments 0.38
Modification 0.02
SUM 0.40
DNA synthesis and processing (mmol ATP ⋅  (mmol DNA) -1 )
Unwinding helix 1.0
Proofreading 0.36
Discontinous synthesis 0.006
Negative supercoiling 0.005
Methylation 0.001
SUM 1.372
Energy requirements for polymerisation of macromolecules was estimated using 
values from E. coli  (Neidhardt et al . (1987))
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